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Protein ligand interaction is a fundamental question in biology and biochemistry, and many
approaches including X-ray crystallography, nuclear magnetic resonance, cryogenic electron
microscopy, mass spectroscopy (MS), infrared spectroscopy, circular dichroism, fluorescence
spectroscopy and many others have been applied to address this question. Among these techniques,
mass spectroscopy has the advantage of high throughput, low sample amount requirement, and
mid-to-high spatial resolution. One of the MS-based approaches is protein footprinting, which
utilizes labeling reagents to map the solvent accessible surface of the protein of interest thus deliver
structural information. Irreversible labeling is represented by covalent labeling and radical
labeling, in which labeling reagents react with amino acid side chains. Reversible labeling, on the
other hand, is represented by hydrogen deuterium exchange (HDX), allowing the analysis of
protein backbone. This dissertation describes the development of mass spectrometry-based
approaches for protein higher order structure analysis, with an emphasize on the characterization
of protein-ligand interaction analysis. The dissertation is divided into seven chapters, five of them
describe original research. The first chapter introduces the mass spectrometry-based protein
xx

footprinting for protein higher order structure analysis, including historical overview, basic
principles, major applications, and recent advancements.
Chapter 2 and 3 describes a novel mass spectrometry-based method, LITPOMS, which combines
ligand titration, fast photochemical oxidation of proteins (FPOP), and mass spectrometry
measurements to assess protein ligand binding stoichiometry, binding sites, binding orders,
affinities, and allosteric behaviors. The method was first demonstrated by melittin – holocalmodulin binding, whose binding stoichiometry is 1:1 (Chapter 2). Chapter 3 describes an
application of the LITPOMS in characterizing the calcium-calmodulin binding system. As a result,
the calcium binding sites, binding orders, site-specific binding affinities, and most importantly the
allosteric behavior of calmodulin upon binding with calcium was revealed via a single experiment.
Chapter 4 highlights a mechanistic study of FPOP chemistry, through selective
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O labeling

coupled with mass spectrometry analysis, and revealed the amino acid-specific oxygen uptake
pathways in the FPOP platform and further highlighted the potential of tailoring the FPOP labeling
condition to address different biological questions.
Chapter 5 and 6 report application of HDX in addressing novel biological questions. Chapter 5
presents a thorough analysis of tetraspanin CD53 and CD81 with their binding partners and
revealed the importance of tetraspanin open conformation in facilitating the interaction network.
Chapter 6 describes an HDX study of the interaction between Class II lanthipeptide synthetase
HalM2 with its partner HalA2-LP. Through a two-temperature HDX workflow, the confidence of
binding site assignment increases significantly, especially for weak binding systems.
The last chapter highlights the perspective and future work. These chapters combine to
demonstrate the scope of developing and adopting mass spectrometry-based approaches to
characterize protein-ligand interactions.
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Chapter 1: Mass Spectrometry-Based Strategies in
Protein Higher Order Structure Analysis: Fast
Photochemical Oxidation of Proteins and Hydrogen
Deuterium Exchange
This Chapter is based on the following publications:
Liu, X. R.; Zhang, M. M.; Gross, M. L. Mass Spectrometry-Based Protein Footprinting for HigherOrder Structure Analysis: Fundamentals and Applications Chem. Rev. 2020, 120, 4355-4454.
Liu, X. R.; Rempel, D. L.; Gross, M. L. Protein Higher Order Structure Determination by Fast
Photochemical Oxidation of Proteins and Mass Spectrometry Analysis Nat. Protoc. 2020,
Accepted.
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1.1 Abstract
Proteins adopt different higher-order structures (HOS) to enable their unique biological functions.
Understanding the complexities of protein higher-order structures and dynamics requires
integrated approaches, where mass spectrometry (MS) is now positioned to play a key role. One
of those approaches is protein footprinting. Although the initial demonstration of footprinting was
for the HOS determination of protein/nucleic acid binding, the concept was later adapted to MSbased protein HOS analysis, through which different covalent labeling approaches “mark” the
solvent accessible surface area (SASA) of proteins to reflect protein HOS. Hydrogen–deuterium
exchange (HDX), where deuterium in D2O replaces hydrogen of the backbone amides, is the most
common example of footprinting. Its advantage is that the footprint reflects SASA and hydrogen
bonding, whereas one drawback is the labeling is reversible. Another example of footprinting is
by reactions with fast, irreversible labeling species that are highly reactive and footprint broadly
several amino acid residue side chains on the time scale of submilliseconds. All of these covalent
labeling approaches combine to constitute a problem-solving toolbox that enables mass
spectrometry as a valuable tool for HOS elucidation.

1.2 Introduction
Proteins carry out the programmed activities encoded by genes. Although constructed by the
polymerization of only twenty distinct amino acids, their numerous biological functions require
the high diversity arising from sequence variations and post-translational modifications. As living
organisms evolve, proteins acquire specialized abilities that can be organized into different
functional classes1: enzymes catalyze different intracellular and extracellular reactions; structural
proteins provide support and maintain the structural rigidity of the cell; transport proteins facilitate
trans-membrane flow of certain materials; regulatory proteins work as sensors and switches to
2

regulate gene expression and protein activities; motor proteins facilitate macroscopic movements;
and signaling proteins transduce messages to facilitate the communication of different cellular
components. Despite high functionality and diversity, a protein’s biological function and
corresponding mechanisms of action are determined by their three-dimensional (3D) structure that
is encoded in its primary sequence as demonstrated through the famous ribonuclease refolding
experiment.2 The exploration of protein structure-function relationship at the molecular level has
developed into an independent subject named structural biology, for which characterization of
protein higher order structure (HOS) is the goal.

1.2.1 Protein Higher Order Structures

Figure 1.1. Four orders of protein structure exemplified by human deoxyhemoglobin (PDB ID
2HHB3).
The understanding of protein HOS is a key topic in biology because the functional mechanisms of
proteins are encoded in their 3D structures. Protein structure can be viewed as having four distinct
orders (Figure 1.1).1, 4 Primary structure refers to a linear combination of amino acids into a
polymeric chain, which was first proposed in 1902.5 Although originally heavily debated, its
3

importance was settled after Sanger and coworkers6, 7 first sequenced insulin. The consensus is
that protein primary sequence is determined by genetic information encoded in nucleic acids; that
genetic information is translated into the order or sequence of the 20 common amino acids in a
protein. The principal means of determining primary structure of proteins has become MS-based
sequencing or proteomics analysis.
Upon forming linear polymeric chain, proteins fold to yield local structures including α-helices, βsheets, β-turns, Ω-loop, etc. with the first two being most common. Such local ordering represents
the secondary structure of proteins.
Tertiary structures of proteins are their overall 3D structures that result from the folding of the
secondary structural components and other unstructured motifs. Although many proteins function
individually, there are others that are not biologically active until they interact with other proteins
or ligands, and these interactions give rise to quaternary structure. An overall 3D structure of a
protein complex that contains multiple protein subunits comprises tertiary structure. The term
“protein higher order structure” often refers to the secondary, tertiary and quaternary structures of
a protein. This is the subject of “structural proteomics”, and protein footprinting is a key
component of the subject.
Besides the covalent peptide bonds that assemble amino acid building blocks into primary
sequence, non-covalent interactions stabilize protein HOS: these interactions include hydrogen
bonding,8, 9 charge-charge interactions (salt bridge),10, 11 hydrophobic interactions,12, 13 aromaticaromatic interactions (π-π stacking),14 cation-π interactions,15 and Van der Waals forces16. There
is also a covalent contributor that stabilizes protein HOS, namely disulfide bonds.17, 18 All these
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forces work together to overcome the conformational entropy of protein folding (decrease in
entropy from random coil to folded protein) and to stabilize a protein in its folded state.19-21

1.2.2 Biophysical Approaches for Characterizing Protein Higher Order
Structure
In 1958, Sir John Kendrew22 first reported the high-resolution structure of sperm whale myoglobin
by X-ray crystallography, for which he shared the 1962 Nobel Prize in Chemistry with Max
Perutz23 for their studies of the structures of globular proteins. Their contributions are a milestone
in the field of structural biology, opening the field to pursuits of protein HOS.

Figure 1.2. A summary of commonly used biophysical tools for characterizing protein HOS.
Protein structure exemplified by calcium-free bovine calmodulin (PDB ID 1CFD24)
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After decades of development, X-ray crystallography and nuclear magnetic resonance (NMR)
became the “gold standard” for determining protein HOS. The interaction of an ordered protein
crystal with X-ray radiation causes the incident beam to diffract. By measuring their diffraction
angles and intensities, it is possible to obtain a 3D electron density map of a crystal, from which
the protein 3D structure is constructed at atomic resolution.25 X-ray crystallography provides
atomic-level resolution of various protein sizes, making it to be the most widely accepted
spectroscopic approach that provides the most definitive information on protein HOS to date
although Cryo-EM will challenge it. Its disadvantage is obvious as well; a crystalized protein
sample is a must, and protein crystallization has always been challenging. 26, 27 Moreover, X-ray
crystallography provides a solid-state structure of proteins, posing concerns about whether proteins
alter their structures upon crystallization as compared with their structures in solution or in vivo.28,
29

NMR resolves protein structure by determining chemical shifts and structural restrains.30-32 The
development of multi-dimensional NMR (pioneered by Richard Ernst, who was awarded the 1991
Nobel Prize in Chemistry for his contributions to high resolution NMR) allowed protein structures
to be determined with near-atomic resolution by employing structural restraints obtained from
homo-nuclear and hetero-nuclear couplings.33,

34

Solution NMR for determining protein 3D

structures was pioneered by Kurt Wüthrich,35, 36 who was later recognized with the 2002 Nobel
Prize in Chemistry. Solution NMR determines the liquid-state protein structures, which should
resemble native states in the absence of interactions with proteins, ligands, and salts. Although
mainly applicable to small proteins, recent work demonstrates that in special cases, the approach
can accommodate protein molecular weights up to 1 MDa.37
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Another unique feature of solution NMR is its ability to measure protein dynamics in solution,
which is not easily accessible at high resolution by other techniques.38 For those proteins that are
not readily soluble, membrane39 and fibril40 proteins for example, solid-state NMR contributes
significantly.41, 42 The “dark side” of NMR-based protein structural elucidation is the sample
amount, which is generally on the order of milligrams. The data acquisition and analysis are also
time-consuming and labor intense. Some proteins cannot maintain their structure for long dataacquisitions and signal averaging.
X-ray crystallography and NMR have distinct advantages and drawbacks, but they complement
each other.43, 44 As two of the most important pillars in protein HOS elucidation, the combination
has contributed over 97 % of high resolution protein structures in Protein DataBank (PDB).45
Another emerging technique in high-resolution protein HOS elucidation is cryogenic electron
microscopy (Cryo-EM), whose name is self-explanatory (EM at cryogenic temperature).46, 47 Upon
snap-freezing the sample at cryogenic temperature, water molecules in the sample remain
amorphous, thus minimizing distortion of the protein structure.48 Damage by the electron beam to
the sample is minimized by the cryogenic temperature.49 The ability to average multiple randomlyaligned EM pictures accelerated the development of Cyro-EM.50 These factors combined to enable
structural determination of proteins with high-resolution. An early electron crystallographic study
by Henderson and coworkers51 demonstrates the capability of cryo-EM for determining membrane
protein structure with near-atomic resolution (< 4 Å). Continued technical advances allow singleparticle cryo-EM to characterize non-crystalline samples52, 53 and determine protein structures with
atomic resolution (to 1.8 Å)47, 54. Cryo-EM is also capable of characterizing protein complexes55,
56

and membrane proteins57. As cryo-EM generally favors proteins with high molecular weights,58

recent advances made possible the characterization of proteins with sizes < 100 kDa54. Its
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requirements of low sample amount, straightforward sample preparation, and high structural
resolution make it the “rising star” in structural proteomics.46, 47 With X-ray crystallography and
NMR, these three methods are the basis for determining protein structure with the highest
resolution.
In addition to the high-resolution approaches, there are others including mass spectrometry (MS)
that can characterize the proteins with lower resolution. Circular dichroism (CD)59, 60, Ultra-violet
(UV) resonance Raman61 and Fourier transform infrared spectroscopy (FT-IR)62, 63 can provide a
general or overall characterization of protein secondary structure without providing atomic
coordinates. UV at 280 nm is most commonly used in fast quantification of protein concentrations
but contributes little to structure.64 Fluorescence and Fӧrster Resonance Energy Transfer (FRET)
specialize in probing protein-protein interactions and protein conformational changes for regions
of a protein.65-67 There are other approaches that characterizes the protein from a global
perspective, including dynamic light scattering68,

69

and its coupling with size exclusion

chromatography70 to focus on the hydrodynamic radius of proteins, negative staining electron
microscopy71, 72 and atomic force microscopy, which examine the morphologies of proteins,73
isothermal titration calorimetry, which discloses the thermodynamic properties of proteins,74, 75
surface plasmon resonance, which measures the kinetic properties of proteins upon interacting
with others,76, 77 and others. All these techniques combine to provide a biophysical toolbox for
protein HOS elucidations; they are summarized schematically in Figure 1.2.
In addition to these biophysical approaches, computer modeling also plays a significant role in
understanding protein HOS.78-80 Early ideas of structural prediction were developed in the 1960s,81,
82

but it was not until 1974 that the first structural prediction algorithm was actually developed.83

These demonstrations were restricted to secondary structure predictions owing to limited
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computing power and mechanistic understanding of protein folding. Later on, with higher
resolution, protein 3D structures could be resolved, and template-based modeling (or homology
modeling) became possible where available high-resolution structures serve as scaffolds when
predicting HOS of unknown proteins.79, 84, 85 Free modeling (ab initio), on the other hand, predicts
protein HOS from scratch,86, 87 and feasibility was first demonstrated in 2005.88 Thanks to the
development of computational approaches and bioinformatics, protein HOS prediction has
developed into an independent research subject and is contributing more and more to the structural
biology.89, 90
Each of these biophysical approaches has both advantages and disadvantages. The throughput of
X-ray crystallography and NMR is limited by the protein crystallization and data acquisition,
respectively. Some NMR analyses also require selective isotopic enrichment and mg levels of
sample, whose preparation is both labor and cost unfriendly. NMR is challenged by large proteins.
Most protein samples require considerable signal averaging, and this can compromise the integrity
of sensitive proteins. The structure from X-ray crystallography is solid-state and may be different
than that in solution, where biochemistry occurs. Further, highly flexible regions diffract poorly
and are not seen, but can be tracked by footprinting. This limitation is particularly serious for
intrinsically disordered proteins. Cryo-EM seems to overcome the throughput limitations;
however, its broad adoption in analyzing small proteins remains to be established, and the
resources are insufficient in number and expensive as of this writing.
Optical approaches including CD, FT-IR, FRET, UV resonance Raman, etc. usually give high
throughput. On the other hand, these approaches report on either global properties (e.g., alpha
helical content in secondary structure from CD) or on the protein region near a label (e.g.,
fluorophore, donor/acceptor chromophore in FRET) and do not produce high-resolution spatial
9

information. Although IR and Raman can give more specific information, they usually fail in
probing a complete structure, particularly of large proteins and protein complexes. All these
limitations motivate the development of MS-based approaches for HOS analysis, as they fill in the
gap by balancing the throughput and spatial resolution. This chapter will provide a brief overview
of the history of MS-based approaches for protein structural analysis and the modern MS-based
protein footprinting approaches for HOS elucidation. Later chapters report technical advancements
and deeper understandings of protein footprinting methods and their application in addressing
novel biological questions, for which overview in this chapter provides a solid introduction.

1.2.3 Mass Spectrometry-Based Protein Structure Analysis
To analyze a protein molecule in a mass spectrometer, ionization is the first step. The MS-based
ionization methods were extensively developed starting in the 1960s and continuing in the 1990s;
key developments include chemical ionization,91 electrospray ionization (ESI),92 field
desorption,93 laser desorption,94,

95

Californium-252 plasma desorption,96 secondary ion mass

spectrometry,97 fast atom bombardment,98,

99

matrix-assisted laser desorption ionization

(MALDI)100, 101 and many more. Several of these techniques involved sample desorption; that is,
MALDI and its precursor laser desorption, plasma desorption (PD),102,

103

and fast atom

bombardment (FAB).104 The latter was extensively used for over nearly two decades (from 1980
to 2000) for studies of peptides and small proteins. Many of these approaches are vital steps in the
long evolution of ionization methods, but none work as well as ESI or MALDI. PD preferentially
ionizes the molecules on the surface of support, and its efficiency is low and affected by the
homogeneity of the surface layer. FAB is a relatively hard ionization method with low ionization
efficiency and a relatively high “chemical-noise” background and a propensity to fragment
proteins upon desorption, limiting its use to peptides and small proteins.
10

Although FAB and PD convincingly demonstrated that proteins are amenable to MS analysis, the
ionization scene improved significantly with two separate but complementary breakthroughs. In
1988, Tanaka and coworkers105 improved MALDI by incorporating 30 nm cobalt particles to
ionize successfully lysozyme and chymotrypsinogen and to obtain their masses while Hillenkamp
and Karas106 were simultaneously developing the MALDI protocol that is used today, moving
systematically from peptides to proteins. Meanwhile, Fenn107, 108 developed ESI and successfully
ionized various proteins, showing that multiple charging brings the m/z of the ions into a mass
range of most mass spectrometers where analysis was possible.
These two developments, particularly ESI, allow MS to become the enabling tool in the field of
proteomics and subsequently in protein HOS analysis; these methods joined as some of the most
important biophysical tools in structural biology. Their efforts led to awards of the 2002 Nobel
Prize in Chemistry to Koichi Tanaka and John Fenn, shared with Kurt Wüthrich (in the field of
protein NMR), for their contribution in “the development of methods for identification and
structure analyses of biological macromolecules”. Among these two methods, ESI (and later nanoESI109, 110) has become more extensively used in proteomics and HOS structure analysis owing to
its capability to install multiple charges in the analyte, its ease in setup, and most importantly its
compatibility with liquid chromatography (LC), uniting in a concatenated way separation and
analysis.
Besides development of ionization methods, development of MS instrumentation also greatly
elevated the detection limit and resolving power, empowering MS to work with larger proteins and
deliver protein structural information with high mass resolving power. The advances in mass
analysis show an evolutionary thread that included quadrupole mass filters,111 double-focusing
sector mass spectrometers;112,

113

both evolved into three114 and four115 (and even more116)
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analyzers for tandem-MS (MS/MS). Time-of-flight (TOF) instruments profited from
developments of straight,117 reflectron,118 and orthogonal119 TOF mass analyzers. Complementing
and possibly exceeding them are quadrupole ion traps,120 Fourier-transform ion cyclotron
resonance (FTICR) instruments,121 and more recently orbitrap mass analyzers122, 123. Modern MS
instruments are almost exclusively hybrid instruments that contain two or more different mass
analyzers (represented by quadrupole-TOF124 and quadrupole-orbitraps125), allowing rapid,
accurate, and precise mass determination of both precursor and product ions, a long sought-after
goal in MS.
The use of MS in protein HOS analysis depends not only on the accurate measurement of the massto-charge ratio (m/z) but also on fragmentation methods that cleave the peptide backbone to
provide sequence information that can locate sites of modification introduced as a protein
footprint.126 MS-based ion fragmentation required the introduction of collision induced
dissociation (CID) and then tandem instruments, establishing the area of MS/MS.126-128
Owing to its rich history and high popularity at the time that peptides and proteins were first
ionized, it is not surprising that CID was soon developed as a method for to sequence peptides and
to apply these ionization advances to unknowns.129-131
Over the years, different fragmentation methods including surface induced dissociation (SID),132,
133

electron transfer dissociation (ETD),134 electron capture dissociation (ECD),135 electron

detachment dissociation (EDD),136 ultraviolet photodissociation (UVPD),137,

138

infrared

multiphoton dissociation (IRMPD)139 were developed as means of activating peptides and proteins
and causing them to fragment. Their unique characteristics, advantages and limitations were
reviewed in detail elsewhere.126, 140
12

MS contributes to peptide and protein determination at all four levels of structure.141 The primary
structure of a protein can be determined through MS/MS based de novo sequencing or partial
sequencing and database searching.142 Although protein sequencing was expedited mainly by
sequencing its corresponding genome, there are still needs to sequence a protein when its
corresponding genome is unknown or the sequence requires verification. MS/MS-based
sequencing has become the nearly exclusive route to primary structure, replacing Edman
degradation owing to the accuracy, certainty, and speed of MS.143 In addition to sequencing, the
MS/MS approach also enables profiling of post translational modifications by following shifts in
m/z that pinpoint the modification type.144-148 Indeed, this capability is the basis for protein
footprinting where finding the location of a chemical modification introduced purposely is the
means of determining protein footprints that are indicative of HOS.
Footprinting probes secondary and tertiary structure by mapping solvent-accessible surface area
(SASA) through various covalent-labeling approaches including hydrogen/deuterium exchange
(HDX). Some view HDX as a “non-covalent” approach and not consider it as “footprinting”, but
we take issue with this classification because N-H and N-D bonds, although reversible, are
covalent, and the pattern of peptide N-H and N-D bonds is a “footprint.” Nevertheless, there are
examples of non-covalent footprinting ,149 but the adoption is far less than of those approaches
involving covalent bonds.
Quaternary structures are often characterized by differential footprinting that locates the contacting
region by responding to changes in SASA for two different states (e.g., bound and unbound).
Native spray MS, a gentle version of ESI that uses aqueous media, can maintain the non-covalent
interactions in the gas phase to yield information on topology and stoichiometry but not on
interface.150-154 Ion mobility MS reports protein shape, a component of HOS, in the gas phase.15513

157

Chemical crosslinking, an in-solution approach, is now extensively used to provide some

information on protein quaternary structures and to locate interfaces.158-160 All these approaches
are the analytical basis for MS-based structural proteomics and provide higher order structure
information, although not as detailed as that from NMR, X-ray crystallography, and Cryo-EM.
Over the years, two distinct categories of covalent labeling approaches have been developed and
applied: reversible and irreversible. Reversible labeling is represented by HDX, which takes
advantage of the hydrogen exchange between active hydrogens in the protein molecule and the
hydrogen in the water solvent.161 Upon dissolving a protein in deuterium oxide (D2O), solventaccessible and weakly H-bonded hydrogen atoms in the protein will exchange with deuterium
atoms in the solution, where mass differences between hydrogen (1.0078 Da) and deuterium
(2.0136 Da) atoms serve as useful indicator for a mass spectrometer to report such exchanges.
Although the exchanged H or D in backbone are covalently bonded in the protein, the exchange
process is highly dynamic and reversible. Thus, for ex situ methods like MS, protein HDX needs
to be performed under constrained conditions to prevent back exchange, which would quickly
“erase” the footprint, and preserve the structural information from the labeling. Details about
protein HDX will be covered in chapter 1.4.
Another category is irreversible protein labeling. Labeling reagents generally react with solvent
accessible amino acid side chains, leaving a chemical “mark” that can be identified in a
forthcoming analysis. Nature already does elegant protein labeling; that is, by post translational
modifications (PTM).144, 162, 163 Mainly enzymatic processes introduce certain functional groups to
incorporate proteins to modify them, often by adding or subtracting charges, so that new biological
functions can be enabled by changing the conformation and the binding opportunities of a
protein.164
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Inspired by nature’s use of PTMs, investigators have developed different chemical reagents that
irreversibly label solvent accessible surface areas of proteins. One sub-class of reagents that are
readily available today are targeted reagents that react with only certain amino acid residues with
high specificity but low reaction rates.165 An example is acetylation of lysine or esterification of
aspartic acid. The second category includes fast labeling reagents, mostly radical species, which
are highly reactive but have lower specificity.166 The advantage of irreversible labeling is that
sample handling and post-labeling analysis can be slower and more efficient and effective than
that of HDX, taking full advantage of all the separation advances made in proteomics. The different
labeling timescales allow irreversible labeling to address several biological questions that are not
amenable to HDX.

1.3 Fast Photochemical Oxidation of Proteins (FPOP)
1.3.1 Hydroxyl Radical – The Labeling Reagent
Hydroxyl radical (●OH) was initially used for nucleic acid footprinting, where it reacts with solvent
accessible hydrogens in deoxyribose (DNA) and ribose (RNA), cleaving their nucleic acid
chains.167 The motivation is to footprint nucleic acids, to reveal their SASA and determine their
HOS, and to map protein DNA/RNA interactions. Later, the idea was extended to protein
footprinting. For DNA/RNA footprinting, the approach is based on selective cleavages, whereas
with protein footprinting, the approach is based on chemical modifications. Today, ●OH has
become the most used fast labeling reagent.
The hydroxyl radical is a naturally occurring reactive oxygen species (ROS) that participates in
several cycles that regulate several physiological functions of living organisms.168-170 Early studies
identified the important signaling role of ●OH in regulating several physiological functions of
living organisms, especially its contribution to retrograde redox signaling from organelles to the
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cytosol and nucleus.168, 170 The size and hydrophilicity of ●OH are similar to those of the water
molecule,171 allowing it to probe the SASA of biomacromolecules (to travel where water can
travel). The oxidative damage in many pathologies caused by ●OH naturally and in radiation
damage attracted early attention, motivating determination of its rate constants166,

172

and

mechanisms173 in amino acid reactions. The reaction rate constants between ●OH and free amino
acids range from 1.7 × 107 to 3.5 × 1010 M-1s-1 with preference toward aromatic, heterocyclic and
sulfur-containing sidechains (Table 1.1). The broad residue coverage in ●OH reactions contrast
significantly with the targeted or specific labeling reagents covered above. The early fundamental
studies, likely driven by radiation concerns, form a solid foundation for the use of ●OH in protein
footprinting, contributing to its growing applications.
Table 1.1. Rate constants for reactions between amino acids and ●OH166, 172
Substrate

Rate Constant (M-1s-1)

pHa

Substrate

Rate Constant (M-1s-1)

pHa

Cys

3.5 × 1010

7.0

Pro

6.5 × 108

6.8

Trp

1.3 × 1010

6.5 – 8.5

Gln

5.4 × 108

6.0

Tyr

1.3 × 1010

7.0

Thr

5.1 × 108

6.6

Met

8.5 × 109

6–7

Lys

3.5 × 108

6.6

Phe

6.9 × 109

7–8

Ser

3.2 × 108

~6

His

4.8 × 109

7.5

Glu

2.3 × 108

6.5

Arg

3.5 × 109

6.5 – 7.5

Ala

7.7 × 107

5.8

cystine

2.1 × 109

6.5

Asp

7.5 × 107

6.9

Ile

1.8 × 109

6.6

Asn

4.9 × 107

6.6

Leu

1.7 × 109

~6

Gly

1.7 × 107

5.9

Val

8.5 × 108

6.9
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a

“pH” indicates the conditions where the rate constants were measured

1.3.2 Generating ●OH in Solution – FPOP and Others
The generation of ●OH has a long history, during which many different methods were developed.
Early approaches made use of

●

OH-induced protein backbone cleavages,167 similar to those in

nucleic acid footprinting. Upon cleavage, gel electrophoresis was used to determine the cleavage
sites. Low cleavage efficiency, lack of accurate mass determination, and low precision greatly
limit the further development of such an approach; thus, it will not be covered in detail.
1.3.2.1 Fenton and Fenton-like Chemistry
The catalytic property of Fe(II) in promoting the oxidation of tartaric acid by hydrogen peroxide
(H2O2) was first reported by Fenton in 1894.174 Later on, Cu(I), Ti(III), Co(II) and Cr(III) were
found to behave similarly.175-178 Such processes were later called Fenton reactions. Although it
was supposed that ●OH is the key reactive species in Fenton chemistry, it was not well established
until Haber and Weiss179, 180 first proposed a chain reaction mechanism in 1932. The understanding
of the mechanism was later expanded by Barb and coworkers181, 182, and it is now referred to as
the “classical Fenton pathway”, as summarized in Eq. 1.1-1.7 below.
Fe2+ + H2O2 → Fe3+ + ●OH + OH- (1.1)
Fe3+ + H2O2 → Fe2+ + HO2● + H+ (1.2)
H2O2 + ●OH → HO2● + H2O (1.3)
HO2● ↔ O2-● + H+ (1.4)
Fe3+ + HO2● → Fe2+ + O2 + H+ (1.5)
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Fe3+ + O2-● → Fe2+ + O2 (1.6)
Fe2+ + ●OH + H+ → Fe3+ + H2O (1.7)
In Fenton chemistry, ●OH is generated by oxidation of Fe(II) and Fe(III) with H2O2 (Eq. 1.1 and
1.2). This chemistry is not optimum for footprinting biomacromolecules. For example, the reaction
has an optimal rate at pH of 3 – 4,181, 182 which is clearly denaturing for many biomolecules. Under
physiological conditions, however, Fe(III) readily precipitates.
In 1985, Tullius and Dombroski183-185 proposed an elegant system that utilizes Fenton chemistry
to map DNA-protein binding sites. By incubating Fe(II)-ethylenediaminetetraacetic acid (Fe(II)EDTA), H2O2, and ascorbate with DNA, they achieved an effective footprint after a few minutes.
The approach exploits Fenton chemistry in two ways. First, with EDTA as chelators for Fe(II) and
Fe(III), the solubility of these ions under physiological pH increases significantly. EDTA also
minimizes the binding of these ions to biomacromolecules and increases their catalytic
efficiency.186 Second, ascorbate can reduce Fe(III)-EDTA back to Fe(II)-EDTA, fulfilling a cycle.
Thus, the Fe(II-EDTA)/H2O2/ascorbate Fenton system had become the usual approach for
footprinting, and it was applied in many subsequent DNA footprinting studies.187
For protein footprinting, the system was first applied to footprint cAMP receptor protein under
backbone-cleavage conditions by Heyduk and coworkers188 in 1994, and then by Sharp and
Hettich189 in 2003, who extended oxidative labeling to apo-myoglobin by using ●OH to map amino
acid side chains as a measure of their SASA. A more recent variation on this theme by Monroe
and Heien190 combines electrochemistry with this classical reaction in which an electrical flow cell
was used to reduce Fe(III) to Fe(II), thus completing a cycle. Footprinting of ubiquitin
demonstrated the efficacy of such method in probing protein SASA.
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Scheme 1.1. Structure of Fe-BABE

Another powerful approach using Fenton chemistry was first demonstrated by Rana and Meares191193

in 1990. As a replacement of Fe(II)-EDTA in a classical Fenton system, they synthesized a

novel class of reagents represented by Fe-(S)-1-(p-bromoacetimidobenzyl)-EDTA (Fe-BABE).
Fe-BABE is composed by three structural units (Scheme 1.1), a metal-chelating unit that binds
with reactive metal centers to facilitate ●OH generation, a sulfhydryl reactive unit that reacts with
cysteine residues on proteins, and a linker separating them. The design localizes the Fe-BABE in
a specific position of a protein. Upon incubating with H2O2, ●OH is only generated in close
proximation with the localized metal center. Fe-BABE has the advantage of high conjugation rate
with proteins, high anchoring yield, and compatibility with neutral pH, making such site-directed
●

OH footprinting effective in probing spatial relationship in protein-nucleic acid194-196 and protein-

protein197 complexes. Very recently, this approach was adopted for characterizing proteincarbohydrate interactions.198
Fenton chemistry is probably the most easily accessible method for ●OH protein footprinting, as it
can be achieved without the help of sophisticated instruments. The biological relevance of iron
makes it “friendly” with most biological systems, as demonstrated by in-cell footprinting of the
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membrane protein porin OmpF.199 Moreover, given that multiple reactive metal centers can initiate
Fenton-like reactions, successful ●OH protein footprinting can be achieved by using Co(II),200
Cr(III),200 Ni(II),201 Cu(II)202,

203

, and Mn(II)/Mn(III) for generating ●OH upon reaction with

H2O2.177 This general property makes Fenton-like chemistry worth considering to footprint
proteins that bind to these active metal centers.
On the other hand, ●OH generation by Fenton chemistry usually takes minutes, during which the
protein may get over labeled and alter its conformation during the footprinting owing to the
changes in hydrophilicity or perhaps to some modification of amino acid residues with low
SASA.204 Once the protected region becomes exposed, additional ●OH can further label the newlyexposed sites, generating a misleading readout. Newer ●OH generation approaches usually label
proteins on the time scale of milliseconds or less to minimize over labeling. Although a subsequent
study employing Fenton chemistry achieves a steady ●OH concentration at 2 ms, the amount of
H2O2 (30%) required is certainly stressful to most biomacromolecules.205
1.3.2.2 Synchrotron Water Radiolysis
A synchrotron X-ray source is capable of delivering a continuous spectrum of 1014 – 1015 photons
per second with energies ranging from 5 to 30 kV.206 Implemented by Chance and coworkers207209

, synchrotron-based ●OH footprinting was first demonstrated for nucleic acids and later for

proteins210. The latter initiates the modern era for protein footprinting by fast-labeling reagents
because, for the first time, the labeling timescale was reduced to milliseconds.171 Mechanistically,
synchrotron X-rays utilize water as the ●OH precursor. High energy photons ionize water to
produce hydrated electrons (eaq-) and activated water (H2O*), and these initiate the subsequent
reactions as summarized in Eq. 1.8-1.10 below.166
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2H2O + e- (ionizing irradiation) → H2O+● + H2O* + eaq- (1.8)
H2O+● + H2O → ●OH + H3O+ (1.9)
H2O* → ●OH + H● (1.10)
Besides labeling solvent-accessible amino acid side chains in the protein, ●OH undergoes
quenching reactions owing to its high reactivity. Under anaerobic conditions, primary quenching
is a self-recombination at a diffusion rate limit (Eq. 1.11-1.12).211
●

OH + eaq- → OH- (1.11)

2●OH → H2O2 (1.12)
Under aerobic conditions, oxygen is involved in the quenching process, leading to other ROS (Eq.
1.13-1.14).
eaq- + O2 → O2-● (1.13)
H0● + O2 → HO2● (1.14)
In subsequent studies, ●OH dosimetry, the effects of different buffers, different beam currents and
other additives in the system were thoroughly investigated.212 These efforts were comprehensively
reviewed elsewhere.166
Synchrotron-based water radiolysis has significant advantages in protein footprinting, as it utilizes
water as ●OH precursor. Water concentration is ~55 M, and it is not limiting. Although water
interacts with proteins, there are many more molecules that constitute bulk, and this may not be
the case for other radical sources that are at lower concentrations. More importantly, water is the
medium for biological systems, and its use simplifies the experimental procedure. The fast labeling
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speed, easy dose control (by controlling exposure time with a shutter212) and high reproducibility
all contribute to its utility. An obvious downside is there are limited synchrotron sources. A recent
development of a new beamline should make the method more powerful and more accessible than
in the past to the general research community.213
1.3.2.3 Laser Photolysis of Hydrogen Peroxide
Upon exposure to UV around 250 nm, H2O2 homolytically cleaves into two ●OH with a primary
quantum yield of 0.4 – 0.5.214, 215 In the absence of reactive substances, the resulting ●OH reacts
with the H2O2 that did not undergo photolysis as shown in Eq. 1.15-1.17.
H2O2 → 2 ●OH (1.15)
●

OH + H2O2 → H2O + HO2● (1.16)

HO2● + H2O2 → H2O + O2 + ●OH (1.17)
The rate constants for the latter two reactions are 2.7 × 107 and 7 × 109 M-1s-1, respectively.215
Large reaction rate constants guarantee fast labeling.
In 2004, Sharp et al.216 first footprinted lysozyme and β-lactoglobulin by ●OH generated from
H2O2 photodissociation. For this protocol, the protein sample contains 15% H2O2, and the
Irradiation (by a UV lamp) takes up to 5 min. This high H2O2 concentration is stressful to many
proteins. Moreover, the long labeling time is a risk that the system will be over labeled, as
discussed above.
To reduce the labeling time and lower the H2O2 concentration, Aye and Sze217 replaced the UV
lamp with a pulsed Nd:YAG laser that operates at 266 nm (frequency quadrupled). They used a
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light pulse energy of 2 mJ/pulse and a pulse width of 3-5 ns in a static system. H2O2 was added to
0.3% just prior laser irradiation to minimize exposure of the protein to this mild oxidizing agent.
The residual H2O2 after irradiation was removed by snap-freezing and lyophilizing the aliquot
(possibly a source of error as protein oxidation by H2O2 can occur in the solid state at low T as
reported later218). These improvements over Fenton chemistry combine to achieve a moderate
oxidation of ubiquitin with a single laser shot. As compared with Fenton chemistry, the H2O2
concentration and labeling time were both reduced significantly, providing higher confidence of
the result.

Figure 1.3. Schematic illustration of FPOP setup
At the same time, Hambly and Gross219 reported a method that couples H2O2 laser photolysis and
a flow system to footprint proteins oxidatively, which was later named fast photochemical
oxidation of proteins (FPOP). As compared with using a Nd:YAG laser, the KrF excimer laser
they chose has an output of 248 nm, which is closer the λmax of H2O2. The laser pulse width was
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17 ns, and the power was 50 mJ/pulse, both readily achieved with such a laser. These efforts
combine to afford measurable oxidation levels of proteins with 0.04% H2O2. The flow system, as
illustrated in Figure 1.3, ensures that most proteins in the aliquot are only irradiated once. The flow
rate was calculated in correspondence with laser pulse width and frequency to allow a 20 – 25%
exclusion volume, which minimizes any “double shots” of the protein solution.220, 221 Left-over
H2O2 was decomposed by catalase in the collection tube. Moreover, the reaction duration was
controlled and became tunable by adding a radical scavenger (Glu219 and later His222), which not
only limits the labeling time to 0.5 μs for minimizing over-labeling but also allows better control
of the labeling process204 and makes possible probes of fast kinetic processes including protein
folding/unfolding223,
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. Such platform also allows the development of novel radicals and

understand the radical reactions in solution.225 These advantages make FPOP a widely adopted
platform for protein footprinting by fast labeling reagents.
As compared to synchrotron water radiolysis, H2O2 photolysis retains most of its advantages in
generating ●OH. Although H2O2 is a necessary precursor, low concentrations minimize any
oxidation interference to protein native states. Most importantly, H2O2 photolysis makes the ultrafast ●OH protein footprinting more accessible to the general research community although efforts
are underway, principally by a commercial developer, to incorporate a discharge lamp to replace
the laser, which imposes safety requirements and some expertise for handling. Nevertheless,
subsequent developments take advantage of the strengths of FPOP, and a description of several
applications will be given in chapter 1.3.4.
On the other hand, H2O2 is a relatively strong oxidant, which may make this approach troublesome
for proteins that are prone to oxidation. A modified FPOP apparatus with a mixer located just
before the laser window largely minimizes the H2O2-induced protein oxidation.226 A recent report
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suggests that H2O2 can interact with the protein, giving local high concentrations of both the H2O2
and the radicals on regions of the protein surface.227
In response to the original claim that the radicals have been scavenged in ~ 1 μs, Konermann and
coworkers228 employed a reporter dye to follow the FPOP kinetics and showed that the free radical
oxidation of the dye extends over tens of ms, indicating a longer radical lifetimes than the original
prediction. This phenomenon likely applies to the secondary radicals formed as ●OH reacts. It
remains to be seen if these less reactive radicals react with the protein. The assertion about ms
lifetime is probably correct for the primary radicals (i.e., ●OH).
Another consideration for this platform is the potential migration of initially formed protein
radicals to other reactive residues that are buried below the surface. The investigators addressing
that question found that two solvent-inaccessible residues were modified by FPOP, possibly in
accord with a potential long-distance radical transfer (radical jumping) to buried residues.229 This
and other considerations need further attention to make FPOP more robust and applicable to more
biological systems.
1.3.2.4 High Voltage Electrical Discharge
High voltage electrical discharge takes advantage of the requirement to use mass spectrometry in
the analysis by a simple adaption of a typical ESI source to increase the spray voltage to 6-8 kV.230
To make the radicals, Downard and coworkers230-233 increased the potential difference between the
emitter tip and the grounded collection plate (either the MS inlet or a collection vessel) to induce
a corona discharge, during which oxygen in the nebulizer gas will be activated to give a plasma at
the tip of the emitter (Eq. 1.18-1.19).
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O2 → O2+● + e- (1.18)
O2+● + 2H2O → H3O+ + ●OH + O2 (1.19)
Meanwhile, water from the ESI spray can be activated as well (Eq. 1.20).
2 H2O → H2O+● + eaq- → H3O+ + ●OH + e- (1.20)
By switching the nebulizer gas from air to pure O2, the oxidation efficiency can be doubled.233 The
approach is also compatible with both positive and negative polarities.234 The oxidatively labeled
protein is then submitted directly to the mass spectrometer for top-down analysis (proteins are
dissolved in ammonium acetate to facilitate sufficient ionization), or the protein can be
accumulated in a collection vessel for further treatment and proteolysis. In subsequent studies, an
O2-assisted electrical discharge was successfully utilized to study protein complexes between
ribonuclease S-protein―S-peptide235 and calmodulin―melittin236. In a more recent twist,
Maleknia and Downard237 joined MALDI and electrical discharge protein footprinting to afford
an even higher throughput.
Given the popularity of ESI in protein analysis, high voltage electrical discharge makes ●OH
protein footprinting readily available to almost every MS lab. The fast-labeling timeframe and high
labeling efficiency seem to be promising. Given that charge-induced protein unfolding occurs in
an ESI source,238 a question arises whether the protein of interest can maintain its high-order
structural integrity during the oxidative footprinting. It is always preferred to perform protein
footprinting under native or near-native states to minimize these ambiguities, where a high-voltage
ESI spray is not optimal. Moreover, it is challenging to footprint binding systems with weak
interactions through this method, as weak interactions are less likely to be preserved in an ESI
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droplet than in neutral solution. The labeling time frame and the radical lifetimes also remain to
be determined, and the on-line approach will be difficult to apply to large proteins.

Figure 1.4. Schematic illustration of PLIMB setup.239
The concern of charge-induced unfolding by electrical discharge-based ●OH labeling was recently
addressed in 2017 by Minkoff and Sussman, who developed a novel experimental approach named
plasma induced modification of biomolecules (PLIMB, Figure 1.4).239 Instead of delivering the
protein through an ESI source, the protein aliquot was placed in a grounded Eppendorf tube with
a charged needle on top of the liquid. A plasma discharge is induced when supplying 1 – 31 kV of
potential to the needle with frequencies of 0 to 15 kHz. Over a period of 60 s, denatured and native
bovine serum albumin were oxidatively labeled to achieve modification fractions up to 15% at
peptide level. As part of the initial demonstration, PLIMB was adopted to characterize the
epidermal growth factor-induced structural changes in the extracellular domain of its receptor.
These examples demonstrate efficacy in facilitating ●OH-based protein footprinting on this
platform.
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PLIMB offers a benchtop solution for radical protein footprinting by overcoming the major
drawback for conventional electrical discharge methods, as the protein of interest is now
footprinted in solution under near-native conditions. On the other hand, the plasma discharge in
PLIMB only happens at the surface of the aliquot. Given the short lifetime of ●OH,166 most of the
●

OH labeling occurs in limited regions of the solution. Means to uniformly label the sample aliquot

and to minimize the over labeling are likely to be future developments of PLIMB.
1.3.2.5 Gamma Ray Water Radiolysis
Gamma ray (γ-ray) is an electromagnetic radiation that composed of high energy photons. Similar
to synchrotron X-ray water radiolysis, γ-rays excite water molecules and trigger reactions that
produce ●OH (Eq. 1.1-1.7).240 γ-ray-based ●OH footprinting, first applied to study nucleic acids,241
was implemented by Nukuna et al.242 to footprint cytochrome C in 2004. This approach was
adopted by a few research groups in subsequent years,243-248 but more recently, the approach is
seldom used due to safety concerns of the highly-penetrable nature of

-rays and the emergence

of other, more readily used approaches.
1.3.2.6 Other Hydroxyl Radical Generation Methods
Besides the methods introduced above, there are other methods that for ●OH footprinting,
including ultrasound sonolysis,249, 250 fast neutrons,251-253 peroxynitrous acid decomposition,254, 255
pulsed electron beam,256 photolysis of N-hydroxypyridine-2(1H)-thione,257,

258

boron-doped

diamond electrochemical surface mapping,259 and ozonolysis233. Because these methods were only
used in nucleic acid footprinting or not developed for protein footprinting, they will not be covered
further. Very recently, GenNext Technologies, Inc. (https://gnxtech.com/) provides an alternative
solution that utilizes a discharge lamp as light source for hydrogen peroxide photolysis. Such setup
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includes a flow system and resemble nicely the FPOP platform without the safety concern of using
laser as light source. Moreover, online dosimetry allows real-time monitoring of ●OH dosage.

1.3.3 Residue Specificity and Proposed Reaction Pathways of ●OH
One of the unique advantages of ●OH in protein footprinting is its broad reactivity. Xu and
Chance166, 244, 260-262 conducted systematic studies and found that the reactivity between ●OH and
amino acid residues rank as Cys > Met > Trp > Tyr > Phe > cystine > His > Leu, Ile > Arg, Lys,
Val > Ser, Thr, Pro > Gln, Glu > Asp, Asn > Ala > Gly. Among all these residues, Gly, Ala, Asp
and Asn are unlikely to serve as useful probes owing to their low reactivity (also see Table 1.1).
Although the reactivities for Ser and Thr are higher than that of Pro, which has been found to be a
reactive and useful substrate, their oxidation products are not easily detectable and may be
dispersed among several pathways (e.g., oxidation of -OH to =O). From rate constant
determinations and reports of experience with ●OH and protein modification, the general
conclusion is that 14 out of 20 amino acid residue sidechains are active in ●OH-based protein
footprinting experiments. In our experience, the presence of highly reactive residues (Cys, Met,
Trp, Tyr, Phe, His) may siphon most of the reagent radicals to their modification, reducing the
coverage. The products resulting from oxidative modifications are residue-dependent, and they
have been covered in detail in the Xu and Chance review166; most are +16 Da oxidations as
summarized in Table 1.2 Below.
Table 1.2. Primary oxidation produces (upon ●OH footprinting) and the corresponding mass
changes (in reactivity order) for various amino acid residue sidechains.244
Sidechain

Modification and Mass Changes
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Cys

sulfonic acid (+48), sulfinic acid (+32), hydroxy (-16)

Met

sulfoxide (+16), sulfone (+32), aldehyde (-32)

Trp

hydroxy- (+16, +32, +48, etc.), pyrrol ring-open (+32)

Tyr

hydroxy- (+16, +32, etc.)

Phe

hydroxy- (+16, +32, etc.)

cystine

sulfonic acid (+48+H), sulfinic acid (+32+H)

His

oxo-(+16), ring-open (-22, -10, +5)

Leua

hydroxy- (+16), carbonyl (+14)

Ilea

hydroxy- (+16), carbonyl (+14)

Arg

deguanidination (-43), hydroxy- (+16), carbonyl (+14)

Lys

hydroxy- (+16), carbonyl (+14)

Vala

hydroxy- (+16), carbonyl (+14)

Serb

hydroxy- (+16), carbonyl (-2, or +16-H2O)

Thrb

hydroxy- (+16), carbonyl (-2, or +16-H2O)

Pro

hydroxy- (+16), carbonyl (+14)

Gln

hydroxy- (+16), carbonyl (+14)

Glu

decarboxylation (-30), hydroxy- (+16), carbonyl (+14)

Asp

decarboxylation (-30), hydroxy- (+16)

Asn

hydroxy- (+16)

Ala

hydroxy- (+16)

Gly

N/A

a

For aliphatic side chains, +14 Da products are normally much less than
+16 Da products. b For Ser and Thr, only trivial amount of +16 and -2 Da
products were found.
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Mechanistically, ●OH activates the solvent accessible sidechains by either removing H● from an
activated site or adding a ●OH to a double bond, both of which result in a protein radical that is
subsequently quenched differently depending on the origin of the radical (H2O or H2O2).
For synchrotron radiolysis, Xu and Chance,166, 260-262 in a comprehensive review, summarized the
modification pathways of ●OH-active amino acid residue sidechains.166 Leu, Ile, Val, Pro, Arg,
Lys, Glu and Gln sidechains are activated through H● abstraction whereas His, Phe, Tyr, Trp and
Met are primarily by ●OH addition. The resulting protein radicals are subsequently quenched by
dissolved O2 in aerobic conditions. Reaction pathways between ●OH and the extremely reactive
Cys and cystine residues are complicated and not well understood. Alternatively, a likely reaction
pathway that covers major oxidative products was proposed for Cys.262 Similar pathways should
apply to the electrical discharge-based ●OH labeling, as the precursor for ●OH is also water.
In contrast to the two systems mentioned above, where uniformly distributed water is the ●OH
precursor, any H2O2 photolysis approach, as represented by FPOP, follows slightly different
reaction pathways. A recent quantum calculation study revealed the hydrogen bonding between
H2O2 and amino acids including His, Arg, Tyr, Cys, Thr, Gln, Asp, Lys, Met and Trp.263 Such
hydrogen bonding will induce a pre-formed H2O2 – amino acid residue complex, which will result
in a local fluctuation in ●OH concentrations upon laser photolysis.
To further understand the FPOP chemistry, Liu, Gross, and coworkers227 studied the reaction
pathways between ●OH and 13 different amino acid residues on a FPOP platform. Details of this
work is covered in Chapter 4. In brief, by using
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O-enrichment of all three available oxygen

sources (H2O, H2O2 and dissolved O2) on an FPOP platform, one at a time, they differentiated
three classes of residues based on their oxygen uptake preferences. His, Arg, Tyr, and Phe
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preferentially take oxygen from H2O2. Met competitively take oxygen from H2O2 and dissolved
O2, whereas Leu, Ile, Val, Pro, Lys, Asp, Glu and Gln take oxygen exclusively from O2. Given
that the ●OH activation pathway is very similar to that in water radiolysis, such differences in
oxygen uptake preferences reveal a different pathway for some activated residues than described
in the Xu and Chance166 review. Besides quenching by dissolved O2, selected activated residues
can also be favorably modified by reaction with another ●OH in the FPOP setup, owing to
hydrogen bonding with H2O2 and preferential localization of the reagent and, of course, the
radicals.
As mentioned earlier, ●OH is also capable of cleaving protein backbones, whose pathways is
reviewed elsewhere.166, 173
Summarizing the role of ●OH in footprinting, it has unprecedented advantages as a fast protein
footprinter. Biological relevance, similar size and hydrophilicity as water, fast labeling time, high
labeling efficiency, multiple generation methods, broad residue coverage, well established
platforms, and mature understanding of the labeling pathways make it the most utilized fastlabeling reagent. Its demonstrated utility forecast many more promising applications. On the other
hand, the +16 Da from oxidative labeling can be problematic in rare cases, as oxidation is common
in native biological systems, and it is challenging to distinguish the oxidations that exist prior to
labeling and those that are from ●OH reactions. Other oxidations besides those producing +16, can
add background of many low abundance products to complicate the analysis. Furthermore, even
though 14 amino acid residues are reactive with ●OH, those that are most reactive (S-containing,
aromatics) can be too competitive, reducing the overall coverage and spatial resolution achieved
for the protein. These drawbacks motivate the development of other fast labeling reagents that
provide complementary coverage to ●OH labeling and employ an MS tag other than +16 Da.
32

1.3.4 Applications of FPOP
Since the initial introduction in 2005, combinations of FPOP and several experimental designs
have successfully demonstrated the reliability of FPOP and their ability to address various
biological questions.

Figure 1.5. Major applications of FPOP. Clockwise from top: Espino, et al.264 labeled live
Caenorhabditis elegans (C. elegans) with FPOP and identified oxidative labeling on several
hundred proteins. Liu, et al.265 combined ligand titration with FPOP and characterized binding
sites, site-specific affinities, and binding orders of the calcium - calmodulin (Ca2+ – CaM) system.
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Li, et al.266 used FPOP to follow the amyloid beta 1-42 aggregation kinetics and revealed the
critical role of its middle domain in the aggregation process. Chen, et al.224 established a
temperature-jump platform and demonstrated its utility for the folding kinetics of barstar with
residue-level FPOP. Aprahamian, et al.267 developed a Rosetta scoring algorithm that utilizes
FPOP data, after which the root mean square deviation (RMSD, as compared with crystal
structure) of the best scoring model improved significantly. Li, et al.268 demonstrated the
applicability of FPOP in mapping epitopes by successfully identified the binding regions between
an antibody and interleukin-23.
1.3.4.1 Labeling in Cells and in vivo
In-cell labeling by radical species was first demonstrated with nucleotides, where Ottinger and
Tullius269 used hydroxyl radicals to footprint the lambda repressor-DNA complex in live E Coli
cells. Hydroxyl radicals in this study were generated by ionizing water molecules with a
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gamma ray source, which required up to 15 min to produce a sufficient concentration of radicals.
To minimize heat damage to the cells during the long irradiation, Woodson and coworkers270, 271
utilized synchrotron X-rays to reduce the exposure time to as short as 100 ms and froze their
samples (-34 °C to -38 °C) to minimize damage272. Recently, similar experiments were done with
a flow system to minimize double labeling and further reduce the exposure time to 10 – 20 ms.273
Better X-ray dose control also improves the accuracy and reproducibility.
In-cell protein footprinting by radical species, however, was not demonstrated until 2009 when
Zhu and Sze199 used hydroxyl radicals generated by Fenton chemistry. Although voltage gating of
OmpF porin from E. Coli was shown previously in vitro, this study for the first time reports the
observation of gating phenomena in a native cellular environment.199 Moreover, the novel
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footprinting also shows the capability of in-cell protein footprinting by radical species in
addressing real biological questions. In subsequent work, Shcherbakova et al.205 shortened the
timescale of ●OH generation. By increasing the concentration of Fe(II)-EDTA to 2 mM, a 40%
loss of fluorescence intensity was observed after 2 ms, suggesting that ●OH can be rapidly
generated and that this approach can label other short-lived intermediates.

Figure 1.6. (a) Pie chart of the subcellular compartment location (African green monkey kidney
cell) of oxidized proteins that were identified by LC-MS/MS. Proteins that are present in multiple
compartments are represented multiple times.274 (b) Correlation of residue-level FPOP
modifications with SASA in the open (circles and solid line) and tight (diamond and dashed line)
states of actin. 274 (c) Schematic illustration of an improved flow system for in vivo FPOP labeling.
Blue arrows indicate flow and colored lines represent tubing.275 (d) Pie chart of the oxidatively
modified proteins within different body systems of c. elegans.264
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The marriage of FPOP with in-cell protein labeling was first demonstrated by Jones and
coworkers,274 they mixed African green monkey kidney cells with H2O2 and submitted the cells to
KrF laser irradiation for ●OH generation and protein labeling. H2O2 crosses the membrane through
both passive diffusion and via channeling proteins such as aquaporin, producing sufficient H2O2
inside the cell to give a good yield of ●OH upon laser irradiation. Although H2O2 is toxic to live
cells, the time required to execute the experiment seems to be short enough to avoid serious
toxicity. Indeed, viability tests prior to labeling suggest that over 70% of cells remain alive under
the experimental conditions used for the footprinting. The investigators observed 105 proteins that
are oxidized by ●OH. These proteins were from different subcellular compartments, as shown in
Figure 1.6a, indicating an outstanding dynamic range for protein detection.274
When zooming into a specific protein (e.g., actin), FPOP modification fractions can be correlated
with SASA of the two different states of actin; namely, open and tight. Results in Figure 1.6b show
a better correlation with the open state (R2 = 0.89), suggesting that majority of actin molecules in
the native Vero cells are in their open state.274 Later the same group improved the experimental
apparatus by introducing a sheath buffer (Figure 1.6c) to reduce cell aggregation greatly and tube
clogging.275 Their design also ensures that radiation exposure of each cell in the flow system
remains comparable. As a result, they were able to increase the number of identified oxidized
proteins by 13-fold.275
In 2019, Jones and coworkers264 introduced small, live worms, C. elegans into the flow system,
and they were able to identify oxidatively labeled proteins from different body systems as shown
in Figures 1.5, top and 1.6d. A closer look at the myosin chaperone protein UNC-45 suggests that
the modification fractions obtained in this in vivo study correlate well with the SASA calculated
from the crystal structure.
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1.3.4.2 Probing Ligand Binding, Affinity and Dynamics
Numerous proteins interact with ligands to facilitate biological processes for which quantitative
understanding is vital.276 Protein-ligand binding affinity measurements are a quantitative measure
of these processes. To date, three approaches have been used in the majority of applications to
characterize such interactions. Measurements include circular dichroism,276 fluorescence and
fluorescence polarization,277, 278 FT-IR,279 and NMR,280, 281 that provide read-out of the system
composition at given ligand concentrations. These readouts are further utilized to derive
macroscopic binding affinities. Surface plasmon resonance (SPR) measures the ligand on and offrates, providing binding affinity through a kinetic approach.76, 282 Isothermal titration calorimetry
(ITC) measures heat flow during a ligand titration, and binding affinities are obtained employing
the van’t Hoff equation.74 All these methods are considered to be standard in binding affinity
determination, and SPR and ITC are commonly used for their speed and ease of operation. 283 On
the other hand, these methods give limited spatial resolution, sometimes providing little structural
information (e.g., SPR and ITC), or by the requirements of large sample amounts (e.g., mg for
NMR) or y special sample preparation (e.g., chip-loading for SPR).
MS-based approaches can advance this field by providing another direct approach that
significantly lowers the sample amount. Similar to concentration-measurement approaches, MS
examines the binding system by measuring its composition (i.e., the concentrations at equilibrium)
either directly or indirectly. The direct approach takes advantage of native spray, a gentle form of
ESI whereby the protein can be sprayed in a native or near-native state, retaining non-covalent
interactions152,

284,

285

and allowing direct measurements of the various equilibrium

concentrations;283, 286 this was first demonstrated by Loo et al.287, who determined the affinities for
binding between ribonuclease S-protein and S-peptide. Early applications were in several
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disciplines including protein-protein,288, 289 protein-peptide,290 protein-oligonucleotide,291 proteinsmall molecule,292 peptide-antibiotic293 and small molecule-RNA294 complexes. This direct
method has been carefully developed for quantifying protein-glycan interactions, as pioneered by
Klassen and coworkers.283, 295-297
Indirect approaches, on the other hand, requires pre-detection labeling. Using this form of labeling
in MS was first done by using HDX, where two separate titration methods were demonstrated in
the early 2000s, namely, SUPREX298,

299

and PLIMSTEX300. Both utilize the differences in

deuterium uptake between ligand-free and ligand-bound states at a selected exchange time.
SUPREX uses denaturant as the titrant, and the titration mid-point is extracted by modeling the
data; those data are further extrapolated to give folding free energies and binding affinities.298, 301
PLIMSTEX, on the other hand, uses the ligand as titrant, and binding constants are derived by
fitting the titration curve.300 Both approaches have been extended to the peptide level, as seen in a
study that characterizes interactions between a small-molecule drug candidate and apolipoprotein
E3, providing regional specificity and improving spatial resolution.302
Owing to the relatively long times used for HDX, neither of these approaches are compatible with
systems with high ligand-off rates. They also suffer from post-labeling back exchange. To
overcome such drawbacks, I proposed, in Chapters 2 and 3, a method named LITPOMS265, 303, 304
(ligand titration, fast photochemical oxidation of proteins and mass spectrometry) that for the first
time marries fast labeling species to binding affinity determination (Figure 1.5, top-right).
Footprinting by radical species overcomes the major drawbacks of HDX owing to the irreversible
and fast labeling that pertain, and such marriage show great potential as demonstrated by the
melittin – holo-calmodulin and calcium-calmodulin studies covered in Chapter 2 and 3,
respectively.
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1.3.4.3 Assaying Protein Aggregation
Studies of protein aggregation and its relationship to neurodegenerative diseases date back to 1910,
when Fritz Heinrich Lewy first observed unusual protein aggregates in the brains of patients with
Parkinson’s disease.305, 306 These aggregates were later termed Lewy bodies307 and became the
diagnostic for Parkinson’s disease. Now, it is well understood that a Lewy body is composed of
misfolded α-Syn. Alzheimer’s disease, as first described by Alois Alzheimer,308 is another major
neurodegenerative disease induced by protein misfolding and aggregation of amyloid beta (Aβ)309.
Unfortunately, neither of these diseases have cures, and their pathologies are not well
understood.306, 309-311 Thus, it is important to develop novel approaches to locate and quantify
protein aggregates, to study the aggregation mechanism, and to develop therapies.
Characterization of protein aggregates is challenging, especially at high spatial resolution. The
final state of these aggregates, solid Aβ fibrils, for example, can be characterized with high
resolution approaches in solution (labeled by D2O and solubilized in dimethyl sulfoxide)312 and by
solid-state NMR313, x-ray crystallography314 and modern cryo-EM315,

316

. The low molecular

weight soluble oligomeric intermediates that “come and go” during aggregation, although
physiologically important, are not amenable to those techniques owing to their low solubility, high
heterogeneity, intrinsic disorder, instability, and high aggregation propensity. Some of these
aggregates can be investigated by atomic force microscopy (AFM) to give a high-resolution
morphological picture of early aggregation intermediates.317 No site-specificity or spatial
resolution, however, are available when using such approaches.
MS-based approaches can contribute to this field from two distinct points of view. MALDIimaging enables label-free quantification of Aβ aggregates.318 Ion mobility MS is capable of
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separating different Aβ oligomers based on their collision cross sections in the gas phase.319 HDX
coupled with MS also reveals structural information of Aβ fibrils,320 protofibrils,321 and even Aβ
aggregation kinetics322. With top-down sequencing and ECD fragmentation, H/D scrambling is
minimized, allowing residue-level information of Aβ oligomers.323, 324
The ability to study Aβ aggregates by radical footprinting was first demonstrated in 2014 when
Klinger, Chance, Axelsen and coworkers325 utilized synchrotron-based HRF to examine the fibrils
and prefibrillar forms of the 40-residue Aβ (Aβ1-40). By comparing the protection factors for
selected residues in prefibrillar and fibril Aβ1-40, they mapped the footprinting data onto highresolution solid-state NMR models and showed that the solution information obtained from HRFMS is consistent with several core filament structural models elucidated in solid state.

Figure 1.7. FPOP and kinetic modeling results for time-dependent aggregation of 42-residue Aβ
(Aβ1-42) at (a, b) global, peptide and residue levels.266 (a) Global (whole protein) level results for
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Aβ1-42 aggregation. Solid curve is from fitting by a model based on two autocatalytic reactions. (b)
Concentrations for representative species (M-monomer, D-paranuclei, D*-protofibrils, D**fibrils) as a function of incubation time based on kinetic simulation. (c, d, e) Peptide-level results
for Lys-N digested Aβ1-42, N-terminal region 1-15, middle region 16-27, and C-terminal region
28-42, respectively. (f, g, h) Residue level results for three representative residues, H6, F19/F20
and M35, respectively. Points in each plot represent experimental data (10 μM, pH 7.4, no
agitation) and error bars are standard deviations from three independent trials. Solid and dashed
lines in (c – h) are model fits independent of or constrained by the global rates, respectively.
Later on, Li et al.266 applied FPOP to study the aggregation process of 42-residue Aβ (Aβ1-42). By
following the Aβ1-42 as a function of incubation time with FPOP, the investigators found a clear
decrease in modification fraction (Figure 1.5, right and Figure 1.7a) consistent with a decrease in
SASA owing to aggregation. By modeling the results with a two-nucleation/two-autocatalytic
mechanism, they successfully fit the data (solid line in Figure 1.7a) and constructed a system
composition plot as a function of incubation time, shown in Figure 1.7b. Plotting relative fractions
for four components, the investigators proposed an Aβ1-42 early aggregation mechanism, where
Aβ1-42 monomer rapidly assembles into paranuclei and further accumulates until a certain
threshold. Upon passing that limit, the paranuclei self-catalyze a structural reorganization to
deplete the monomers and form readily the mature fibrillar aggregates.266
Upon digesting the Aβ1-42, spatial resolution is elevated to regional and even to some residue levels.
The N-terminal region remains solvent accessible throughout aggregation (Figure 1.7c) as seen by
the minimal change in modification in that region during aggregation. The central (Figure 1.7d)
and C-terminal regions (Figure 1.7e), however, actively participate in aggregation, as evidenced
by significant decreases in modification fraction. Similar logic applies to residue-level
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interpretation, where SASA of H6 (Figure 1.7f) changes little during aggregation whereas residues
F19/F20 (Figure 1.7g) and M35 (Figure 1.7h) are actively involved in aggregation. The
investigators proposed that F19/F20 contributes a driving force for Aβ1-42 aggregation by serving
as a hydrophobic nucleation interface.266 Although some residue-level resolution was obtained,
not all residues could be studied, reaffirming the need for alternative free-radical footprinters that
prefer to react with other residues than those reactive with ●OH and give complementary
information.
1.3.4.4 Tracking Protein Folding/Unfolding
Dating back to 1961, the ribonuclease refolding experiment by Christian B. Anfinsen2 showed that
small globular proteins can fold, without assistance from other biomolecules, to their free energy
minimum state. Following the ribonuclease refolding experiment, Anfinsen later proposed a
thermodynamic hypothesis wherein the protein native structure is only determined by the protein’s
amino acid sequence.326 It is now accepted that protein folding is driven primarily by interactions
including hydrogen bonding, van der Waals interactions, backbone dihedral angle preferences,
hydrophobic interactions, and electrostatic interactions.327 Understanding protein folding
pathways and their corresponding intermediates, however, remains a huge problem that now has
become a field of research onto itself.
Experimentally, folding or unfolding is followed, after introducing a perturbation as a function of
time, through characterization by several methods;328 perturbations that can be used are a sudden
change typically in temperature,223, 224, 329, 330 denaturant concentration,331, 332 pH,333 or pressure334.
For decades, several approaches including circular dichroism,335 fluorescence,66 FT-IR,336 and
NMR337, 338 have been most extensively used. Although lower in spatial resolution, the detection
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time limit for optical approaches can be as low as 10 fs,339 a time that is ideal for tracking rapid
structural transitions. On the other hand, using rapid mixing and multidimensional NMR coupled
with HDX has been successful in characterizing folding processes on the time scale of milliseconds
with high spatial resolution.338
Following protein folding/unfolding by MS was first demonstrated by Chait and coworkers340 in
1990, who electrosprayed cytochrome C at different pHs. They observed different charge-state
distributions when the protein was introduced in different conformations; an unfolded form favors
higher charge states. This observation enables MS to follow, in a simple and global way, the
protein conformational changes upon perturbation, a representative one being myoglobin
reconstitution coupled with online continuous-flow labeling.341 In the same decade, HDX was
married to MS,342, 343 and the combination was used soon after to address lysozyme folding.344
Further development of a “rapid mixing” apparatus made possible the measurement of folding
kinetics by HDX-MS.337, 338, 345
The application of free-radical footprinting in folding studies was first demonstrated by Chance,
Woodson, and coworkers206,

207

for RNA, where a “stopped-flow” apparatus combined with

synchrotron-generated ●OH radicals probed ribozyme folding dynamics. Proteolysis to form
peptides and MS to locate the footprinting provided some regional specificity for the folding.
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Figure 1.8. (a) Schematic illustration of the three-syringe, continuous-flow, rapid mixing setup for
oxidative ●OH labeling. (b) Normalized oxidation levels of tryptic peptides plotted as a function
of unfolding time t. Blue boxes highlight three peptides that retain considerable protection at 50
and 500 ms whereas the peptide highlighted by a red box is protected at 50 ms but not at 500 ms.346
Although the approaches in equilibrium measurements are useful, it is challenging and likely more
informative, to examine protein folding kinetically. Taking advantage of the Hambly and Gross219
demonstration of ●OH protein footprinting through laser photolysis of H2O2 in a flow system,
Konermann and coworkers346 first integrated continuous-flow rapid mixing with ●OH labeling to
study the protein folding/unfolding in a kinetics experiment (Figure 1.8a). The rapid mixing
apparatus has two mixing “tees”. Using three syringes, the investigators mixed native protein
(hMb), H2O2, and denaturant HCl in a continuous fashion. By tuning the flow rate, pulsed laser
frequency, the distance between the second mixing tee M2 and the window for laser irradiation,
the delay time between protein denaturation and ●OH labeling can be manipulated from 50 ms to
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5 min. Using tryptic digestion, the investigators followed oxidative modifications as a function of
denaturing/unfolding time of hMb with regional specificity. Peptide T7 represents a region that
unfolds initially upon adding denaturant (Figure 1.8b). Peptides T2, T10 and T13, on the other
hand, stay relatively protected up to 500 ms after mixing with HCl. Peptide T16 represents the
region that unfolds between 50 to 500 ms. The hMb becomes completely unfolded after mixing
with HCl for 5 min. On the other hand, by starting with the denatured protein and replacing HCl
with a renaturing buffer, the investigators could study the folding of cytochrome c,347 the folding
and dimerization of S100A11,348 the folding of an integral membrane protein bacteriorhodopsin,349
and even sub-millisecond folding of aMB.350
Recently, the delay time was further shortened to the microsecond timescale by a newly designed
microfluidic mixer, and the unfolding was followed by FPOP. The data reveal two kinetic phases
of egg lysozyme that occur before 1 ms.351 The requirement for low sample amounts, the
achievement of regional specificity, and the capability for kinetics open new possibilities for
protein folding studies even on the sub millisec time frame.

Figure 1.9. (a) Schematic illustration of the flow system intersected by two laser beams at a
transparent window, as part of a temperature-jump apparatus.223 (b) Proposed intermediate for
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barstar early folding.224 Residues colored in red, pink and gray represent residues that are closely
associated with hydrophobic core, weakly associated with hydrophobic core and not involved in
early folding intermediate, respectively.
In 2010, Chen, Rempel and Gross223 reported a design that combined FPOP with a laser-induced
temperature-jump to probe sub millisecond folding. As demonstrated in Figure 1.9a223, two lasers
(KrF excimer laser at 248 nm for FPOP and Nd:YAG laser with a Raman shifter at 1900 nm for ~
20 °C temperature-jump) were controlled by a signal generator and a delay circuit. The laser beams
were aligned to intersect sequentially at the same transparent window on the flow capillary. By
controlling the delay time between firing the two lasers, it is possible to track the protein
folding/unfolding kinetics with high spatial and time resolution. The delay time of this two-laser
approach is no longer limited by fluid dynamics, as in rapid mixing, but by the time separation
between two lasers. By tuning the reaction conditions, ●OH should be able to footprint the protein
irreversibly in times as short as 1 μs204, 223 or less, making it possible to follow folding dynamics
of fast folding proteins.
The investigators successfully footprinted the first intermediate state of barstar folding, which
happens within 2 ms of the temperature jump.224 Changes of the modification fractions at the amino
acid residue level revealed the key residues that serve as a nucleus for barstar early folding as seen
in Figure 1.5, bottom-middle and Figure 1.9b,224 where residues H17, L20 and L24 can be assigned
as closely associated with the hydrophobic core around which barstar folds; residues I5 and F74
are weakly associated with the hydrophobic core; residues W53, L88 and many others, however,
are not involved in the fast folding.
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Radical species have the advantage of short reaction times, which are ideal for following fast
processes. The ●OH FPOP-based two laser approach brings high resolution to submillisecond
protein folding studies,223,

224

which was not easily accessible prior to this work. Secondary

structural motifs for some fast-folding proteins, however, can form as fast as 0.1 μs352 thus
requiring an even faster probe. Carbene diradicals label proteins on the nanosecond timescale,353
suggesting that those footprinters may be appropriate to address such problems.
1.3.4.5 Footprinting in Support of Computer-based Structural Predictions
So far, most applications described in this section have been based on differential experiments,
where the modification fractions for specific peptides and residues were tracked as a function of
protein states. Although various systems can be characterized, comparisons require relatively pure
systems where different protein states can be clearly differentiated.
Ideally, HOS would be determined directly by footprinting a single protein state. Radical labeling
and even other MS-based approaches, however, are not capable of providing enough restraints to
construct a high-resolution protein structure as can NMR and X-ray crystallography. Computerbased protein HOS prediction is powerful and has great potential, yet the incomplete understanding
of protein folding does not allow accurate prediction of protein HOS.79, 354 Data from NMR,355
small angle X-ray scattering,356 cryo-EM357, 358 and site-directed spin labeling EPR359 overcome
such limitations because they are based on structural restrictions or restraints.
An MS-based approach that is particularly amenable to modeling is chemical crosslinking.360, 361
Most of HOS elucidated from this workflow, however, is of protein complexes, because only with
large and complex systems is it possible so far to obtain sufficient crosslinks for modeling. Further,
the principal HOS outcome is a protein-protein interface and not the full structure although more
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detailed structure determinations are becoming possible. It may be that footprinting combined with
crosslinking will lead to more reliable models than from either method itself.362-364
Structural prediction based on radical footprinting data was not possible until it can be properly
quantized and reasonably correlated to the absolute SASA. In 2015, Huang and Chance365 first
proposed a protection factor (PF) that successfully correlates single-state footprinting data with
absolute SASA. The observed reaction rate from a dose-response curve from synchrotron-based
●

OH footprinting is a function of both intrinsic reactivity of ●OH and the amino acid residue and

its solvent accessibility.366 Teasing out a structural contribution can be done by normalizing the
observed reaction rate constant with respect to the residue-specific intrinsic reactivity. As a result,
solvent accessibilities (calculated from X-ray structures) for three model systems exhibit a
quantitative agreement with calculated PFs, motivating future developments.
In another elegant experiment, Xie and Sharp367 introduced a method for assessment of sidechain
absolute SASA values by using an FPOP-based ●OH footprinting platform. By incorporating
adenine as ●OH dosimeter, they obtained reaction rates for each residue through multi-point FPOP
experiments (different ●OH doses). These data were further normalized with respect to intrinsic
reaction rates of ●OH and free amino acids. Normalized protection factors obtained through these
efforts were compared with fractional SASA, and a good linear regression was obtained.367
Although the incorporation of radical protein footprinting data in some structural modeling is
successful, use of the footprinting data directly in protein structure prediction is yet to be
established.
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Figure 1.10. (a) Rosetta score versus RMSD (with respect to the native structure) plots for 20000
models generated from Rosetta ab initio for each of four proteins. Top scoring model is highlighted
by a star in each plot. (b) Top scoring models from the Rosetta score versus RMSD distributions
in (a) (color) superimposed on the respective native model (gray). PDB ID for these native models
are depicted at the top of the figure. (c) Rosetta score + hrf_ms_labeling versus RMSD (with
respect to the native structure) plots for each of the four proteins after rescoring with the new score
term. The top-scoring model is highlighted by a star in each plot. (d) Top scoring models from the
Rosetta score + hrf_ms_labeling rescoring distributions in (c) (color) superimposed on the
respective native model (gray).267
In 2018, Lindert and coworkers267 developed a new Rosetta score term named hrf_ms_labeling
that utilizes residue-level PFs from ●OH footprinting data as constrains to predict protein
structures. PFs were calculated based on the formula proposed by Huang and Chance365. With
Rosetta, they generated 20,000 structural models with an ab initio method for four different
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proteins (i.e., calmodulin, cytochrome C, myoglobin and lysozyme). The Rosetta score for each
model was plotted against their RMSD with respect to their native crystal structures as shown in
Figure 33a. The 20,000 models for each of the proteins covers a broad range of RMSDs. Aligning
the top-scoring model with the native structure allows better visualization of the differences, as
there are even topology mismatches for calmodulin and lysozyme (Figure 1.10b). Although there
are models that have near-atomic resolution (RMSD ≤ 2Å), they were not recognized as the top
scoring models by Rosetta. When rescoring the same 20,000 models with restraints from
experimentally determined PFs, similar distributions were identified (Figure 1.10c). With the help
of new scoring function hrf_ms_labeling, the RMSDs for the top-scoring models improve
significantly for all four proteins. A visualization of the outcome (Figure 1.10d) shows that all
models identify the correct protein topology.267 Structure models for cytochrome C and myoglobin
come with near-atomic resolution, indicating the efficacy and applicability of the newly developed
scoring function. This work demonstrates for the first time that incorporation of ●OH protein
footprinting data can greatly enhance model quality in protein structural prediction, elevating the
use of MS-based footprinting from a qualitative description to a quantitative evaluation. If these
efforts continue to be successful, protein footprinting may no longer limited to differential
experiments, and the results for a single protein state may be transformed into a high-resolution
structure. The script of this newly developed scoring function and the corresponding instructions
are freely available with Rosetta.
In another example, the same group368 developed novel Rosetta scoring function that utilizes SID
MS data and demonstrated that SID data significantly enhance the confidence of structural
predictions of protein complexes.
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Although still in its early stages and requiring further work, structural prediction utilizing
footprinting data shows significant promise. It will be necessary to generalize these workflows and
make them compatible with other footprinting approaches. Further, it will be even more significant
to develop a new structural prediction algorithm that is guided by footprinting data rather than by
rescoring the existing models, as hinted in a subsequent study by Lindert and coworkers369 in 2019.
1.3.4.6 Mapping Epitopes
Monoclonal antibodies (mAb)370 are important biomacromolecules owing to their broad
applications in analytical assays371-373 and their profound potential in therapeutics.374,
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Interacting surfaces in antibodies and antigens are termed as paratopes and epitopes, respectively.
Paratopes mainly consist of loop regions of 10–15 amino acid residues and are termed
“complementarity determining regions” (CDRs). The structure and position of the paratopes are
usually well-defined in accord with the rigid scaffold of the antibodies.
Antigens, however, differ dramatically from antibodies and from each other. Epitopes in antigens
do not exist in a specific structure. The binding site for the antigen (epitope) depends on the
location of the actual binding interface that interacts with antibodies. In other words, epitopes can
be located anywhere on the antigen surfaces.376
X-ray crystallography,377 NMR280 and alanine-scanning mutagenesis378 are the most commonly
used high-resolution biophysical approaches in mapping epitopes. Mutagenesis maps the epitope
from a functional aspect, but that approach may not be informative for higher order structure and
the amino acid substitutions may affect the protein HOS. MS-based epitope mapping methods
were developed substantially and now are regarded as reliable approaches.379-381 Two different
schemes were originally used; that is, epitope excision379 and epitope extraction.382 Both
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approaches utilize the specific binding between antigen and immobilized antibodies. More
recently, MS-based epitope mapping approaches utilize HDX to label the protein chemically and
monitor changes in SASA that result when antigens bind with antibodies.383 Thanks to the high
binding affinities for many immunocomplexes, off-rates do not heavily distort the HDX kinetics.
Both the antigen and the immunocomplex can be footprinted under native-like conditions,
minimizing potential perturbations of structure. Although the HDX rates are significantly slowed
(quenched) at a pH of 2.5 and 0 °C,384, 385back-exchange cannot be avoided. Proteases that function
under acidic environments are generally limited to pepsin and Fungal protease XIII,386 both of
which are non-specific, and the resulting peptide mixture is complicated and challenges the data
analysis. Moreover, H/D scrambling during MS/MS analysis limits the spatial resolution to the
peptide level; that resolution can be increased possibly to the residue level by using ECD135 and
ETD387, which presumably do not scramble the D labels,387, 388 or by digestion to smaller and
overlapping peptides389.

52

Figure 1.11. (a) Extent of modification of thrombin alone (darker bars) and antibody-bound
thrombin (lighter bars) for the five peptides that span the 130-171 region. (b) Extent of
modification of thrombin alone (darker bars) compared to antibody-bound thrombin (lighter bars)
at the residue level. (c) Structural model of thrombin (PDB file 2AFQ390) with the proposed epitope
colored in red and the loop regions colored in blue. The individual residues that show increased
modification for antibody-bound thrombin are specified. (d) Extent of modification of peptides
from thrombin alone (darker bars) and antibody-bound thrombin (lighter bars) show increased
solvent accessibility in the antibody-bound form.391
Epitope mapping by FPOP was first demonstrated by Jones and Gross391 in 2011, where the
epitope of serine protease thrombin was footprinted. Two regions show binding-induced protection
as evidenced by the decrease in extent of modifications (representative results are in Figure 1.11a),
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where five distinct peptides exhibit increased protection upon binding (darker bar represents
unbound and lighter bar represents bound). The protection spans 42 amino acid residues, but such
protection seems too extensive considering the size of thrombin. Taking advantage of the
irreversible labeling of FPOP chemistry, the investigators could further assign protection at the
residue level (results in Figure 1.11b). Among 14 resolvable residues, protection in the antibodybound form occurs between residue D133 and Y150; those results are mapped in Figure 1.11c.
Proposed epitopes agree well with those from an earlier HDX study.383
Moreover, four residues (Figure 1.11b) and three peptides (Figure 1.11d) show deprotection upon
forming the immunocomplex. This deprotection, not observed with HDX, is assigned as a remote
conformational change. HDX monitors both backbone amide hydrogen bonding and solvent
accessibility whereas FPOP emphasizes the latter. If allosteric or remote conformational changes
do not involve changes in hydrogen bonding but occur as reorientation of amino acid residue side
chains, they will not be seen by HDX.
Subsequent studies of similar design reveal the epitope of human epidermal growth factor receptor
(EGFR)-Andectin 1,392, 393 IL-6R-Adnectin 1&2,394 and human immunodeficiency virus 1 gp120
envelope glycoprotein,395 demonstrating even more the efficacy of fast labeling approaches and
making a case for generality.
A 2017 study by Li et al.268 applied orthogonal methods including FPOP, HDX, and alanine shave
mutagenesis and determined energetic epitopes of an antibody/Interleukin-23 interaction (Figure
1.5, top-left). By examining the system with FPOP footprinting, they found that five regions of IL23 p19 domain show protection. Similarly, HDX reveals four slightly different protected regions,
three of which overlap with those reported by FPOP. Imperfect overlap motivates subsequent
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alanine shave analysis, where a series of mutants can be designed based on MS-analysis, enabling
confirmation of the residues/peptides identified by the two MS methods. Four distinct mutants
show significant lower binding affinities as compared with the wildtype protein. Thus, this
comprehensive approach points to the first two regions of IL-23 p19 domain as epitopes, whereas
protection for regions 124-139 (by FPOP) and 145-153 (by HDX) are from remote bindinginduced conformational change. This study is a good example of the workflow of FPOP and HDX
MS to guide mutagenesis and functional assay for epitope mapping.

1.4 Hydrogen Deuterium Exchange
1.4.1 An Historical Perspective
HDX is one of the most important and used covalent labeling protein footprinting approaches to
date despite its reversible nature. Although HDX is usually distinguished from other irreversible
footprinting approaches by classifying the latter as covalent labeling or covalent footprinting, HDX
labeling also involves covalent bonds. The distinction is not covalent labeling as the exchange but
rather that the exchange of N-H for N-D in HDX is a reversible process.
Protein HDX was first demonstrated in 1954 by Kaj Linderstrøm-Lang,396 who was later
recognized as “father of HDX”397. In the very first HDX experiment, Hvidt and LinderstrømLang396 incubated dried pork insulin into D2O to allow exchange, followed by snap-freezing and
lyophilization. The protein powder was then suspended in H2O. The deuterium content was
measured by the density of the newly obtained protein-H2O solution in a gradient tube. Later, they
studied the pH and temperature dependence of H/D exchange rates,384, 385 made a connection
between H/D exchange rate and the dynamics of protein molecules,398,

399

and formulated

equations that underpin the basis for protein HDX.385, 399, 400 Efforts by Linderstrøm-Lang and
coworkers397, 401 are part of the early history of protein HDX, but in a display of scientific insight,
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these investigators demonstrated an approach of tremendous potential, opening a new era of
covalent labeling-based protein HOS elucidation.
To enhance spatial resolution, HDX was later coupled with other characterization approaches (e.g.,
UV spectroscopy,402 IR spectroscopy,403, 404 neutron diffraction405), among which NMR was the
most successful in early applications. The NMR applications began with a series of studies in late
1950s when Saunders and Wishnia406-408 first demonstrated that the exchange of proteins and D2O
solvent can be measured by NMR with high spatial resolving power to give residue-level
information at least for small proteins.409 In 1976, these efforts were extended to the determination
of individual amide proton exchange rates, as demonstrated by Wüthrich and coworkers.30 Later,
Wagner and Wüthrich410 coupled two dimensional correlation spectroscopy (2D-COSY) NMR
with H/D exchange rate measurements whereby exchange rates for every amino protons in a
protein can be obtained in a single experiment. Recent development of fast 2D 1H-15N correlation
NMR demonstrates measurement of fast HDX for amide bonds within a few seconds of acquisition
time.411 Along with these developments, NMR measurements also contributed significantly to the
mechanistic understanding of protein HDX phenomena.412, 413
The use of HDX-NMR in studying protein-protein interactions was first demonstrated by Roder
and coworkers414 in 1990. Although powerful and promising, HDX-based protein-protein
interaction studies are not often made in NMR. Early protein NMR approaches suffered from
limited spatial resolution, making it even more challenging to characterize large proteins by NMR.
As a complement to NMR, MS began to “pick up the baton” to extend HDX further to larger
proteins at lower and lower concentrations. The demonstration of HDX followed by ESI MS was
first by Katta, Chait, and Carr342 in 1991 who showed that the mass spectrum of a small protein
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(ubiquitin) changed significantly when it was sprayed in deuterated solvent. As the mass of the
deuteron (2.014) differs measurably from that of hydrogen (1.008), MS monitors HDX by tracking
the centroid mass of the isotopic envelop of a specific protein or peptide. As exchange-in
continues, the centroid shifts to higher m/z and reports the average number of Hs that have
exchanged with Ds.
The first example of off-line HDX and proteolytic digestion to reveal the regions of protein that
exchanges was by Zhang and Smith.415 They termed their approach as “the protein fragmentation
method”, and they used fast atom bombardment (FAB) as their ionization method. This approach
is the precedent for what is done today (except FAB has been replaced by ESI).

1.4.2 Mechanism of Exchange
To provide a basic understanding of the mechanism of HDX of the amide backbone requires brief
discussion of the fundamentals.161, 412, 416 Among all hydrogens in a protein molecule, those that
are part of O-H, S-H and N-H bonds exchange most rapidly with solvent water (D2O) molecules.
In a commonly executed “exchange-in” scenario, the protein is first solubilized in H2O. Upon
diluting with D2O, labile Hs on the protein exchange with the surrounding solvent Ds, leading to
an increase in mass that can be measured by a mass spectrometer. There is also an “exchange-out”
mode where the protein is first incubated in D2O, followed by addition of H2O to cause a D-to-H
exchange. Exchange-out is not as often used as “exchange-in,” and it will not be discussed further.
Although HDX happens for both protein backbones and amino acid sidechains containing
exchangeable Hs (e.g., NH2, OH, SH), most experiments focus on backbone hydrogens. The
hydrogens on the sidechains are weakly involved in hydrogen bonding, making their exchange fast
and not easily followed with most experimental setups. These exchanges do not confuse the
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experimental outcome because, as fast exchangers, they return to an -XH state during workup and
proteolysis that uses H2O, as expected in an ex situ measurement.
Because the HDX of protein side chains is fast and not readily measurable, the total exchange is
nearly only that of the amide N-H in peptide bonds, making HDX an “unbiased” labeling method
because every amino acid residue (except Pro) has an N-H hydrogen that can be exchanged. The
rate of exchange is fastest for amides that are solvent-exposed and not involved in hydrogen
bonding, for example, unstructured regions in a protein. HDX rates for these N-H hydrogens are
represented by kch, which is a function of pD, the temperature of the solvent, and the nature of the
side chains on neighboring amino acid residues. Previous studies reveal that HDX is both acid and
base-catalyzed, and that kch minimizes at a pH around 2.5,417, 418 the pH that is chosen for quenching
the reaction in a step that is essential for any ex situ measurement.
HDX for HOS determination is successful because the rate of HDX for backbone N-H hydrogen
atoms is determined by local conformation. Protein local orders are stabilized by intramolecular
N-H···O=C hydrogen bonding.419 The breathing motion of these hydrogen bonds will alter the
conformational states of the targeted hydrogens that comprise the N-H bonds from closed to open
states with a rate constant of kop. As the protein is highly dynamic, the open N-H bonds can also
close with a rate constant of kcl. A local view of HDX process for a backbone N-H, thus, can be
represented by Eq. 1.21.
𝑘𝑜𝑝

𝐷2 𝑂, 𝑘𝑐ℎ

N-Hclosed ← → N-Hopen →
𝑘𝑐𝑙

𝑘𝑐𝑙

N-Dopen ← → N-Dclosed (1.21)
𝑘𝑜𝑝

In principle, every N-H possesses a unique combination of kop, kch and kcl. The observed rate
constant for HDX, kHDX, is determined mainly by two factors: the solvent accessibility and the
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local hydrogen bonding in the region of the amide bond. For regions that are highly flexible, the
effect of these two factors is minimized so that kHDX = kch. For regions that are structured, HDX
occurs under two limiting regimes, EX1 and EX2.416, 420 EX1 is characterized by kch >> kcl, for
which kHDX = kop. In EX2, kcl >> kch, so that kHDX = Kopkch, in which Kop = kop/kcl. Practically, EX2
is more prevalent than EX1.399,

413

There are also intermediate exchange regimes that are

combinations of EX1 and EX2.420, 421

1.4.3 Experimental Approach
Most HDX measurements compare two states of a protein (e.g., bound vs. unbound, wildtype vs.
mutant); thus, this approach in footprinting is termed “differential”. In a differential experiment,
HDX for a ligand-unbound protein is compared to the ligand-bound state, and the effects of local
hydrogen bonding and back exchange cancel, leaving the differences in HDX to represent changes
in solvent accessibilities and H-bonding for the two different states as the only factors determining
the relative differences in HDX.422 Usually, ligand binding will induce a decrease in deuterium
uptake at the binding region, but there are also cases that indicate a different scenario ( i.e.,
increased deuterium uptakes at the binding sites upon interacting with ligands).421

Figure 1.12. Schematic illustration of a bottom-up peptide mapping workflow, a necessary step
prior to HDX. Green dots in the protein structure indicate hydrogen atoms in the peptide bonds.
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Experimentally, HDX is most commonly executed in a “bottom-up” fashion,418,

423

which

originated from early experiments of tritium exchange.424, 425 Bottom-up HDX was first introduced
by Zhang and Smith415 in 1993. In the peptide mapping mode, the protein or peptide (in H2O) is
denatured and, following quenching at pH ~ 2.5 (in H2O), is digested and made ready for LCMS/MS analysis for peptide identification and m/z determination to establish the average number
of D taken up in the exchange (Figure 1.12). One goal is to optimize the quenching conditions to
permit high sequence coverage and make available a peptide list comprised of peptide sequences,
precursor masses, and their elution times under optimized quenching conditions. The quenching
solution is usually composed of denaturant and an agent for disulfide bond reduction (if there are
any) and is at pH = 2.5, where the rates of back-exchange (exchange of deuterium in the protein
to hydrogen) are minimized. The quenching conditions, once optimized, are then used in further
HDX experiments.

Figure 1.13. Schematic illustration of a bottom-up HDX workflow. Green and red dots in the
protein structure indicate hydrogen and deuterium atoms in the peptide bonds, respectively.
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In the actual HDX experiment, the protein of interest is initially dissolved in H2O, and the solution
diluted with D2O and incubated for several different times to allow measurement of the HDX
kinetics (Figure 1.13). Upon exchanging, solvent-accessible amide hydrogens become replaced by
D. The exchange is then quenched by decreasing the solution pH to 2.5. Quenching is followed by
fast protease digestion and then MS analysis. The digestion is usually carried out online by flowing
the protein solution through a pepsin column. The solvents used in HPLC are at acidic pH, and the
LC-MS analysis is usually done at low temperature to minimize back exchange. Optimized
experimental design shortens the time prior to when the deuterated peptides are analyzed by MS
to minimize back-exchange. The obtained data are analyzed by fitting the isotopic distribution for
each peptide, from which a mass centroid is calculated, and the deuterium uptake is determined by
the difference in peak centroids between the exchanged protein (or the peptides) and the
unexchanged or control.
Measurement of HDX at the residue level with MS is challenging. Low-energy collisional
activation found on orbitraps, ion traps, or Q-Tofs cannot be used because that activation induces
deuterium scrambling,426, 427 erasing all the forward exchange that was scrupulously introduced.
Novel fragmentation methods that minimize scrambling include ECD135, 388 and ETD,387 making
possible, in some cases, measurement of residue-level deuterium uptake or of HDX in a “topdown” fashion428, 429.

1.4.4 Recent Advances and Applications
In this thesis, I report two HDX studies that involves both technical advancements and novel
biological questions. Chapter 5 outlines a study that utilizes HDX to study membrane proteins and
ultimately leads to a structural model that reveals the functioning mechanism of tetraspanin CD53CD2 and CD81-CD19 pairs.430 Chapter 6 reports a two-temperature HDX approaches to study the
61

binding sites between Class II lanthipeptide synthetase HalM2 and its binding partner HalA2LP.431 These two studies represent nicely the application of HDX in addressing novel biological
questions.
From the broader perspective, one important goal in the HDX field is to increase its spatial
resolution, ultimately to a single amino acid. Several approaches were developed to achieve a
single-residue resolution, including vigorous proteolytic fragmentations to give overlapping
peptides,389,

432

high-pressure on-line digestion to improve digestion efficiency,433,

434

incorporation of ETD and bottom-up HDX for enhanced spatial resolution,435-437 and computation
methods that facilitate processing the data from aforementioned methods389, 438, 439. Novel digestion
protocols give shorter peptides and more overlapping peptides. Single-residue HDX information
can be obtained by considering the absolute deuterium uptake levels of two overlapping peptides
that differ by a single amino acid residue.389, 432-434 This spatial resolution should also be achievable
through fragmentation to give smaller peptides formed by ETD or ECD fragmentation that can
occur with minimal deuterium scrambling. Quantification of the resulting fragments will give data
that resemble the deuterium uptakes for those fragments in solution.435 Novel computation
methods either facilitate the automatic processing of the overlapping peptides438 or utilize novel
algorithms to deconvolute the residue-level HDX behavior through a peptide-level HDX curve (by
either close examination of isotopic envelope shape information220 or a Bayesian approach for
deconvolution226).
To shorten further the exchange time, investigators developed theta capillary spray440 and gasphase HDX441-443 that allow exchange times as short as 20 μs to be followed. With further
optimization, it should be possible to track deuterium uptake on the amino acid residue sidechains,
which was not possible in conventional HDX (even with rapid mixing or stopped-flow) because
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the back-exchange of the active protons is rapid. It also allows HDX to capture, for the first time,
fast dynamic processes.
To expand the capabilities of HDX to binding affinities, investigators developed titration-based
HDX workflows including stability of unpurified proteins from rates of H/D exchange
(SUPREX)298 and protein–ligand interactions by mass spectrometry, titration, and H/D exchange
(PLIMSTEX).300 These approaches characterize ligand binding sites, binding orders (if there are
multiple ligands that bind the protein of interest), and, most importantly, site-specific binding
affinities. Both of these workflows were demonstrated at the peptide-levels,302 showing that it is
possible to carry out single-residue level with the combination of the efforts mentioned above
(ETD or multiple proteolytic digestions).
To expand the ability of HDX to characterize membrane proteins, effective removal of detergent444
and lipid,445 optimization of HDX conditions for enhanced transmembrane domain sequence
coverage,446 and post-HDX deglycosylation447 were developed. Post exchange detergent and lipid
removal are based on either chromatographic separation and organic solvent extraction444 or on
the interaction between zirconium(IV) oxide and phospholipids445. These advances make possible
the characterization of HDX for membrane proteins without incurring extensive back-exchange.
Post-HDX deglycosylation removes highly heterogenous glycans without compromising the
deuterium labeling on the peptides, allowing an investigator to obtain a well-resolved, highcoverage HDX analysis.447 All these advances broaden the horizon of HDX.
Other than the experimental advances, we witnessed a burst of HDX data processing software in
the past decade, some of the examples include HDExaminer,448 DynamX (formerly HXExpress),449 HDX Workbench,450 AUTOHD,451 Mass Analyzer,
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452, 453

HD Desktop,454

HeXicon,455 ExMS,456 HDX-Analyzer,457 HDX Finder,458 and Mass Spec Studio459. There are also
new HDX data visualization software include MSTools,460 MEMHDX,461 Deuteros,462 and HDXViewer463. The development of these software tools contributes greatly to the broad application of
HDX.

1.4.5 Conclusion
The union of HDX and MS launched MS into the field of protein HOS determination. Because
HDX causes a minimal perturbation on protein structure, has now a robust setup and analysis,
aided by a number of data processing packages, and requires no design or synthesis of reagents,
the adoption by the biochemistry community has been rapid. HDX covalently “labels” all protein
solvent-accessible backbone amide hydrogens (except Pro). Unlike targeted- and the fast-labeling
reagents whose labeling efficiencies are hugely variable and determined by residue-specific
reactivities, HDX occurs across the whole protein, and its labeling efficiencies depend on local
structure (solvent accessibility and hydrogen bonding). Moreover, deuterium labeling in HDX is
less disruptive to the protein structure as compared with other labeling approaches. Any
susceptibility is due to isotope effects, for which bond-making and bond-breaking could be
susceptible. In general, HDX footprints proteins in a relatively “unbiased” way. The advantages
of HDX, as envisioned by early pioneers, have been realized, and new applications are being
implemented, making HDX an important technology for HOS nearly three decades after its
introduction. Chapter 5 and 6 present two examples of using HDX to address practical biological
questions.

1.5 Conclusions
MS-based protein HOS analysis has increased the throughput and decreased the sample amount
requirements of protein HOS determination while becoming an effective complement to traditional
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biophysical characterization methods. More importantly, different protein footprinting approaches
allow MS-based approaches to view protein HOS from different perspectives. For example, HDX
usually measures the kinetics of exchange and infers HOS from the “labeling” of protein backbone
amide bonds. Targeted or specific labeling reagents exploit various organic reactions to report on
side-chain solvent accessibilities. Fast labeling reagents react with the residue side chains on the
time scale of ns to ms, affording a “snapshot” of protein structure and dynamics. Taken together,
MS-based protein labeling approaches “paint” the protein solvent accessible surfaces over a time
frame from ns to days to afford a comprehensive understanding of the protein of interest.
Moreover, modern proteomics digestion (bottom-up) workflows, top-down fragmentation
techniques together with ultra-sensitive MS instruments yield not only HOS information at midto-single-residue level but also dynamics of the protein under various conditions that are hardly
accessible by a single technique. This is important because a footprint should be done with high
coverage, unlike primary structure identification in traditional proteomics where 100% coverage
is not needed. Over the past decades, MS-based structural proteomics approaches have grown
extensively and now can answer important and challenging biological questions. None of these
developments were possible without the impressive technical innovations in the field of MS that
have occurred over 40 y.
In the coming chapters, I’ll present some of my work that utilizes MS as a tool for protein HOS
analysis. Chapter 2 describes the development of a novel approach to characterize protein-ligand
interactions, namely, LITPOMS. Chapter 3 focuses on the application of LITPOMS in addressing
a complex binding system, calcium-calmodulin, whose binding order and allosteric behaviors were
not well understood until this work. Chapter 4 presents a selective isotopic labeling approach for
FPOP labeling pathway determination. Chapter 5 documents membrane protein characterization
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by HDX-MS, whose results were further adopted for molecular docking. Chapter 6 reports an
HDX-MS characterization of the interaction between HalM2 and its substrate recognition motif,
through which a two-temperature workflow was implemented to increase the confidence of
binding site assignment.
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Titration, Fast Photochemical Oxidation of Proteins
and Mass Spectrometry: LITPOMS
This Chapter is based on the following publication:
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2.1 Abstract
We report a novel method named LITPOMS (ligand titration, fast photochemical oxidation of
proteins and mass spectrometry) to characterize protein-ligand binding stoichiometry, binding
sites, and site-specific binding constants. The system used to test the method is melittin –
calmodulin, in which the peptide melittin binds to calcium-bound calmodulin. Global-level
measurements reveal the binding stoichiometry of 1:1 whereas peptide-level data coupled with
fitting reveal the binding sites and the site-specific binding affinity. Moreover, we extended the
analysis to the residue level and identified six critical binding residues. The results show that
melittin binds to the N-terminal, central linker, and C-terminal regions of holo-calmodulin with an
affinity of 4.6 nM, in agreement with results of previous studies. LITPOMS, for the first time,
brings high residue-level resolution to affinity measurements, providing simultaneously qualitative
and quantitative understanding of protein-ligand binding. The approach can be expanded to other
binding systems without tagging the protein to give high spatial resolution.

2.2 Introduction
Protein-ligand interactions are the basis for numerous biological processes for which quantitative
understanding is vital.1,2 To quantify binding, investigators have used circular dichroism,2
fluorescence and fluorescence polarization,3,4 nuclear magnetic resonance,5 surface plasma
resonance,6,7 and isothermal titration calorimetry.8 The macroscopic binding affinity, however,
does not permit complete understanding of a protein-ligand system. The requirements for specific
fluorescence labeling,3,4 special sample preparation5,6 and large sample amounts5 also limit these
approaches.
Among the mass spectrometry (MS)-based approaches for quantitative protein-ligand interactions,
one class, termed direct methods, utilize the spectrometer to measure concentrations at
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equilibrium.9-12 Despite their convenience, there is always a question of whether the measured gasphase concentrations represent those in solution. To avoid this, indirect methods using
hydrogen/deuterium exchange (HDX) were also developed. Stability of unpurified proteins from
rates of HDX (SUPREX)13 yields a protein-ligand binding affinity by measuring the
thermodynamic stability of proteins as bound and unbound.
Another method, protein-ligand interactions by MS, titration and HDX (PLIMSTEX),14,15 gives
binding affinity through titration-based experiments.16-19 Titrating the protein at high concentration
(e.g., 100 times Kd) yields binding stoichiometry, whereas titrations at ~ Kd give the binding
affinity without any special modifications (e.g., tagging by a fluorophore).14,15 The indirect
methods can also sensitively characterize the binding-induced conformational changes at a
regional level represented by peptides from digestion.20-22 Although complementary information
for apolipoprotein E3 and a small-molecule drug candidate can be obtained simultaneously,19 HDX
is reversible and occurs at sec-to-min timescale,22 which may be competitive with off-rates of
protein-ligand equilibrium, giving convergence in HDX for bound and unbound at long times. D2O
dilution decreases the working concentration of the protein, making it challenging to characterize
tight binging. Back-exchange and deuterium scrambling during fragmentation challenge the
extension beyond the peptide level.
Fast photochemical oxidation of proteins (FPOP) labels proteins with hydroxyl radicals generated
through hydrogen peroxide photolysis.23-29 Hydroxyl radicals irreversibly label solvent-accessible
areas23,24 in sub-milliseconds, faster than protein conformational changes.24,26,27 This ensures that
FPOP labeling will not distort or compete with the binding equilibrium. Because the labeling is
irreversible, experiments can be executed off-line, where working concentrations are no longer
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determined by the detection limit of the mass spectrometer. Moreover, there are no back-exchange
and scrambling issues, making it possible to extend the detection to amino-acid residues.26,28,29
This chapter reports a novel FPOP-based ligand-titration method, protein-ligand interaction by
ligand titration, fast photochemical oxidation of proteins and mass spectrometry (LITPOMS). This
new approach allows us to measure binding stoichiometry and site-specific binding constants for
any protein-ligand system that experience a change in solvent accessible area upon binding. Such
measurements also access the equilibrium composition indirectly and importantly provide the
affinity in the liquid phase. LITPOMS overcomes disadvantages of PLIMSTEX, as stated above,
providing another significant strategy to assess binding stoichiometries, affinities, and dynamics.

2.3 Materials and Methods
2.3.1 Materials
Calcium-free calmodulin was purchased from Ocean Biologics (Seattle, WA, USA). Melittin from
honey-bee venom (≥ 85%, HPLC) was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Catalase (from bovine liver) was from Sigma-Aldrich (St. Louis, MO, USA). Concentrations for
each were determined by UV absorption with a Thermo Scientific NanoDrop OneC (Thermo
Scientific, Waltham, MA, USA). Trizma base, urea, potassium chloride (anhydrous, ≥ 99.0%),
calcium chloride (≥ 99.0%), L-methionine (≥ 99.5%), L-histidine (≥ 99.0%), hydrogen peroxide
solution (containing inhibitor, 30% wt. in H2O), hydrochloric acid (36.5% - 38%) were acquired
from Sigma-Aldrich (St. Louis, MO, USA). A trypsin/Lys-C digestion kit was purchased from
Promega (Madison, WI, USA). All these chemicals were used without further purification. Tris
buffer solution (10 mM) was made by dissolving Trizma base into water. Hydrogen chloride
solution was added to obtain a desired pH of 7.4 (measured with an Orion Star A211 pH meter,
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Thermo Scientific, Waltham, MA, USA). Potassium chloride was added to the tris buffer to give
a concentration of 100 mM to insure appropriate ionic strength of the buffer solution.

2.3.2 LITPOMS

Figure 2.1. Schematic illustration of LITPOMS workflow.
To start, calmodulin was first diluted into Tris buffer. Calcium chloride solution was then added
and the mixture was incubated for 45 min to ensure all the calmodulin was saturated with calcium
ions (CaM converted to holo-CaM). After the formation of the holo form, melittin was added at
different concentrations as part of a titration. The mixtures were then kept overnight at room
temperature to ensure that the holo-CaM and melittin had equilibrated. The other components were
added just prior to laser irradiation to form the OH radicals.
As stated in the main text, experiments were performed at two different protein concentrations. At
high protein concentration, aliquots of 50 μL with the final concentration of [CaM] = 10 μM, [Ca2+]
= 0.2 mM, [L-histidine] = 1 mM, [H2O2] = 10 mM (after optimization), [Melittin] = 0 – 20 μM
were prepared for laser irradiation. A mixture of 10 μL 70 mM L-methionine (in Tris buffer) and
1.0 μL 500 nM catalase (in Tris Buffer) was used as a quench for each sample aliquot. At low
protein concentration, a total volume of 150 μL was used, and the final concentration of each
species was [CaM] = 200 nM, [Ca2+] = 14 μM (after optimization), [L-Histidine] = 20 μM, [H2O2]
= 1.6 mM (after optimization), [Melittin] = 0 – 600 nM. All samples were prepared in duplicate to
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assess the precision. A mixture of 15 μL 700 μM L-methionine (in Tris buffer) and 1.5 μL 500 nM
catalase (in Tris Buffer) was used as the quenching solution for each individual sample.
The FPOP platform was the same as previously reported.28 The sample was introduced through a
capillary tubing (I.D. of 150 μm) by a syringe pump (Pump 11 Elite, Harvard Apparatus, Holliston,
MA, USA). The beam from a KrF excimer laser (EX50/250, GAM Laser, Orlando, FL, USA) with
a wavelength of 248 nm and frequency of 7.2 Hz was introduced through a transparent window.
The average laser energy was tuned to ~ 25 mJ/pulse and measured with a pyroelectric energy
sensor (PE25-SH-V2, Ophir Optronics Solutions, North Logan, UT, USA) The flow rate was
chosen to be 22-25 μL/min based on the laser spot width and the operating frequency to ensure a
25% exclusion volume. The irradiated sample was collected at the end of capillary tubing in the
quenching solution to ensure that the protein does not get over labeled by residual radicals or leftover H2O2.
A global-level response was determined with a Quadrupole Time-of-Flight instrument (Bruker
MaXis, Billerica, MA, USA) coupled with an HPLC system (FLX. 10371, Leap Technologies,
Morrisville, NC, USA). A C-8 column (Agilent, Santa Clara, CA, USA) was used for sample
loading and separation. Electrospray ionization (ESI) was used for ionization. A total of 10 pmoles
labeled protein was used for signal collection.
To measure the extent of footprinting at the peptide level, the sample was first digested with
Trypsin/Lys-C mixture. For the protein concentration of 200 nM, a total of 100 μL of labeled
protein solution was added to an Eppendorf tube. The solvent was then evaporated with a
SpeedVac (Thermo Scientific, Waltham, MA, USA), leaving a protein pellet at the bottom of the
Eppendorf. Urea (3.3 μL of 8 M) was added to the top of the protein pellet to dissolve and denature
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the protein. The mixture was kept at room temperature for 30 min to ensure that the protein had
been fully denatured. TAB buffer (29.7 μL of 0.1 mM) was then added to dilute the urea. Finally,
0.15 μL of 0.2 mg/mL trypsin/Lys-C (in H2O) was added to the solution. The solution was then
kept at 37°C overnight so that the protein had been fully digested. After incubation, 0.33 μL formic
acid was added to the mixture to quench the digestion, yielding a solution ready for analysis.
Peptide-level responses were determined with a Thermo Scientific Q Executive Plus Orbitrap mass
spectrometer (Waltham, MA, USA) coupled with a Thermo Scientific Dionex UltiMate 3000
RSLCnano UPLC system (Waltham, MA, USA). A custom-packed C-18 column was used for
peptide separation. Fragmentation was in an HCD cell at the end of the instrument. Unmodified
and modified peptides were identified by Byonic (Protein Metrics, San Carlos, CA, USA), and the
data were processed with Byologic (Protein Metrics, San Carlos, CA, USA).

2.3.3 Modification Fraction Calculation

Figure 2.2. (a) An extracted ion chromatogram for modified (top) and unmodified (bottom)
peptide 127-148 at [Mel]/[Holo-CaM] = 0. Colored areas are integrated and used for modification
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fraction calculation. Peak assignment was done through MS/MS analysis, and the corresponding
spectra were shown as (b) +16 on residue M145, (c) +16 on Residue M144, (d) +16 on residue
Y138 and (e) unmodified peptide. Peak assignment with corresponding amino-acid sequence was
depicted in each spectrum.
Modification fractions at peptide and residue level were calculated by integrating the areas of
extracted ion chromatograms for each individual peptide (example in Figure 2.2a, where an
extracted ion chromatogram for peptide 127 – 148 at [Mel]/[Holo-CaM] = 0 was plotted). Through
MS/MS analysis, the lower peak (Figure 2.2a) was assigned to an unmodified species whereas
three distinct modified species could be assigned. The purple peak was assigned to a +16
modification on M145, the cyan peak was assigned to a +16 modification on residue M144, and
the green peak was assigned as a +16 modification on residue Y138. Corresponding product-ion
(MS/MS) spectra with peak assignment and amino acid sequences are shown as Figure 2.2b to e.
To calculate modification fraction at peptide level, we utilize:

𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛127−148 =

𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑
𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑢𝑓𝑖𝑒𝑑 + 𝐴𝑅𝐸𝐴𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

where AREAModified corresponds to total integrated area of the upper extracted-ion chromatogram
in Figure 2.2a whereas AREAUnmodified indicates the integrated area of the lower extracted-ion
chromatogram in Figure 2.2a.
Residue-level modification fraction was calculated in a similar fashion. For example, modification
fraction for residue M145 was evaluated as

𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑀145 =

𝐴𝑅𝐸𝐴𝑀145(𝑝𝑢𝑟𝑝𝑙𝑒 𝑝𝑒𝑎𝑘)
𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑢𝑓𝑖𝑒𝑑 + 𝐴𝑅𝐸𝐴𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑
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and the corresponding results were plotted in Figure 2.7.

2.4 Results and Discussion
2.4.1 FPOP Labeling Condition Scanning

Figure 2.3. Modification fraction as a function of hydrogen peroxide concentration at calmodulin
concentration of 10 μM. Error bars are standard deviations from two independent runs whereas the
data points represent the average of the two runs.
To ensure that the binding-induced conformational change is properly reported through
modification fraction, the FPOP labeling conditions were optimized. With scavenger concentration
fixed, a good modification extent with a moderate hydrogen peroxide concentration were goals.
Figure 2.3 shows the modification fraction as a function of hydrogen peroxide concentration at
high protein concentration of 10 μM. A previous study showed that [Ca2+]/[CaM] = 10 is sufficient
for the calmodulin to be fully saturated with Ca2+ to give holo-calmodulin at [CaM] = 10 μM;
[Ca2+] in current experiment was 0.1 mM.29 As shown in Figure 2.3, an increase in the modification
extent was observed as increasing hydrogen peroxide concentration. Because the hydrogen
129

peroxide is a weak oxidant and could oxidize the protein when [H2O2] is high and exposure time
is long, [H2O2] = 10 mM was chosen as the proper concentration, and all high protein concentration
experiments were all carried out under such conditions.

Figure 2.4. (a) Modification fraction as a function of hydrogen peroxide concentration at
calmodulin concentration of 200 nM. (b) Modification fraction as a function of calcium ion
concentration at calmodulin concentration of 200 nM. Error bars are standard deviations from two
independent runs, and the data points represent the average of the two runs.
Similar experiments were carried out at low protein concentration of 200 nM, and the
corresponding results were plotted (Figure 2.4a). In this experiment, no calcium was added, and
as a result, the hydrogen peroxide concentration of 1.6 mM was considered as optimized and was
used in all the titration experiments. Moreover, to ensure the complete formation of holocalmodulin, the calcium concentration was also scanned at [CaM] = 200 nM, and the results were
plotted (Figure 2.4b). It was quite clear that modification fraction saturates when calcium
concentration is higher than 14 μM, suggesting the complete formation of holo-calmodulin at
[Ca2+] = 14 μM. Therefore, the calcium concentration was determined as 14 μM for all lowconcentration experiments.
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2.4.2 Global Level LITPOMS Responses at Two Concentrations

Figure 2.5. Modification fraction measured at global level as a function of melittin concentration
with initial protein concentration of (a) 10 µM and (b) 200 nM. Error bars are standard deviations
from two independent runs whereas the data points are the average of the two runs.
To demonstrate LITPOMS, we chose calmodulin-melittin as a model. Melittin (Mel) binds to
calcium-bound calmodulin (holo-calmodulin or Holo-CaM) at a ratio of 1:1 with a Kd of 3 nM.3033

Crosslinking suggests that melittin binds with the N-terminus, C-terminus, and the central linker

region of the holo-calmodulin.31,32
Given that the shape of the titration curve is sensitive to protein concentration, experiments were
carried out at two different protein concentrations, namely, 10 µM and 200 nM (Figure 2.5). A
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more compact conformation forms as Holo-CaM binds with melittin, leading to a lower overall
solvent accessibility and a decrease in the macroscopic modification fraction. At a [Holo-CaM] of
10 µM, 3000-fold > Kd of the system, a sharp-break curve is obtained (Figure 2.5a). The breakpoint, at [Mel]/[Holo-CaM] of 1.0, indicates the binding stoichiometry is 1:1. For a lowconcentration titration ([Holo-CaM] = 200 nM), the fraction modified decays smoothly as [Mel]
is increased (Figure 2.5b). This promising tendency encouraged us to digest the protein and obtain
spatial resolution for binding and affinity.

2.4.3 Peptide Level LITPOMS Responses for Binding Affinity Measurements

Figure 2.6. Modification fraction as a function of melittin:holo-calmodulin for eight tryptic
peptides. Red solid lines in (a) and (d) represents the fitting result with the algorithm described
previously.14,15 Error bars are standard deviations from two independent runs whereas the data
points represent the average of two runs.
Taking advantage of the irreversible labeling of the protein through FPOP, we combined titration
with FPOP-based bottom-up proteomics to report the modification change as a function of ligand
concentration. To model the titration process and obtain the binding affinity, we carried out
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peptide-level experiments at a protein concentration of 200 nM, allowing us to plot the
modification fraction as a function of ligand concentration for each individual peptide (Figure 2.6).
Note that sequence coverage for calmodulin in the current study is 99%. Two different behaviors
can be distinguished (Figure 2.6), namely, increased protection for binding regions and constant
protection for non-binding regions. Fractional modifications for peptides 1-13, 31-37, 38-74, 7690 and 91-106 remain relatively stable as the titration proceeds, indicating that the local
conformations for these regions remain unchanged at the peptide level upon binding. Thus, these
regions are unlikely to be involved in binding with melittin and serve as controls.
On the contrary, regions 14-30, 107-126 and 127-148 experience increased protection as reported
by decreases in fractional modification as the titration proceeds. The increase of protection
becomes constant at the later titration stages (i.e., when [Mel]/[Holo-CaM] ≥ 2), indicating
complete formation of the complex. These regions are likely to contain residues that are involved
in binding. Moreover, the decrease in modification, whether caused by a conformation change or
direct binding, provides quantitative information of the binding interaction (Kd). Because melittin
binds with holo-calmodulin at 1:1 (Figure 2.5a), all three curves were modeled together to afford
a single binding affinity (modeling algorithm described previously14,15). In brief, both the holocalmodulin and the melittin – holo-calmodulin complex has their distinct modification fraction. A
search utilizes both of the fractions and the overall equilibrium binding Kd to find a best fit of the
experimental data in the plot. Since all the data points were measured at equilibrium, modeling is
simplified. As a result, we could extract a dissociation constant of 4.6 nM (R2 > 99%), in good
agreement with a reported affinity of 3 nM.30 Even though each sample was measured in duplicate,
statistical certainty of the data set increases through curve fitting and resampling. A total of 128
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resampling trials were executed based on a previously developed strategy15 and the estimated
standard deviation is 2.7 nM.

2.4.4 Residue Level FPOP Reveals Key Binding Residues

Figure 2.7. Modification fraction as a function of melittin:holo-calmodulin for selected aminoacid residues. Red bars show modification fraction for holo-calmodulin itself whereas blue bars
represent melittin-bound holo-calmodulin where [Mel]/[Holo-CaM] = 3. Residue F19 and K21
data are enlarged in top left. Error bars are standard deviations from two independent runs, and
data points are the average of the two runs.
Accepting that FPOP footprints in sub-millisecs, faster than binding-induced conformational
changes,24,26,27 we propose FPOP “snapshots” the real-time equilibrium composition. These
features provide a solid foundation for making LITPOMS reliable and informative. The
irreversible FPOP modifications preserve structural information upon sample workup and MS/MS
fragmentation, allowing extension to the residue level26,28,29 (Figure 2.7) at the three binding
regions. For the full protein, 10 amino acid residues can be successfully resolved (Figure 2.7).
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Among them, K21 does not show any significant change upon binding, suggesting it is not
involved. Residues F19, M109, M124 and M145 show decreases in modification fraction upon
binding, indicating that these residues are binding with melittin, thus experiencing decreases in
solvent accessibility owing to spatial hindrance from the melittin ligand. Residues Y138 and
M144, however, become more exposed upon binding with ligand, suggesting a binding-induced
conformational change.
Another promising observation involves the two adjacent residues M144 and M145, where M144
becomes exposed whereas M145 becomes protected upon binding. The observations not only
provide deeper understanding of melittin–holo-calmodulin binding system but also demonstrate
the promising spatial resolution for LITPOMS.
Out of the previously identified binding regions, three different residues M51, M71 and M72/R74
were successfully identified. Note that the spectral quality is currently not sufficient to distinguish
M72 and R74 and the result is reported as M72/R74. M71 is a residue that becomes more exposed
through binding-induced conformational changes since the modification fraction increases upon
binding with melittin. Other than this, M51 and M72/R74 are both involved in binding owing to a
decrease in modification fraction. Given that peptide 38-74 does not exhibit a noticeable change
upon binding with melittin, as shown in Figure 2.6d, this once again reveals that LITPOMS brings
more detail to our understanding of protein-ligand as compared with PLIMSTEX.
In summary, not only the N-terminal (peptide 14-30) and C-terminal region (peptide 107-126 and
peptide 127-148), but also central linker region (residue M51, M72/R74) of holo-calmodulin are
involved in binding with melittin. We identified six critical binding residues and three
conformational-change residues and determine a Kd = 4.6 nM. These findings agree with those in
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a previous crosslinking study.32 The coupling of FPOP with ligand titration and MS permits
successful characterization of protein-ligand binding stoichiometry, binding sites (peptide and
amino-acid levels), and site-specific binding constants, even for a tight binding system like
melittin:holo-calmodulin.

2.5 Conclusion
The high-concentration mode for stoichiometry and the low-concentration mode for binding-site
determinations and site-specific binding affinities make LITPOMS promising for characterizing
protein-ligand binding for high picomole quantities of protein. Moreover, irreversible labeling by
FPOP makes possible post-labeling sample treatment without erasing any labeling information
(e.g., from back exchange). LITPOMS is also readily compatible with various buffers, pH, salts,
lipid-based media (e.g., nano and pico disks), and binding affinities (ranging from nM to µM),
making it generally applicable even to membrane proteins. We also expect the approach should
not be affected by high off-rates for weaker binding systems as is HDX, but that remains to be
established. Importantly, residue-level analysis becomes possible owing to the irreversible labeling
that will be maintained for successful MS/MS measurements, and more complete residue
determinations will be enabled by the development of complementary footprinters (e.g., CF3∙,34
carbenes35). Although we demonstrated here the applicability to tight binding (nmolar) of 1:1
binding system, we plan to extend the method development to other, more complex binding
systems with stoichiometries greater than 1:1.
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3.1 Abstract
Signaling proteins exemplified by calmodulin usually bind cooperatively to multiple ligands.
Intermediate states and allosteric behavior are difficult to characterize. Here we extend a recently
reported mass spectrometry (MS)-based method named LITPOMS (ligand titration, fast
photochemical oxidation of proteins and mass spectrometry) that characterizes complex binding
systems typically found as signaling proteins. Peptide-level LITPOMS applied to Ca2+ binding to
calmodulin reveals binding order and site-specific affinity, providing new insights on the behavior
of proteins upon binding Ca2+. We established that EF hand-4 (EF-4) binds calcium first, followed
by EF-3, EF-2 and EF-1 and determined the four affinity constants by modeling the extent-ofmodification curves. We also found positive cooperativity between EF-4, EF-3 and EF-2, EF-1
and allostery involving the four EF-hands. The composite, peptide-level conformational changes
at several regions can be dissected either by digestion with a different protease or by tandem MS
of LITPOMS behavior at the amino-acid residue level. Such dissection greatly elevates spatial
resolution and increases the confidence of binding order assignment. These complementary views
of complex protein conformational change recapitulate the cumulative understanding via a single
approach, providing new insights on poorly understood yet important allostery and underpin an
approach applicable for exploring other signaling systems.

3.2 Introduction
Cell signaling adapts to changing environments, requiring messengers that change their
concentrations in response to local stimulation. Ca2+ signaling system includes hundreds of cellular
proteins.1 Their Kd’s with Ca2+ range from nanomolar to millimolar while binding to multiple Ca2+
ions in a cooperative fashion, as exemplified by neuronal calcium sensor family,2 synaptotagmin,3
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and calmodulin1, 2, 4. The binding, chelation with negatively charged residues, alters the protein
conformation and facilitates signal transduction by opening new binding regions.
The canonical Ca2+ chelating motif is an EF-hand, composed of a “helix-loop-helix” domain.5, 6
During binding, Ca2+ binds with the negatively charged residues in the calcium loop, further
triggering a structural change whereby the two helices alter their interhelical angles. As a result,
the EF-hand binding transforms the protein from a closed to an open conformation during which
the negatively charged chelating residues become less solvent-accessible and the two helices
become more. Among all EF-hand-containing Ca2+ signaling proteins, calmodulin (CaM) is the
archetype owing to its ubiquitous presence in eukaryotic systems and its role as a signaling
protein.7, 8 Within its 148-amino-acid sequence reside four canonical EF-hands, two each in the Nterminal and C-terminal lobes.9 Macroscopically, CaM binds with four Ca2+ ions with µM affinity,
changing its high order structure.1,

10

Upon binding, CaM opens to a ‘dumbbell-shaped’

conformation, exposing hydrophobic residues that interact with targets to cause signaling and
regulation.6, 11
Understanding these interactions has required decades of research, during which various
approaches were developed10,

12-25

and applied.10,

17-22, 24

Fluorescence-based methods reveal

overall conformational changes, Ca2+ binding affinities,10, 22 and, in combination with microfluidic
mixers, the kinetics of conformational change upon binding.20 NMR shows the EF-hand local
conformational change induced by binding.17 Isothermal titration calorimetry examines the system
thermodynamically, providing valuable binding constants.18, 21 Protein engineering of the calcium
loops leads to their intrinsic binding affinities.26 Although the complex binding scheme of CaM
and Ca2+ have been revealed by many approaches, important features including allostery and
binding orders remain unclear. On the other hand, the needs for specific fluorophore labeling,
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special sample preparation, and high sample quantity limit applications. Thus, a new approach that
overcomes these problems and delivers improved spatial resolutions will be a significant
improvement in tool set for protein - metal-ion binding.
To date, NMR resolves protein solution-state structure with the highest spatial resolution. A
titration-type affinity measurement for metal-ion binding, however, requires low micromolar
concentrations, which are not accessible today to NMR. A mass spectrometry (MS) structural
proteomics approach should significantly lower sample amount and eliminates the need for
specific isotopic labeling as for NMR. Moreover, a structural proteomics approach may also
greatly elevate the spatial resolution and sensitivity when compared with fluorescence.23, 24 Indeed,
spatial resolution is achievable by protease digestion and MS.27
Although lower in resolution, MS uses smaller sample amounts, allowing studies with the native
protein and eliminating the need for isotopic enrichment, mutation, or addition of a reporter.23, 24,
28

To follow the conformational changes of proteins upon metal binding, investigators have

developed and applied synchrotron-based hydroxyl radical labeling,29,

30

hydrogen/deuterium

exchange (HDX)-based titration including SUPREX (stability of unpurified proteins from rates of
H/D exchange)23 and PLIMSTEX (protein ligand interactions by MS, titration and H/D
exchange)24, footprinting of specific residues by slow labeling reagents such as glycine ethyl ester
(GEE)31 and benzhydrazide (BHD)32 that targets solvent-accessible carboxyl groups on aspartic
(D) and glutamic acids (E). They all contribute to the understanding of complex metal binding
proteins.
Moreover, recent advances of MS fragmentation methods such as electron transfer dissociation33,
34

and electron capture dissociation35 allow following HDX at amino acid residue resolution. Fast
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photochemical oxidation of protein (FPOP) was also extensively demonstrated to extend the
spatial resolution to single residue level.36-38 These advances can be extended to study the
composite behavior of metal binding proteins. Recently, we communicated a new MS-based
approach, “ligand titration, fast photochemical oxidation of proteins and mass spectrometry
(LITPOMS)” that resolves complex binding dynamics by means of a ligand titration.25, 39 The
titration is monitored by FPOP that labels irreversibly the solvent-accessible surface at submillisecond times,40, 41 enabling a “snapshot” of the system state. LITPOMS, first applied to a 1:1
binding system, revealed binding sites, site-specific binding affinities and even critical binding
residues.25
This chapter reports that application of LITPOMS can meet the challenge and determine binding
sites, binding affinities, binding orders, site-specific affinities, and importantly the complex,
composite behavior of the protein upon metal-ion binding. Moreover, it can reveal cooperativity
and allostery. Information from LITPOMS recapitulates the long-term cumulative efforts to
understand calcium-calmodulin binding. In this end, we report an expansion of that study whereby
we increase the spatial resolution, even to the amino-acid level, using different protease digestion
and MS/MS, describe additional data processing, and provide new insights on the results. The
outcomes indicate that LITPOMS can characterize complex binding dynamics via a single
approach, providing insights that are not easily accessible from any single or simple combination
of conventional methods.

3.3 Materials and Methods
3.3.1 Materials
Calcium-free bovine calmodulin was purchased from Ocean Biologics (Seattle, WA, USA).
Catalase (from bovine liver) was from Sigma-Aldrich (St. Louis, MO, USA). Concentrations for
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each were determined by UV absorption with a Thermo Scientific NanoDrop OneC (Thermo
Scientific, Waltham, MA, USA). Trizma base, urea, potassium chloride (anhydrous, ≥ 99.0%),
calcium chloride (≥ 99.0%), L-methionine (≥ 99.5%), L-histidine (≥ 99.0%), hydrogen peroxide
solution (containing inhibitor, 30% wt. in H2O), hydrochloric acid (36.5% - 38%) were acquired
from Sigma-Aldrich (St. Louis, MO, USA). Formic acid (LCMS Grade) was from CovaChem
(Loves Park, IL, USA). Trypsin/Lys-C and chymotrypsin digestion kits were purchased from
Promega (Madison, WI, USA). All these chemicals were used without further purification. Tris
buffer solution (10 mM) was made by dissolving Trizma base in water. Hydrochloric acid solution
was added to obtain a desired pH of 7.4 (measured with an Orion Star A211 pH meter, Thermo
Scientific, Waltham, MA, USA). Potassium chloride was added to the tris buffer to give a
concentration of 100 mM to ensure physiologically relevant ionic strength of the buffer solution.

3.3.2 LITPOMS
To start, a solution of calmodulin was diluted with Tris buffer. Calcium chloride solution was
added stepwise in a titration. The mixtures were kept at room temperature for 45 min to ensure
that the CaM and Ca2+ had equilibrated. The other components were added prior to the laser
irradiation that formed the OH radicals.
To extract binding affinities, experiments were performed at protein concentration of 1 µM.
Aliquots of 100 µL with a final concentration of [CaM] = 1 µM, [L-histidine] = 0.1 mM, [H2O2]
= 3 mM, [Ca2+] = 0 – 60 µM (titrant) were prepared for laser irradiation. A mixture of 10 µL 7
mM L-methionine (in Tris buffer) and 0.3 µL 500 nM catalase (in Tris Buffer) was used as a
quench for each sample aliquot. All samples were prepared in duplicate to assess precision,
followed by FPOP labeling, where the sample was introduced through a capillary tubing (I.D. of
150 µm) by a syringe pump (Pump 11 Elite, Harvard Apparatus, Holliston, MA). The beam from
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a KrF excimer laser (EX50/250, GAM Laser, Orlando, FL) with wavelength of 248 nm and
frequency of 7.2 Hz was introduced through a transparent window in the capillary tubing. The
average laser energy was tuned to ~ 25 mJ/pulse as measured with a pyroelectric energy sensor
(PE25-SH-V2, Ophir Optronics Solutions, North Logan, UT) The flow rate was 22-25 µL/min so
that the laser spot width and the operating frequency ensured a 25% exclusion volume. The
irradiated sample was collected at the end of capillary tubing in the quenching solution to ensure
that there is no further oxidative labeling of the protein by residual radicals or left-over H2O2.

3.3.3 Protein Digestion
To measure the footprinting extent at the peptide level, samples were digested by using two
different proteases, trypsin/Lys-C mixture and chymotrypsin.
For trypsin/Lys-C digestion, a total of 60 µL of each labeled protein solution was added to an
Eppendorf tube. The solvent was evaporated with a SpeedVac (Thermo Scientific, Waltham, MA,
USA), leaving a protein pellet at the bottom of the Eppendorf. Urea (10 µL of 8 M) was added to
the top of the protein pellet to dissolve and denature the protein. The mixture was kept at room
temperature for 30 min to ensure that the protein had been fully denatured. Tris buffer (90 µL of
10 mM) was then added to dilute the urea. Finally, 0.35 µL of 0.2 µg/µL trypsin/Lys-C (in H2O)
was added to the solution, which was then kept at 37 °C overnight so that the protein can been
fully digested. Similar procedures were adopted for chymotrypsin digestion, where a total of 30
µL labeled protein solution was used. After evaporating the solvent, 5 µL of 8 M urea was added
to denature the protein, followed by addition of 44.6 µL of 10 mM Tris buffer and 0.35 µL of 0.1
µg/µL chymotrypsin solution (in H2O) for overnight incubation. Under both digestion conditions,
formic acid was added to give 1% (by volume) to quench the proteolysis.
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3.3.4 Data Acquisition and Analysis
A global-level (intact protein) response was determined with a Quadrupole Time-of-Flight
instrument (Bruker MaXis, Billerica, MA) in the ESI mode coupled to an HPLC system (FLX.
10371, Leap Technologies, Morrisville, NC). A C-8 column (Agilent, Santa Clara, CA) was used
for sample loading and separation. Note that maximum resolvable mass shift at the global level is
+64, which the percent modification in Figure 3.3 was based on the following equation.
𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑔𝑙𝑜𝑏𝑎𝑙
=

𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+16 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+32 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+48 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+64
𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦𝑤𝑖𝑙𝑑𝑡𝑦𝑝𝑒 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+16 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+32 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+48 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦+64

Peptide-level responses were determined with a Thermo Scientific Q Executive Plus Orbitrap mass
spectrometer coupled with a Dionex UltiMate 3000 RSLCnano UPLC system (Waltham, MA). A
custom-packed C-18 column was for peptide separation. Fragmentation was in the HCD cell.

Figure 3.1. (a) An extracted ion chromatogram for modified (top) and unmodified (bottom)
peptide 76-90 at calcium to calmodulin of 0. Colored areas are integrated and used for modification
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fraction calculation. Peak assignment was done through MS2 analysis, and the corresponding
spectra were shown as (b) +16 on residue M76, (c) unmodified peptide. Peak assignment with
corresponding amino-acid sequence was depicted in each spectrum.
MS/MS data were identified by Byonic (Protein Metrics, San Carlos, CA) at peptide and aminoacid residue levels, and the data were processed with Byologic (Protein Metrics). As the most
abundant modifications were oxidations, only +16Da and +32Da were quantified in global,
peptide, and residue levels. Modification fractions at peptide level was calculated by integrating
the areas of extracted ion chromatograms (example shown in Figure 3.1) for each individual
species as:

𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑃𝑒𝑝𝑡𝑖𝑑𝑒 =

𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑,𝑃𝑒𝑝𝑡𝑖𝑑𝑒
𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑 + 𝐴𝑅𝐸𝐴𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

Similarly, residue-level modification fractions were calculated by using the peak area of a specific
modified species versus the overall peak area as:

𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑅𝑒𝑠𝑖𝑑𝑢𝑒 =

𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑,𝑅𝑒𝑠𝑖𝑑𝑢𝑒
𝐴𝑅𝐸𝐴𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑 + 𝐴𝑅𝐸𝐴𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

The -30Da and the -44Da were included in the search for residue D and E. The result suggest that
most abundant modifications were oxidations, that is +16Da and +32Da. The abundance of -30Da
and -44Da is extremely low and the quality of those MS/MS were poor therefor not accounted for.
Note that even though it is possible for D and E to react with ·OH, their reactivities are poor.42
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Figure 3.2. A sequence coverage map for one of the test runs. Each green horizontal line indicates
a kind of MS2 experiment, and a red dot under a residue indicates a modification at that site. Note
that a greater number of green lines for a peptide does not indicate that the absolute abundance for
that peptide is high, as longer peptides have more possible sites to be modified thus resulting in
more kinds of MS2 experiments (and more horizontal bars).
For quantitative analysis, peptides were chosen for an inclusion list. A suitable peptide needs to
occur reproducibly, have a resolvable extracted ion chromatogram, appropriate accurate mass, and
satisfactory MS2. In the case of trypsin digestion, eight peptides were used in the analysis and other
tryptic peptides were captured occasionally. The first of these peptides arose from missedcleavages. A good example is at the N-terminus of the protein, where three distinct peptides were
observed, 1-13, 14-30 and 1-30. Peptide 1-30 came from a missed cleavage at C-terminal side of
K-13, and it was not placed on the inclusion list. Because it is from a missed cleavage, its
abundance was low, as determined in the test-runs. Moreover, its length appeared to “dilute’ the
structural information, and as a long peptide, it eluted later than the other two peptides and didn’t
fragment as well. Similar phenomena also occur for the peptides at the C-terminus of calmodulin,
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where peptide 107-126, 127-148 and 107-148 were observed. The peptide 107-148 was not
involved in the inclusion list for the same reasons.
A second scenario was that some peptides do not appear reproducibly in the test-runs. For example,
the peptide 107-115 was captured once with a single product-ion (MS2) spectrum (not captured in
this specific test-run in Figure 3.2). Its FPOP oxidized form was never captured in the test-runs.
The peptide 22-37 was also observed occasionally, but the quality of its MS2 was not promising
from run-to-run. Further, these kinds of peptides usually occur at low abundance and give
inadequate fragmentation in the MS2. Thus, this kind of peptide was not a proper candidate in the
titration format approach and was not included in the inclusion list. Even though these peptides
also end with K or R at their C terminus, these are not the preferred trypsin cleavage sites in
calmodulin. Similar observations apply to peptide 14-21, 76-86, 78-90 and 95-106, which either
underwent poor MS2 fragmentation or gave an unresolvable extracted ion chromatogram. Similar
principles apply to the selection of chymotryptic peptides, and three tryptic peptides were selected
for LITPOMS analysis.
To extract the site-specific binding affinities, all peptide level responses for eight tryptic peptides
were co-fitted by using a previously developed algorithm24, 28 implemented by Mathcad 14.0
(Parametric Technology Corporation, Needham, MA). To be specific, EF-1 and EF-2 were
grouped into the N-terminal whereas EF-3 and EF-4 in the C-terminal lobes. A fitting model was
constructed,10 where positive cooperativity in each lobe and independent binding in the two lobes
were assumed. Each binding state (Apo-CaM, CaM-1-Ca2+, CaM-2-Ca2+…) had a distinct
modification fraction. Under these assumptions, a high order partition polynomial was constructed
as a function of calcium concentration. A search utilized the experimental data to determine an
answer for the polynomial, after which binding affinities and peptide-specific fitting curves were
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obtained. Only eight tryptic peptides (1-13, 14-30, 31-37, 38-74, 76-90, 91-106, 107-126 and 127148) were brought into the search owing to the limitation of the current searching algorithm. Red
lines in other peptide (90-99, 125-138 and 139-145) and residue level (F16, F19, K21, M51, M71,
M72/R74, F92, Y99, M109, M124, Y138, M144 and M145) LITPOMS responses were
reconstructed from search results and agreed with the experimental data.

3.4 Results and Discussion
3.4.1 Global Level LITPOMS Response

Figure 3.3. (a) NMR structure of apo-calmodulin (top, PDB ID 1CFD) and crystal structure holocalmodulin (bottom, PDB ID 1CLL). Flexible linker, E-helix, calcium loop, F-helix and calcium
ions were color coded as blue, grey, cyan, green and red, respectively. (b) Global level LITPOMS
response at calmodulin concentration of 1 µM. Error bars are standard deviations from two
independent runs whereas the data points represent the average of the two runs. Data adopted from
ref. 39. (c) Global level mass spectrum for calmodulin at [Ca2+]/[CaM] = 60 at +16 charge state.
(d) Global level mass spectrum for calmodulin at [Ca2+]/[CaM] = 0 at +16 charge state.
Upon binding of CaM and Ca2+, the interhelical angles alter to facilitate a ‘closed’ to ‘open’
transition for each EF-hand. CaM responds by assuming a ‘dumbbell’ conformation from a
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protected form.6, 11 This structural transition leads to an increase of the overall solvent accessible
surface area (SASA), which is clearly captured as an increase in modification fraction as a function
of calcium concentration at the global or whole protein level (Figure 3.3). We observed a decrease
in modification fraction at [Ca2+]/[CaM] between 2 to 5, suggesting one or more steps of Ca2+
binding induced protection, thus motivating digestion and analysis at the peptide and amino-acid
levels.

3.4.2 Four Classes of LITPOMS Behaviors on Trypsin Digested Calmodulin

Figure 3.4. Sequence coverage map of the CaM protein sequence. Black lines under the sequence
indicate tryptic peptides whereas red lines designate chymotryptic peptides. The four EF-hands are
super-scored by red (EF-1), magenta (EF-2), olive (EF-3) and navy (EF-4). Residues shaded in
green, cyan and dark yellow represent the E helix, calcium loop and F helix of each EF-hand,
respectively. Residues boxed in red are resolved by MS/MS analysis.
We can identify four distinct classes of conformational change among eight tryptic peptides.39 (A
sequence coverage map, Figure 3.4, shows 99% tryptic sequence coverage was achieved by using
MS/MS incorporating a precursor-ion inclusion list.) The irreversible labeling of FPOP

41, 43, 44

allowed extension of LITPOMS to the amino-acid level for some residues and improved the spatial
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resolution. In this chapter, I present a new, highly resolved view of the conformational changes
induced by Ca2+ binding.

Figure 3.5. LITPOMS response at peptide level, where modification fractions were plotted as a
function of calcium:calmodulin ratio. Four different classes of behaviors are shown in black (a and
c), magenta (b), blue (d, f and h) and olive (e and g). Red solid lines in (b), (d), (e), (f), (g) and (h)
are from fitting using an algorithm reported previously.24, 28 Data points represent average of two
runs, and error bars are standard deviations. Modification fractions reported here accounts for all
resolvable oxidations, for which a maximum of +32 were observed at peptide level.
When titrated with Ca2+ by using the LITPOMS protocol, CaM shows four remarkable and distinct
classes of behavior upon titration with Ca2+ (Figure 3.5), each successfully fit for binding. These
curves are sensitive representations of opposing conformational changes that impart a composite
of protection and deprotection (binding with tightening of structure vs. loosening or opening in
allostery).
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Figure 3.6. Residue-level LITPOMS responses for residue (a) M109 and (b) M124. Data points
represent averages of two runs, and error bars are standard deviations. Red solid lines are reconstructed based on fitting results of eight tryptic peptides by an algorithm reported previously.
A protein region exhibiting Class I behavior undergoes a loss of protection upon binding (with
Ca2+). Peptide 76-90, which covers the central linker together with part of helix-E of EF-3 (Figure
3.5e), opens as calmodulin transitions from a compact conformation to a ‘dumbbell-shape’ upon
Ca2+binding. LITPOMS captures this change and that for region 107-126 (Figure 3.5g), which
covers the linker between EF-3 and EF-4. To increase further the spatial resolution, we analyzed
the amino-acid residue data (results in Figure 3.6a and b) to show that residues M109, in the Fhelix of EF-3, and M124, in the E-helix of EF-4, become more exposed upon binding with Ca2+.
Class II behavior epitomizes locations where the modification fraction remains relatively constant
as Ca2+ interacts with CaM. Peptide 1-13 (Figure 3.5a), part of the N-terminus of CaM, and peptide
31-37 (Figure 3.5c), covering the F-helix of EF-1, represent two regions not involved in binding
or remote conformational changes. Because the only FPOP-modified residue in peptide 31-37 is
M36, the behavior (Figure 3.5c) represents the M36 residue level LITPOMS response.
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Class III behavior represents classic binding (peptide 14-30, Figure 3.5b). This region remains
relatively unprotected at early stage of the titration (until [Ca2+]:[CaM] ≅ 2). As the titration
proceeds, peptides representing binding regions becomes protected owing to Ca2+ binding,
consistent with a decrease in modification fraction at [Ca2+]:[CaM] of 2–10. At the later titration
stages, region 14-30 stays protected because it is saturated with Ca2+.

Figure 3.7. Residue-level LITPOMS responses for residue (a) F16, (b) F19, and (c) K21. Red
solid lines are re-constructed based on fitting results of eight tryptic peptides by an algorithm
reported previously. Data points are averages of two runs; error bars are standard deviations (see
SI for a discussion of error).
Magnifying the view to the residue level, we resolved three amino acid residues: F16 (Figure 3.7a)
and F19 (Figure 3.7b) reside on the E-helix of EF-1 whereas K21 (Figure 3.7c) occupies the
calcium loop of EF-1. LITPOMS curves for these residues are similar to those for peptide 14-30,
indicating that the Ca2+ loop together with part of the E-helix are involved in either the Ca2+ binding
of EF-1 or conformational changes induced by binding. Although the resolved residues are not
negatively charged or directly involved in binding, they reside in proximity with the actual binding
residues, thus reporting binding-induced conformational changes. Such detailed spatial resolution
is difficult to achieve, usually only by an X-ray crystal determination.45 NMR can utilize changes
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of chemical shifts upon titrating with a ligand,46 but NMR is time and labor consuming and
challenging to resolve high-resolution structure at each titration point. LITPOMS fills the gap by
resolving complex binding of signaling proteins with amino-acid residue resolution.
Regions represented by peptides 38-74, 91-106 and 127-148 that cover the remaining three EFhands behave differently than peptide 14-30 and are termed Class IV. The curves reveal composite
behavior including a combination of binding and remote conformational change induced by
binding, some of which is allostery.19, 20 Region 127-148, covering the calcium loop and F-helix
of EF-4 (Figure 3.5h), shows a gain in protection at the initial stage of the LITPOMS curve,
followed by a loss of protection upon adding more Ca2+. The initial gain-of-protection originates
from Ca2+ binding by EF-4, during which the loop in EF-4 chelates Ca2+, thus becoming more
protected. Upon reaching saturation with calcium at [Ca2+]:[CaM] of ca. 1.5, the region,
represented by peptide 127-148, becomes less protected. This loss in protection can be reasonably
explained by a binding-induced conformational change of F-helix in the EF-4. Once the calcium
loop becomes protected, the F-helix re-orientates to a more exposed configuration, preparing CaM
to take a subsequent Ca2+. Such cooperativity and allosteric behavior will be discussed in greater
detail in later sections.
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Figure 3.8. LITPOMS responses for (a) chymotryptic peptide 125-138, (b) chymotryptic peptide
139-145, (c) residue Y138, (d) residue M144, and (e) residue M145. Data points represent average
of two runs, and error bars are standard deviations. Red solid lines are re-constructed based on
fitting results of eight tryptic peptides by an algorithm reported previously.
Among all regions of CaM, three peptides representing 38-74 (Figure 3.5d), 91-106 (Figure 3.5f),
and 127-148 (Figure 3.5h), show composite behavior.39 Composite LITPOMS curves are highly
informative, revealing CaM binding dynamics as a function of [Ca2+] at peptide-level resolution
and providing new information. Composite-behavior information can be enhanced with additional
protein digestion. To dissect the composite behavior, we chose chymotrypsin to give different
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cleavage sites from those of trypsin and yield peptides 125-138 and 139-145 (Figure 3.8a and 3.8b,
respectively), which cover the majority of calcium loop of EF-4 and the F-helix of EF-4,
respectively. Indeed, region 125-138 exhibits classical binding behavior, where the modification
fraction starts to decrease in a similar manner as tryptic peptide 127-148. At later stages of the
titration where [Ca2+]:[CaM] > 1.5, the modification fraction of chymotryptic peptide 125-138
stays relatively constant until the very end of the titration, unlike the increasing modification for
peptide 127-148. Peptide 125-138 must contain the critical binding region of EF-4, consistent with
canonical calcium-loop binding behavior. On the other hand, the modification fraction of
chymotryptic peptide 139-145 remains stable until [Ca2+]:[CaM] is ~ 1.5, after which a clear loss
of protection occurs (Figure 3.8b). Because region 139-145 includes the F-helix of EF-4, the loss
of protection is expected. Three residues in peptide 127-148 (Y138, M144 and M145 in Figure
3.8c to e) demonstrate the improved spatial resolution.

Figure 3.9. LITPOMS responses for (a) chymotryptic peptide 90-99, (b) residue F92, (c) residue
Y99. Data points represent average of two runs, and error bars are standard deviations. Red solid
lines are re-constructed based on fitting results of eight tryptic peptides by an algorithm reported
previously.
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Like peptide 127-148, tryptic peptide 91-106 falls into Class IV (Figure 3.5f). Its modification
fraction stays relatively constant until [Ca2+]:[CaM] is ~ 0.7, after which significant bindinginduced protection occurs. An increase of modification happens at later stages of the titration
owing to a binding-induced conformational change that facilitates binding of other EF-hands.
Residue Y99 on the calcium loop of EF-3 shows a composite LITPOMS curve (Figure 3.9c). The
chymotryptic peptide 90-99 (Figure 3.9a) and residue F92 (Figure 3.9b) better illustrates the actual
binding event. A decrease in modification occurs between [Ca2+]:[CaM] of 0.7 and 5.0, resembling
the binding of the calcium loop in EF-3. Once again, the use of a combination of different proteases
dissects the composite LITPOMS curve and elevates the spatial resolution.

Figure 3.10. LITPOMS responses for (a) residue M51, (b) residue M71, (c) residue M72/R74.
Data points represent average of two runs, and error bars are standard deviations. Red solid lines
are re-constructed based on fitting results of eight tryptic peptides by an algorithm reported
previously.
Although also assigned to Class IV, tryptic peptide 38-74 (Figure 3.5d) behaves differently than
the other two. It loses protection at the initial stage of titration, seen by an increase followed by a
decrease in modification at [Ca2+]:[CaM] of 1.7, suggesting binding. When [Ca2+] is > 5
equivalents of CaM, peptide 38-74 becomes less protected. Given that the peptide covers the
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central linker between EF-1 and EF-2 and the entire EF-2 , its complex behavior is expected.
Unfortunately, we found no chymotryptic peptide in this region. The LITPOMS responses for
selected residues, however, do capture some of the features (Figure 3.10a to c). Residues M71
(Figure 3.10b) and M72/R74 (Figure 3.10c) lose protection simultaneously at [Ca2+]:[CaM] of ~
1.5. These residues sit in the F-helix of EF-2, altering its conformation from ‘closed’ to ‘open’ and
facilitate the structural transformation of CaM upon Ca2+ binding. Residue M51, however, loses
protection initially followed by a significant gain and remains protected till the end of titration
(Figure 3.10a). The Loss of protection is consistent with a binding-induced conformational change
whereas the gain corresponds to the actual binding of Ca2+ at EF-2. M51, in proximity to the
calcium loop of EF-2, shows protection consistent with that of the loop.

3.4.3 Determining the CaM Allostery
To access the allosteric behavior of CaM upon Ca2+binding, we take a combined view of the Ca2+dependent behavior of peptides covering four EF-hands. Upon interacting with Ca2+, EF-4 first
responds by taking-up a Ca2+ as seen by an increase in protection for tryptic peptide 127-148
(Figure 3.5h) and chymotryptic peptide 125-138 (Figure 3.8a). The protection then decreases at
[Ca2+]:[CaM] of ~ 1.5, when the two flexible linkers represented by peptides 76-90 (Figure 3.5e)
and 107-126 (Figure 3.5g) become more exposed. Moreover, modification of region 38-74 keeps
increasing until [Ca2+]:[CaM] ~ 1.7 (Figure 3.5d), where EF-4 finishes binding Ca2+ (Figure 3.5h
and Figure 3.8a) and binding at EF-3 is still underway (Figure 3.5f and 3.9a). Importantly, loss of
protection for peptides 38-74, 76-90 and 107-126 occurs during the Ca2+ binding of EF-4 and EF3. Peptide 38-74 covers EF-2 (Figure 3.4), and its behavior reveals the CaM allostery upon Ca
binding. The LITPOMS results suggest that Ca2+ binding at EF-3 and EF-4 triggers a
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conformational change for EF-2 (and other parts of the protein), preparing it for the subsequent
Ca2+ binding.
As the titration proceeds to [Ca2+]:[CaM] ~ 5.0, the majority of CaM has opened as captured by
LITPOMS for peptides 38-74, 76-90, 91-106, 107-126, and 127-148. Meanwhile, EF-1 (covered
by tryptic peptide 14-30) is starting to bind Ca2+ (Figure 3.5b). The curves also reveal the
cooperative nature of four EF-hands in CaM binding to Ca2+. At later titration stages when
[Ca2+]:[CaM] is > 15, all LITPOMS responses become nearly constant, indicating saturation with
Ca2+. Tracking LITPOMS responses as a function of [Ca2+] informs us on the Ca2+ binding
dynamics at the peptide and even at amino-acid levels (Figure 3.10a), which cannot be achieved
with low-to-medium resolution approaches (e.g., proteolytic footprinting 19 and fluorescence20).

3.4.4 Defining Calcium Binding Order

Figure 3.11. Normalized (to 1) peptide-level LITPOMS responses for selected peptides and
residue showing increases in protection (decreases in modification) for peptides 125-138, peptide
90-99, residue M51 and peptide 14-30 representing EF hands 4 – 1 of CaM, respectively. The
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insert shows expanded decreases in modification for peptide 90-99, residue M51 and peptide 1430. Data are averages of two independent runs, and error bars are standard deviations and are
normalized accordingly.
There has been a long-standing debate on the order of Ca2+ binding to CaM. Its four EF-hands
exist in two lobes, EF-1 and EF-2 in the N-terminal lobe and EF-3 and EF-4 in the C-terminal
lobe. Early tyrosine fluorescence and terbium luminescent studies suggested a binding first at the
N-terminal lobe then at the C-terminal lobe.47 Later, a binding assay with a chromophoric chelator
gives the four binding affinities; the six-fold higher calcium affinity at the C-terminal than at the
N-terminal lobe suggests the C-terminal lobe binds first.10 Subsequently, the results of mutational
studies and tryptophan fluorescence allowed the binding order to be adjusted as EF-3 > EF-4 >
EF-1 > EF-2.48 Using the same four-site mutants, isothermal titration calorimetry confirmed that
binding occurs first at the C-terminal lobe.21 So far, this is the accepted binding order, although
other mutations may cause adjustments. Low resolution fluorescence, however, limits the
confidence of these conclusions. Ye et al.26 grafted four calcium loops individually onto a scaffold
protein and concluded that the intrinsic binding affinity of four loops rank as EF-1 > EF-3 > EF-2
> EF-4. It is, however, risky to assign calcium binding orders by comparing their intrinsic binding
affinities because the four EF-hands often work cooperatively in Ca2+ binding. Thus, the calcium
binding order remains unsettled.
LITPOMS offers a novel approach to address this important question. Ca2+ binding increases
protection (decreases reactivity) at a binding site owing to spatial hinderance. Thus, comparing the
onset point of the LITPOMS decay as a function of [Ca2+] affords the binding order. Elevated
spatial resolution for each EF-hand can give more accuracy. We chose peptides 125-138, 90-99
and 14-30 that cover primarily calcium loops of EF-4, EF-3 and EF-1, respectively (no peptides
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or resolved residues for calcium loop of EF-2 were captured). Fortunately, residue M51 is close to
the calcium loop of EF-2 and exhibits binding-induced protection, and we chose it for comparison.
To illustrate better calcium binding orders for each EF-hand, plots of the decay region for four
candidates were normalized to 1 and plotted together (Figure 3.11). Clearly, the first binding
occurs at EF-4 (peptide 125-138) whereas EF-1 binds last (peptide 14-30). Curves for EF-3 and
EF-2 are now well separated at the early stage of the titration, clearly indicating that EF-3 binds
prior to EF-2. With improvement of LITPOMS, the overall binding order can be confidently
assigned as EF-4 > EF-3 > EF-2 > EF-1.

3.4.5 Measure Site-specific Binding Affinity
Following an assignment of binding order, we obtained four binding affinities for each EF hand
(summary in Table 3.1) by fitting the various binding curves in Figure 3.5 by using a previously
reported fitting algorithm, 24, 28 where EF-1 and EF-2 were grouped into N-terminal lobe and EF3 and EF-4 in the C-terminal lobe. Positive cooperativity was assumed in each lobe whereas the
two lobes bind calcium independently.10 Each state (Apo-CaM, CaM-1-Ca2+, CaM-2-Ca2+ …) has
its distinct modification fraction. A search utilizes the experimental data to determine the system
composition at different calcium concentrations, after which binding affinities and a peptidespecific fitting curve are obtained.
Table 3.1. Summary of binding order and site-specific binding affinities for calcium-calmodulin
system

Binding Order

EF-hand

LITPOMS Ki (M-1)

Literature Ki (M-1)10

1

EF-4

1.4 × 106

8.0 × 104

2

EF-3

6.2 × 106

4.0 × 106
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C-Term Lobe

8.6 × 1012

3.2 × 1011

3

EF-2

4.1 × 104

2.5 × 104

4

EF-1

2.9 × 106

4.0 × 105

N-Term

1.2 × 1011

1.0 × 1010

The results (Table 3.1) show
Lobe that LITPOMS successfully reveals the binding order and the sitespecific binding affinities for four EF-hands in calmodulin upon binding with calcium. The binding
affinities for EF-2 and EF-3 agree reasonably well with those in the literature (within a factor of
1.6) whereas for EF-1 and EF-4 are within 20-fold.10 Although an advantage of LITPOMS to
affinity measurements may be the peptide-level modeling is of at least four binding curves rather
than a single global-level fluorescence response,10 we view the affinities as estimates that need
further validation. Nevertheless, the affinity constants show that the binding in each lobe is
positively cooperative (EF-3 > EF-4 and EF-1 > EF-2).
The binding affinities obtained from fitting the eight original tryptic peptides were adopted to
reconstruct simulation curves for the newly obtained LITPOMS curves of chymotryptic peptides
(Figure 3.8a, 3.8b, and 3.9a) and residues (Figures 3.6a-b, 3.7a-c, 3.8c-e, 3.9b-c, and 3.10a-c). The
current fitting algorithm cannot fit all available LITPOMS responses; thus, the LITPOMS
responses for chymotryptic peptides and residues were not part of the fitting. The reconstructed
simulations for these LITPOMS responses agree well with the data, indicating confidence in the
binding affinities and the LITPOMS approach. It is possible that the values determined here are
more accurate than those in the literature.

3.4.6 Dissecting the Composite Behavior
In general, spatial resolution can be elevated by tracking smaller peptides, obtainable by either a
combination of multiple enzymes to cleave differently the protein or by fragmentation in MS 2
accompanied by improved LC separation.
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Class IV tryptic peptides 38-74, 91-106 and 127-148 behave compositely because the peptides are
long and represent regions undergoing multiple conformational changes (e.g., peptide 127-148
covers the calcium loop and F-helix of EF-4). These two structural motifs behave differently in
the Ca2+ titration, resulting in a composite curve. By digesting with a different protease, however,
the two motifs can be cleaved into two peptides that cover each region and reveal single behavior.
Furthermore, given the irreversible labeling by FPOP, the resolution can be enhanced by tracking
at the amino-acid residue level.41, 43, 44 The response of peptide 38-74 can be dissected by three
residue-level LITPOMS curves, each showing simpler behavior. Residue M51, however, is either
involved with or near an allosteric site, as seen from its “up and down” modification behavior. The
promise of increased spatial resolution motivates the development of new FPOP reagents that
provide complementary labeling to OH radicals,49-51 even of residues directly involved in binding.

3.4.7 Probing Local Conformational Changes in Calcium Loop
The elevated spatial resolution allows differentiating direct binding sites from those not directly
involved in binding, even in a calcium loop. Residue Y138 sits in the calcium loop of EF-4.
Binding of Ca2+ tightens the loop by chelating with negatively charged residues and protecting
them. Tyrosine, however, is not involved in Ca2+ chelation and becomes less protected upon
binding owing to a structural transition of the calcium loop whereby the SASA of the unbound at
23 Å2 becomes 50 Å2 in the bound form. Residue-level LITPOMS successfully captures these
transitions, as demonstrated in Figure 3.8c.

3.4.8 Advancing LITPOMS over Other Approaches
Another hydroxyl radical-based protein footprinting approach utilizing synchrotron radiation was
previously applied to a Ca2+ binding protein. With an X-ray exposure time of 80 ms, Chance and
coworkers followed structural transitions of gelsolin upon Ca2+ titration and successfully identified
167

a three-state activation process.29, 30 Moreover, three classes of residues/peptides were identified,
which become more and less protected while titrating with Ca2+. Although conceptually similar,
the synchrotron footprinting does not reveal composite behavior or the relative timing of change
from one region to another. This may be because the timescale for footprinting by LITPOMS is
shorter by two orders of magnitude.
Quantitative measurements of protein ligand interactions by HDX were pioneered in the
SUPREX23 and PLIMSTEX24 methods, both of which were brought to regional-level spatial
resolution by protease digestion.27 HDX detects changes of SASA by probing the changes in
hydrogen bonding. Protein conformational changes, however, do not necessarily associate with reorganization of its hydrogen bonding pattern. In an HDX study that compares Ca2+-free and Ca2+bound CaM, kinetic curves successfully reveal the binding regions of Ca2+ in CaM, whose
deuterium uptake decreases upon Ca2+ binding. HDX fails to probe regions that open-up, whose
SASA increases upon Ca2+ binding.52 Ca2+-binding tightens the calcium loop in an EF-hand, which
strengthens the hydrogen bonds in the backbone. Structural opening of E and F helices, however,
is due to changes in their interhelical angles that is not easily captured by HDX. FPOP is more
sensitive to subtle changes in the SASA of amino acid side chains, making it suitable to probe such
structural transitions.
In addition to HDX and free radicals, slower reacting reagents such as GEE31 and BHD32 also shed
light on this field. Negative-charged side chains of D and E in the calcium loop of EF-hands are
the actual binding motifs that chelate with the positive-charged Ca2+. GEE53 and BHD32
footprinting of CaM reveal decreases in modification extents for D and E that located in the
calcium loop upon Ca2+ binding, but these changes have not yet been followed in a titration format
and composite behavior not seen. Other spectroscopic methods such as fluorescence and circular
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dichroism cannot afford the detailed structural information afforded by LITPOMS.10 LITPOMS,
for the first time, combines high resolution with an ultra-short timescale for footprinting. The
labeling time of hydroxyl radical-based FPOP is in the sub-millisecond range, which is comparable
or even shorter than the calcium off-rates,40, 41 allowing structural details to be revealed at high
spatial resolution without diminishing the footprint between bound and unbound states.

3.5 Conclusion
The application of LITPOMS not only recapitulates, via a single approach, the understanding of
the calcium-calmodulin binding system gained over many decades but also provides new insights
that cannot be easily accessed through other approaches. Specifically, LITPOMS can provide
unprecedented structural details to determine Ca2+ binding sites, Ca2+ binding orders, site-specific
binding affinities, allostery, and cooperativity. That LITPOMS can accomplish this is seen by its
ability to reveal the composite behavior of CaM upon binding with Ca2+ and to uncover allostery
and cooperativity accompanying binding. Moreover, the composite behavior can be further
dissected by using a different protease digestion or a residue-level MS/MS analysis. The improving
sensitivity of modern mass spectrometers allows these advances to be made with high picomoles
of samples whereas the irreversible labeling of FPOP broadens the application of LITPOMS by
overcoming the major disadvantages of HD exchange,24, 54 making it possible to extend it to the
amino-acid residue level. With proper selection of labeling reagents,49-51 it may be possible to
characterize the affinity of a specific binding residue even at the nM level for many different
ligands.25 This bodes well for studies of signaling proteins,1, 55, 56 where conformational changes
are widespread and concomitant changes in solvent accessibility are readily followed by reactions
of free radicals and other reactive species.
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High-resolution approaches such as NMR and X-ray crystallography can resolve protein structures
in solution and solid state, respectively. Most of these resolved structures, however, are either in
their ligand-unbound or ligand-bound states, and the requirement to look at many intermediate
states places high demands on time and sample quantity. For signaling proteins, whose binding
usually involves multiple ligands in a cooperative fashion,1, 2 understanding the intermediate states
between unbound and bound is difficult45 and perhaps impossible for large proteins that don’t
crystallize. Understanding binding intermediates with mid-to-high resolution makes it possible to
explore complex allostery during binding, which is challenging for optical approaches but feasible
for LITPOMS, as demonstrated in the current study. Moreover, by tailoring labeling conditions57
or utilizing new labeling reagents49-51, it should be possible to monitor selectively or nearly all
amino-acid residues, enabling the direct and complete spatial tracking of ligand binding.
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4.1 Abstract
Fast photochemical oxidation of protein (FPOP) has become an important mass spectrometrybased protein footprinting approach. Although the hydroxyl radical (●OH) generated by photolysis
of hydrogen peroxide (H2O2) is most commonly used, the pathways for its reaction with aminoacid side chains remain unclear. Here we report a systematic study of ●OH oxidative modification
of 13 amino acid residues by using 18O isotopic labeling. The results differentiate three classes of
residues on the basis of their oxygen uptake preference towards different oxygen sources.
Histidine, arginine, tyrosine and phenylalanine residues preferentially take oxygen from H2O2.
Methionine residues competitively take oxygen from H2O2 and dissolved oxygen (O2) whereas the
remaining residues take oxygen exclusively from O2. Results reported in this work deepen the
understanding of ●OH labeling pathway on a FPOP platform, opening new possibilities for
tailoring FPOP conditions in addressing many biological questions in a profound way.

4.2 Introduction
Proteins adopt different higher order structures to facilitate their unique biological functions.1 Over
more than five decades, researchers have developed and applied numerous approaches to
understand structure-function relationships. X-ray crystallography,2 nuclear magnetic resonance
(NMR),3 mass spectrometry (MS),4 infrared spectroscopy,5 fluorescence,6 circular dichroism,7 and
cryo-electron microscopy (CryoEM)8 are fulfilling in part the demanding needs in the field. One
advantage of MS-based protein footprinting approaches are that the technology has improved
immensely owing to advances in proteomics. Further, MS has lower sample requirements, shorter
time for analysis while preserving mid-to-high resolution for proteins in solution, where
biochemistry occurs.4 Prior to MS sampling, proteins are usually submitted to a labeling process
that “marks” the solvent accessible surface area (SASA) of the proteins. By tracking the changes
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of SASA, it is possible to distinguish structure and locate sites of binding, unusual dynamics,
differences between mutants and wild-type proteins, to follow fast folding, and to map epitopes to
provide deep understanding of protein structure.9-10
Protein Footprinting is usually accomplished by either reversible hydrogen/deuterium exchange
(HDX)11 labeling or by irreversible covalent labeling12-14. Among various covalent labeling
methods, hydroxyl radical (●OH) based fast photochemical oxidation of proteins (FPOP) is among
the fastest (on the timescale of sub-milliseconds), which is competitive in time with most protein
conformational changes.12,

15

This feature allows “snapshots” of complex biological systems,

making feasible the capture of transient intermediate states and providing new insights that
previously required a combination of many sophisticated approaches.16-19 In a FPOP experiment
that uses ●OH as labeling reagent, ●OH is generated through laser photolysis of hydrogen peroxide
(H2O2) in a flow system, allowing ●OH to react with various amino acid residues and producing
an oxygen uptake after labeling. This oxygen uptake can be located even on a specific amino-acid
residue level often as a “+16” modification through a combination of post labeling protein
digestion and high-resolution MS2 analysis.9, 12, 20-21 During the past 15 years, FPOP has been
expanding in academics and biotechnology. It is being used to address successfully significant
biological questions including epitope mapping,22-25 protein folding/unfolding,18-19, 26-27 protein
aggregation,28-29 ligand-binding affinity determination,16-17 and in vivo footprinting.30-32
Development of ●OH dosimetry control33 and incorporation of a reporter peptide34 also enable
precise quantification.
Despite its success, labeling pathways of ●OH in a FPOP platform remain unclear even though the
reaction mechanisms between ●OH and free amino acids were extensively studied over decades
by using electron paramagnetic resonance (EPR),35-39 absorption spectroscopy40-44, MS45-46,
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NMR47 and NMR-based hydrogen deuterium exchange.48 The outcomes allowed key reaction
intermediates and reaction pathways to be identified. The principal focus has been hydroxyl
radicals generated primarily by radiolysis, utilizing high-energy X-rays to ionize water molecules
and subsequently produce ●OH. Turning to more complex substrates, we expect that ●OH reaction
pathways for amino acid residues in a peptide or protein differ significantly owing to elimination
of the free-standing carboxyl and amino group when peptide bonds form. A good example is
methionine, which forms a cyclic intermediate when ●OH forms an S● with a free-standing amino
acid48 but not for a methionine residue in a peptide or protein.
Chance and coworkers13, 49-52 reviewed reaction pathways between ●OH and amino-acid residues
in a peptide or protein with a focus on synchrotron-based hydroxyl radical footprinting (HRF) that
utilizes ●OH produced by ionization of water followed by loss of H+. Stable isotope was also
introduced, where

18

O-enriched water (H218O) was used to reveal the reaction pathway for

phenylalanine in an HRF system.49
Although both synchrotron-based HRF and FPOP utilize ●OH as labeling reagents, they are likely
to be mechanistically different. In FPOP, ●OH is from photolysis of H2O2, whose distribution in a
protein solution is potentially heterogeneous owing to localized hydrogen bonding between
selected amino acid residues and H2O2.53 The heterogeneity of H2O2 distribution prior to laser
irradiation will induce fluctuations in local ●OH concentration during labeling and possibly alter
the oxygen uptake scheme for selected residues and can be potentially utilized to tailor the labeling
conditions. In synchrotron-based HRF, the ●OH, coming from water ionization, is distributed
homogeneously.
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This chapter presents a systematic study of ●OH labeling pathway on a FPOP platform. We
distinguished the three oxygen sources for the labeling, dissolved oxygen (O2), H2O2 and water
(H2O), in a set of FPOP labeling experiments. We substituted these components with 18O-enriched
oxygen sources one at a time to reveal the oxygen uptake preferences across different experimental
conditions owing to a 2 Da mass shift between high natural abundance
purposely introduced

18

16

O (99.76 %) and

O. Through analyzing reactions with two different samples, 69 distinct

residues were successfully resolved. Among these residues, we covered 13 different amino-acid
residues and analyzed their isotope patterns as a function of different experimental conditions. The
outcome allowed us to propose, on the basis of our new results and previous mechanism studies,
reaction pathways for each kind of amino acid residue. We found that amino-acid residues can be
clearly differentiated in three classes based on their oxygen-uptake preferences. Besides revealing
the pathways for FPOP footprinting and the differences between H2O radiolysis and H2O2
photolysis, the outcome also provides a foundation for tailoring FPOP conditions in the future.

4.3 Materials and Methods
4.3.1 Materials
Peptide retention time calibration mixture (RTC, composition depicted in Table 4.1) and bovine
serum albumin protein digest (BSA digest) were chosen as the test samples; they were purchased
from Thermo Fisher Scientific (Waltham, MA, USA). Composition of RTC is provided in
Supporting Information. Concentrations for each of the samples was determined by UV absorption
with a Thermo Scientific NanoDrop OneC (Thermo Fisher Scientific, Waltham, MA, USA).
Catalase (from bovine liver), Trizma base, potassium chloride (anhydrous, ≥ 99.0%), L-methionine
(≥ 99.5%), L-histidine (≥ 99.0%), hydrogen peroxide solution (containing inhibitor, 30% wt. in
H2O), hydrochloric acid (36.5% - 38%) were acquired from Sigma-Aldrich (St. Louis, MO, USA).
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18

O-enriched oxygen gas (18O2, 99 atom %

(H218O2, 90 atom %

18

18

O, 2-3 % in H2O) and

O, 99 % purity),
18

18

O-enriched hydrogen peroxide

O-enriched water (H218O, 97 atom %

18

O) were

obtained from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were used without further
purification. The solvent in the 0.5 pmol/µL RTC solution was first removed by a SpeedVac
(Thermo Fisher Scientific, Waltham, MA, USA), and the residue was reconstituted with water to
the concentration of 5.0 pmol/µL. Tris buffer solution (10 mM) was made by dissolving Trizma
base in water. Hydrochloric acid solution was added to obtain a pH of 7.4 (measured with an Orion
Star A211 pH meter, Thermo Fisher Scientific, Waltham, MA, USA). Potassium chloride was
added to the tris buffer to give a concentration of 100 mM to ensure appropriate ionic strength of
the buffer solution.
Table 4.1. Composition of RTC (Peptide sequences) and their hydrophobicity factors
Peptide
Peptide Sequence*
Number

Mass

Hydrophobicity
Factor

1

SSAAPPPPPR

985.5220

7.56

2

GISNEGQNASIK

1224.6189

15.50

3

HVLTSIGEK

990.5589

15.52

4

DIPVPKPK

900.5524

17.65

5

IGDYAGIK

843.4582

19.15

6

TASEFDSAIAQDK

1389.6503

25.88

7

SAAGAFGPELSR

1171.5861

25.24

8

ELGQSGVDTYLQTK

1545.7766

28.37

9

GLILVGGYGTR

1114.6374

32.18

10

GILFVGSGVSGGEEGA
R

1600.8084

34.50
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11

SFANQPLEVVYSK

1488.7704

34.96

12

LTILEELR

995.5890

37.30

13

NGFILDGFPR

1144.5905

40.42

14

ELASGLSFPVGFK

1358.7326

41.18

15

LSSEAPALFQFDLK

1572.8279

46.66

* Amino acids in bold are labeled with heavy stable isotopes (all carbons replaced by 13C). Lysine
(K) is 8Da heavier and arginine is 10 Da heavier.

4.3.2 Custom-made Degassing Apparatus and Experimental Conditions

Figure 4.1. Schematic illustration of custom-designed degassing and sample-handling apparatus
used in current study. A brief summary of the protocol steps for degassing is separated with the
large blue arrows.
To examine systematically the oxygen source of the common oxygen addition in a FPOP
experiment, a custom-designed, mini degassing apparatus was assembled. All parts of the
apparatus were from Swagelok (Solon, OH, USA) and were assembled by following the
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manufacturer’s instructions. The design, as can be seen in Figure 4.1, was inspired by that of a
Schlenk line where three valves with a pressure gauge were connected to both vacuum pump and
nitrogen / 18O2 source through two ends. Stainless-steel tubbing was bent into a U-shape, which
was submerged in liquid nitrogen (LN2) to serve as a trap for the vacuum pump.
Degassing process was started by connecting the apparatus to N2 supply (on the left) and vacuum
pump (on the right) as indicated in Figure 4.1, at which time all three valves were closed. An
aliquot in the Eppendorf containing buffer, protein and scavenger was snap-frozen in LN2 after
which valves 2 and 3 were opened to pump-out the dissolved oxygen in the aliquot and the pressure
gauge was to monitor the process. After equilibration, valve 3 was closed and the LN2 bath was
removed, followed by opening valve 1 to backfill the volume with inert N2 until aliquot thawing.
The first degassing cycle was completed by thawing the aliquot under the protection of inert N2,
which ensures the efficiency of removal of dissolved O2. After aliquot thawing, valve 1 was closed,
and the Eppendorf was submerged into the LN2 bath to freeze again the sample and begin the
second cycle. The process was repeated three times to ensure the complete removal of dissolved
O2 in the original aliquot. Note that valve 2 was kept open during these processes so the pressure
gauge provides a good measure of the pressure of the system. After the last cycle, valves 1 and 2
were left open to allow the volume to be filled with N2. A syringe with H2O2 solution (normal or
18

O enriched) was punched through the septum, and the needle-tip was pushed under the liquid to

deliver set amounts of H2O2 into the sample. The H2O2 syringe was then removed and a second
syringe was used to pick up the sample and insert on the syringe pump for submission to the FPOP
setup for laser irradiation.
For backfilling the aliquot with 18O2, the 18O2 tank was connected to the left of the apparatus to
replace the N2 supply (the

18

O2 tank comes with its own valve, which offers suitable control).
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Operation procedures were similar with the one described above. The aliquot was submerged into
a LN2 bath for snap-freezing, during which all three valves were opened so that both the apparatus
and the frozen aliquot can be pumped properly. After equilibration, valves 1 and 3 were closed,
followed by momentary-opening of the valve on the 18O2 tank, during which highly-pressurized
18

O2 filled the dead volume between the 18O2 tank valve and valve 1 of the apparatus. Valve 1 was

then opened to allow the pressured 18O2 to fill the volume of the apparatus. LN2 bath outside the
Eppendorf was removed at the same time. The aliquot was allowed to thaw completely, during
which time the 18O2 in the atmosphere dissolved into the aliquot.
This constituted a complete cycle, and the cycle was repeated three times to ensure complete
replacement of originally dissolved 16O2 with 18O2. Note that valve 2 was kept open during these
processes so the pressure gauge has a good measure of the pressure of the system. After the last
cycle and the complete thawing of the aliquot, valves 1 and 2 were left open. A syringe with H2O2
solution (normal) was punched through the septum, and the needle-tip was pushed under the liquid
to deliver set amounts of H2O2 into the sample. The H2O2 syringe was then removed and a second
syringe was used to pick up the sample and insert on the syringe pump for submission to the FPOP
setup for laser irradiation.
Table 4.2. Summary of experiments used for isotopic labeling

Number

Experimental
Condition

1

Regular Control

2

Vacuum Control

3

Vacuum + 18O2

4

Regular + H218O2
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5

Vacuum + H218O2

6

Regular + H218O

7

Vacuum + H218O

Experiments were executed under seven conditions. “Regular control” indicates that the sample
was prepared in air whereas “vacuum control” communicates that the sample was degassed and
backfilled with N2 prior to FPOP labeling. Both do not contain any
“Vacuum +

18

18

O-enriched components.

O2” indicates that the aliquot was degassed and backfilled with

18

O2. “Regular +

H218O2” and “vacuum + H218O2” indicates that the hydrogen peroxide in these two conditions was
18

O-enriched, with first one being prepared under air and the second one being prepared with the

degassing procedure (backfilled with N2). Following the same scheme, “regular + H218O” and
“vacuum + H218O” denotes that water in these two conditions were 18O-enriched and were prepared
under air and then degassed (back-filled with N2), respectively. Each experimental condition was
given an identifying number in Table 4.2, and the numbers were used in all data plots.

4.3.3 FPOP Conditions
For experiments with RTC, aliquots of 50 µL with the final concentration of [RTC] = 0.2 µM, [Lhistidine] = 20 µM and [H2O2] = 3.2 mM were prepared for FPOP labelling. With the BSA digest,
aliquots of 50 µL containing [BSA digest] = 1 µM, [L-histidine] = 0.1 mM and [H2O2] = 16 mM
were used. For each experimental condition, RTC samples were prepared in duplicate, and the
BSA digest was in triplicate.
The FPOP platform was the same as previously reported.20, 28 The sample was introduced through
a capillary tubing (150 µm I.D.) by a syringe pump (Pump 11 Elite, Harvard Apparatus, Holliston,
MA, USA). The beam from a KrF excimer laser (EX50/250, GAM Laser, Orlando, FL, USA) with
a wavelength of 248 nm and frequency of 7.2 Hz was introduced through a transparent window.
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The average laser energy was tuned to ~ 25 mJ/pulse and measured with a pyroelectric energy
sensor (PE25-SH-V2, Ophir Optronics Solutions, North Logan, UT, USA). The flow rate was 2225 µL/min chosen by considering the laser spot width and the operating frequency to ensure a 25%
exclusion volume. Final quenching solutions containing 10 µL of 0.7 mM methionine and 0.5 µL
500 nM catalase (for RTC experiments) and 10 µL of 7 mM methionine and 1 µL 500 nM catalase
(for BSA experiments) were placed at the end of capillary tube to remove any remaining radicals
and consume leftover H2O2 before storing the samples and analyzing them.

4.3.4 LC/MS Conditions
After FPOP labeling, the samples were submitted to a Thermo Scientific Q Exactive Plus Orbitrap
mass spectrometer (Waltham, MA, USA) coupled with a Thermo Scientific Dionex UltiMate 3000
RSLCnano UPLC system (Waltham, MA, USA) for analysis. Liquid chromatography (LC)
separation was by a custom-packed C-18 column with bead size of 3 µm. A 10 min desalting
followed by an 80 min LC gradient was used for separation, in which water with 0.1% formic acid
was used as A phase and 80% water, 20% acetonitrile with 0.1% formic acid was phase B. The
solvent gradient was started from 2.5% phase B, increasing to 17.5% in 30 min, 50% in 52 min
and 80% in 57 min. Followed by a steady 80% B phase until 65 min, the organic phase
subsequently dropped to 2.5% in 70 min and remained until the end of the gradient to re-equilibrate
the column. Flow rate during the gradient was 0.4 µL/min. Fragmentation was by an HCD cell at
the end of the instrument, where the top ten ions were selected for MS2. Maximum ion injection
time was 100 ms and dynamic exclusion was 5 s to ensure the observation of both
labeled species.

4.3.5 Data Analysis
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16

O and 18O

Figure 4.2. (a) Extracted ion chromatograms for +18O modified (top, in red), +16O modified
(middle, in olive) and wildtype (bottom, in black) peptide ELGQSGVDTYLQTK from RTS. Area
shaded in yellow, maroon, blue and pink represents chromatographic peak for residue Y10, D8,
L2 and Q4, respectively. Peak intensity is normalized to better illustrates their lineshape, thus is
not drawn to scale. Peak assignment was done through MS2 analysis. (b) MS2 spectra for +18O
modified (top, boxed

in

red),

+16O modified (middle, boxed

in

olive) peptide

ELGQSGVDTYLQTK at Y10 position. MS2 spectrum for its wildtype is boxed in black at bottom.
Peak assignment with corresponding amino-acid sequence was depicted in each spectrum. Note
that residue K in C-terminus was colored in cyan, communicating a +8 Da mass shift due to a
purposely-induced 13C enrichment.
The LC-MS2 data were first searched against a database containing corresponding peptide
sequences by Byonic (Protein Metrics, San Carlos, CA, USA) to identify all

16

O and

18

O

modifications at the peptide and amino-acid residue levels. Searching results were analyzed by
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Byologic (Protein Metrics, San Carlos, CA, USA), allowing three extracted ion chromatograms
(EIC) representing wildtype, 16O modified (+16) and 18O modified (+18) to be processed for each
peptide. Given the high-quality MS2, chromatographic peaks in the EIC can be assigned to a
modification of a specific amino-acid residue. The chromatographic peak shape and elution times
for the +16 and +18 species were similar despite some fluctuations of intensities, and there should
not be a significant isotopic effect between 16O and 18O, justifying direct comparison of the +16
and +18 integrated EICs as shown by top two EICs in Figure 4.2a. All data were searched against
both

16

O and

18

O modifications and their EIC peak lineshapes and assignments were identical,

consistent with no significant isotopic effect in LC elution and adding confidence to the data
processing.

Figure 4.3. Schematic illustration of data analysis procedures
After proper assignment of peaks in both EICs representing +16 and +18 modifications,
normalized +18O fraction for each individual resolvable residue was calculated according to:
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𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 + 18𝑂 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑅𝑒𝑠𝑖𝑑𝑢𝑒 1 =

∑ 𝐸𝐼𝐶 𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎+18,𝑅𝑒𝑠𝑖𝑑𝑢𝑒 1
∑ 𝐸𝐼𝐶 𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎+16,𝑅𝑒𝑠𝑖𝑑𝑢𝑒 1

By introducing a stable isotope, a complicated quantitative issue was transformed into an analysis
of isotopic distribution, cancelling the need for absolute measurements and minimizing the effect
of sample-handling and instrumental errors.
All the normalized +18O fractions were plotted against experimental conditions (denoted by a
number code, Table 4.2) as solid bars for each resolved residue, as exemplified by the yellow bar
in Figure 4.3. Error bars at the top of solid bars represent the standard deviations of three and two
independent runs for BSA digest and RTC samples, respectively.
Most peptides in this study usually have a minimum of 10 residues, whose A + 2 peak intensities
(combinations of
accurate

18

13

C, 15N, or

18

O,

34

S at their natural abundance) must be considered to obtain

O-enriched FPOP modifications. To correct, an isotopic distribution of

16

O-modified

species was calculated by Protein Prospector (University of California, San Francisco, San
Francisco, CA, USA) (example shown in Figure 4.3) to obtain the expected ratio of A + 2 and A
signals (underlined in blue in Figure 4.3) at natural abundance (before introducing 18O isotope) as
background and reference in subsequent analysis. All the peptide-specific references were plotted
as horizontal dashed lines in the bar graph. Any normalized +18O fraction that is greater than the
dashed reference line was considered to be a contribution by the purposely introduced 18O isotope.

4.4 Results and Discussion
By using a mini vacuum line, we designed an approach whereby oxygen sources in the footprinting
can be replaced one at a time with 18O2, H218O2 and H218O to highlight the preferred oxygen uptake
pathways of 13 amino acid residues. We chose two complex samples of peptides as tests for the
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footprinting. The following discussion is built around the amino acids and amino-acid types
according to their uptake of 18O in this pathway study.

4.4.1 Histidine

Figure 4.4. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for five peptides from (a) RTC and (b-e) BSA digest containing histidine. Error bars
represent standard deviations of two and three independent runs for RTC and BSA digest,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.
We present five different histidine residues, one from RTC (Figure 4.4a) and four from the BSA
digest (Figure 4b-e) to show the remarkable singularity and simplicity of the footprinting chemistry
for this amino-acid residue. For the regular control (1, Table 4.2 and Figure 4.4) and vacuum
control (2) experiments, where no 18O was intentionally added into the system, experimental values
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for the normalized +18O fraction agrees reasonably well with the calculated value (dashed line),
validating the data processing method and serving as a control for the upcoming data interpretation.
From Figure 4.4a and 4.4b, the normalized +18O fractions for the experimental conditions 4 and 5
are all significantly higher than the background, suggesting the footprinting reaction involves an
uptake of

18

O only from H2O2, and essentially no

18

O labeling by oxygen gas or by water

molecules. Results for three other resolved histidines show uptake consistent with that seen here
(see Figure 4.4c, d, and e).

Scheme 4.1. Proposed reaction pathway of histidine residue based on the results. Oxygen
highlighted in red represents 18O.
Based on our observations, we can propose a reaction pathway (Scheme 4.1). The reaction starts
by ●OH addition at the ε1 position of the side chain, resulting an OH addition and an unpaired
electron at the δ1 nitrogen.35, 39, 48 The unpaired electron, now delocalized,40 is capped with a second
●

OH to provide a final product (Scheme 4.1).13 It is also possible that ●OH to attacks the β position

of the side chain by ●H abstraction,48 but this reaction route is minor (not shown in Scheme 4.1).
In the HRF setup, whose ●OH was from synchrotron water ionization, allyl-type intermediate 1.1
and 1.2 subsequently react with O2 for the same product.13, 50

4.4.2 Arginine
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Figure 4.5. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for a peptide from BSA digest containing arginine. Error bars represent standard
deviations of three independent runs. Dashed horizontal line represents calculated background A
+ 2 fraction.
Like histidine, arginine takes oxygen exclusively from H2O2 (Figure 4.5) where a specific arginine
residue in a peptide from the BSA digest was analyzed under the different experimental conditions.

Scheme 4.2. Proposed reaction pathway of arginine residue based on the results. Oxygen
highlighted in red represents 18O.
In the proposed reaction pathway, ●OH abstracts ●H from the sidechain, yielding an arginine
radical intermediate 2.1 that can be readily quenched by a second ●OH to form the final product
(scheme 4.2). Previous studies indicate that ●H abstraction by ●OH preferentially happens at the d
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position,44 with a ratio of δ-CH2 : γ-CH2 : β-CH2 of 11 : 3 : 1.48 Under physiological conditions,
the guanidyl is protonated, and its charge is delocalized over the guanidyl group. The delocalized
positive charge increases the electron density on the adjacent δ-CH2 to a greater extent than on γCH2 and β-CH2.36 Given that ●H abstraction by ●OH is an electrophilic process, the ●OH
preferentially reacts with the electron-rich δ-CH2. Higher electron density at δ-CH2 also leads to a
higher reaction rate of arginine towards ●OH.13, 54 For synchrotron-based HRF, the arginine radical
was quenched by O2 instead of by a second ●OH as it is when footprinting is on the current FPOP
platform.13, 50

4.4.3 Tyrosine

Figure 4.6. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a-g) BSA digest and (h-j) RTC containing tyrosine. Error bars
represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.
We resolved ten different tyrosine residues to represent a typical oxygen uptake preference, seven
in peptides from the BSA digest (Figure 4.6a to g) and three from RTC (Figure 4.6h to j). In the
two representative peptides (Figure 4.6a and h), normalized +18O fractions for the last five
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experimental conditions are all significantly higher than the background, even when H218O2 is the
main source of 18O. Tyrosine takes oxygen from all three oxygen sources (i.e., dissolved O2, H2O2
and H2O), with a preference for H2O2.
Among all resolved tyrosine residues, six of ten tyrosines (Figure 4.6a, b, e, g, h, and j)
preferentially pick up oxygen from H2O2, the favored sources of oxygen for the remaining four are
unclear. Part of the uncertainty is that the modification fraction for these four residues is only a
few percent, allowing background noise and interference with other chromatographic peaks to
contribute. Effects due to adjacent residues may also lead to the complexity.

Scheme 4.3. Proposed reaction pathway of tyrosine residue based on the results. Oxygen
highlighted in red represents 18O.
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Based on the experimental results, we propose a reaction pathway (Scheme 4.3). Laser irradiation
homolytically cleaves H2O2 into two ●OH that initiate all reactions by ●H abstraction, as evidenced
by an NMR-based hydrogen deuterium exchange study.48 The unpaired electron in the resulting
tyrosyl radical is delocalized in the aromatic ring (3.1 and 3.2),47-48 which is electron-rich,
stabilizing the tyrosyl radical. Following attack of a second ●OH (red arrows in Scheme 4.3), the
tyrosyl radical is quenched to form a single bond (3.3), and keto-enol tautomerization produces
dihydroxyphenylalanine (DOPA) is the major product of the preferred reaction route.13, 45 As the
electron-rich aromatic ring stabilizes the unpaired electron, the tyrosyl radical is long-lived and
available for other competitive modifications. For example, dissolved O2 reacts via a minor route
with the tyrosyl radical (3.4) and subsequently eliminates a HOO●, yielding the DOPA product
through a keto-enol tautomerization.13 In contrast, this is the preferred reaction route in the HRF
setup.13 Via another route, ●OH exchanges with solvent water, affording a 18O labeled radical.55
Given that the concentration of water is over 50 M, this minor route becomes competitive. The
secondary ●OH then reacts with tyrosyl radical to give a labeled DOPA product, showing that the
radical chemistry can be complex. We note that reaction pathways proposed here are the preferred
routes, and that minor routes are not precluded.

4.4.4 Phenylalanine
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Figure 4.7. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a-h) BSA digest and (i-o) RTC containing phenylalanine. Error
bars represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.
We resolved 15 different phenylalanine residues in the BSA digest (Figure 4.7a to h) and RTC
(Figure 4.7i to o). Like tyrosine, phenylalanine takes oxygen from all three sources, with a
preference for H2O2 as seen through 11 phenylalanine residues (Figure 4.7a-d, f-k, and n).
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Scheme 4.4. Proposed reaction pathway of phenylalanine residue based on the results. Oxygen
highlighted in red represents 18O.
We propose a reaction pathway that accounts for these observations (Scheme 4.4). It is wellaccepted that ●OH predominately reacts with phenylalanine by addition to the phenyl ring to give
a radical intermediate 4.113, 48, 56-57 that is quenched by a second ●OH, giving a tyrosine residue as
final product (represented by red arrows in Scheme 4.4). The initial attack of ●OH has small
preferences for different positions on the phenyl ring of ortho : meta : para = 2 : 1 : 1.5,48 and thus
the reaction is not regiospecific. Because the lifetime of intermediate 4.1 is relatively long, as
discussed earlier, it can be quenched by dissolved O2 (4.2), followed by a loss of HOO● to give mtyrosine residue as resulting product. Similar with tyrosine, quenching by O2 is the dominant
reaction pathway in the HRF scheme.13 The phenylalanine can also be labeled with a secondary
●

OH,55 which is produced, for example, by an exchange between primary ●OH with H2O as

illustrated in the top left of Scheme 4.4.
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Besides ●OH addition, ●OH is also able to abstract a ●H from β-CH2,48 resulting an unpaired
election (4.3), which is delocalized over the phenyl ring (4.4), as depicted on the left of Scheme
4.4. This unpaired electron can be readily paired by the addition of a second ●OH, resulting an
oxidized form of phenylalanine.

4.4.5 Methionine

Figure 4.8. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for three peptides from the BSA digest containing methionine (a, b and c). Error bars
represent standard deviations of three independent runs. Dashed horizontal line represents
calculated background A + 2 fraction.
Methionine takes oxygen from both dissolved O2 and H2O2 with comparable preferences, as shown
by the comparable normalized +18O fraction between experimental conditions of vacuum + 18O2
(3), regular + H218O2 (4) and vacuum + H218O2 (5, Figure 4.8a to c).
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Scheme 4.5. Proposed reaction pathway of methionine residue based on the results. Oxygen
highlighted in red represents 18O.
We explain these preferences by a reaction pathway proposed in Scheme 4.5. It was previously
shown that ●OH reacts with methionine by adding to the sulfur atom, leaving an unpaired electron
on it.48, 52, 58-59 Upon forming this intermediate 5.1, there is a comparable chance for a second ●OH
(5.2) or a O2 (5.3) to react and quench the radical species. This contrasts sharply with HRF, as a
distinct preference of O2 is proposed to quench intermediate 5.1.13, 52 Under both reaction routes,
the final product is likely methionine sulfoxide, detected as +16 by MS2.13 Results all resolved
methionine residues fit well the pathway proposed above.

4.4.6 Leucine, Isoleucine, Valine and Proline
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Figure 4.9. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a-j) BSA digest and (k-s) RTC containing leucine. Error bars
represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.

Scheme 4.6. Proposed reaction pathway of leucine residue based on the results. Oxygen
highlighted in red represents 18O.
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Figure 4.10. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for three peptides from the RTC containing isoleucine (a and b). Error bars represent
standard deviations of two independent runs. Dashed horizontal line represents calculated
background A + 2 fraction.

Scheme 4.7. Proposed reaction pathway of isoleucine residue based on the results. Oxygen
highlighted in red represents 18O.
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Figure 4.11. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a-c) BSA digest and (d) RTC containing valine. Error bars
represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.

Scheme 4.8. Proposed reaction pathway of valine residue based on the results. Oxygen highlighted
in red represents 18O.
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Figure 4.12. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a) BSA digest and (b) RTC containing proline. Error bars
represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.

Scheme 4.9. Proposed reaction pathway of proline residue based on the results. Oxygen
highlighted in red represents 18O.
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Leucine, isoleucine, valine and proline, as aliphatic amino acids, are presented together (Figure
4.9 to 12). These aliphatic residues take oxygen nearly exclusively from O2, well aligned with
HRF13 because there is unlikely any localized concentration of H2O2 in the region of these
hydrophobic peptides. Mechanistically, all four residues behave similarly (Scheme 4.6 to 9). To
begin, ●OH converts the residue into a radical by ●H abstraction. Following O2 addition to give a
radical protein-O-O●, the peroxy radical is readily quenched by water, resulting an oxidized
protein-O product. ●H abstraction by ●OH has been well characterized as the first step in the
oxidative modification of aliphatic amino acids,13, 48, 56, 60 with a preferred abstraction occurring at
the branch point (γ-CH for leucine (Scheme 4.6), β-CH for isoleucine (Scheme 4.7), and β-CH for
valine (Scheme 4.8)) because tertiary radical > secondary radical > primary radical in stability.
The cyclic nature of proline complicates the picture (Scheme 4.9). As previously reported, ●H
abstraction for proline takes place at δ-CH2, γ-CH2 and β-CH2 in the ratio of 2.7 : 1.4 : 1.48 The
higher reactivity of δ-CH2 is explained as an inductive effect of the adjacent peptide bond.

4.4.7 Lysine, Aspartic Acid, Glutamic Acid and Glutamine

Figure 4.13. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for three peptides from the BSA digest containing lysine (a and b). Error bars represent
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standard deviations of three independent runs. Dashed horizontal line represents calculated
background A + 2 fraction.

Scheme 4.10. Proposed reaction pathway of lysine residue based on the results. Oxygen
highlighted in red represents 18O.

Figure 4.14. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a and b) BSA digest and (c) RTC containing aspartic acid. Error
bars represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.
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Scheme 4.11. Proposed reaction pathway of aspartic acid residue based on the results. Oxygen
highlighted in red represents 18O.

Figure 4.15. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for ten peptides from (a-c) BSA digest and (d) RTC containing glutamic acid. Error
bars represent standard deviations of three and two independent runs for BSA digest and RTC,
respectively. Dashed horizontal line represents calculated background A + 2 fraction.

Scheme 4.12. Proposed reaction pathway of glutamic acid residue based on the results. Oxygen
highlighted in red represents 18O.
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Figure 4.16. Normalized +18O fraction determined under number-coded experimental conditions
(Table 4.2) for three peptides from the RTC containing glutamine (a and b). Error bars represent
standard deviations of two independent runs. Dashed horizontal line represents calculated
background A + 2 fraction.

Scheme 4.13. Proposed reaction pathway of glutamine residue based on the results. Oxygen
highlighted in red represents 18O.
The charged residues of lysine (Figure 4.13, Scheme 4.10), aspartic acid (Figure 4.14, Scheme
4.11), and glutamic acid (Figure 4.15, Scheme 4.12) take oxygen exclusively from O2 as does the
polar, uncharged glutamine (Figure 4.16, Scheme 4.13). The lysine, amine group is positively
charged at physiological pH, leading to a lower electron density at ε-CH2. As a result, ●OH
preferentially reacts with β-CH2, γ-CH2 and δ-CH2 (Scheme 4.10).37, 48 For aspartic acid, glutamic
acid and glutamine, a previous NMR-based hydrogen deuterium exchange study revealed that the
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carboxylate and carboxamide groups deactivate the ●H abstraction at physiological pH.48 Such
deactivation lowers the rate constant between ●OH and these residues.13 Moreover, oxygen uptake
by these residues is not the dominant reaction pathway upon ●OH labeling as evidenced in previous
studies. Other possible reaction pathways are not the primary focus of this work and will not be
discussed in detail.13

4.4.8 Three Classes of Residues in FPOP Platform
We can group the thirteen resolved amino-acid residues into three different classes based on their
reactivity and preferences towards different oxygen sources. Class 1 residues (histidine, arginine,
tyrosine, and phenylalanine) preferentially take oxygen from H2O2, most likely by addition of ●OH
to a previously formed radical. Among these four residues, we can identify three sub-classes based
on their distinct reaction pathways.
Class 1a residues are histidine and arginine that take oxygen solely from H2O2. The rationalization
for their behavior begins with an interaction of H2O2 via hydrogen bonding with histidine, arginine
as well as with tyrosine, cysteine, threonine, glutamine, aspartic acid, lysine, methionine, tyrosine
and tryptophan.53 This interaction gives rise to a high local concentration of H2O2 with the protein
in the vicinity of these amino-acid residues, allowing photolysis to produces a high local
concentration of ●OH where the first ●OH adds onto histidine and abstracts the ●H from arginine,
and another ●OH, in close proximity, reacts with the radical intermediate. Such reaction pathways
contrast significantly with synchrotron-based HRF,13,
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where no local fluctuation of ●OH

concentration is expected since the radical precursor is water. The two radical intermediates for
histidine and arginine have shorter radical lifetimes that minimize the side reactions, causing these
two residues to be less likely to uptake oxygen from dissolved O2 and water.
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Class 1b residue is tyrosine. Because H2O2 hydrogen bonds to tyrosine as well, the reaction
involves H abstraction to give a protein free radical that then is capped by reaction with another
●

OH nearby. The unpaired electron of tyrosyl radical is delocalized into the electron-rich aromatic

ring, stabilizing it and prolonging its radical lifetime. The longer lifetime makes it possible for
tyrosine to react along other reaction routes, for which tyrosine also takes oxygen from dissolved
O2 and from water through an exchange process as discussed earlier. We can also view the
preference as experimental evidence to support the hydrogen bonding between H2O2 and these
amino acid residues.
Class 1c residue is phenylalanine. The oxygen uptake by phenylalanine is similar to that of tyrosine
because ●OH addition and abstraction are electrophilic processes, and both aromatic rings are
electron-rich, particularly tyrosine. They differ probably because H2O2 does not hydrogen-bound
with phenylalanine. Even if the local ●OH concentration is not elevated owing to a lack of a preformed H2O2 – phenylalanine complex, the electron density of the phenyl ring still attracts the ●OH
radicals. Moreover, ●OH reacts with phenylalanine via multiple pathways, including ●OH addition
of the phenyl ring and ●OH abstraction at β-CH2, both favoring a path having a clear preference
for taking oxygen from H2O2. Furthermore, the long radical lifetime of the aryl radical, side
reaction of taking oxygen from dissolved O2 and from water through an exchange process are
weakly competitive facilitated.
Class 2 residue is methionine. Although methionine can be hydrogen bounded to H2O2 prior to
laser irradiation, which leads to a high local ●OH concentration after photolysis, methionine has a
high reactivity towards with both ●OH or O2 after adding the first ●OH, permitting us to classify
methionine differently than class 1 residues.
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Class 3 residues include leucine, isoleucine, valine, proline, lysine, aspartic acid, glutamic acid
and glutamine. These residues take oxygen nearly exclusively from O2 following similar pathways
for each residue (Scheme 4.6 to 13). Although some of these residues (lysine, aspartic acid and
glutamine) hydrogen bond to H2O2 to give a high local ●OH concentration, they are sufficiently
stable to show high specificity towards O2. Similar preference for these residues was proposed in
the HRF system.13

4.5 Conclusion
To serve a need for elucidating reaction pathways for FPOP, we developed a simple but effective
platform for 18O isotopic labeling on a under different reaction conditions and used it to reveal the
oxidation pathways for 13 amino-acid residues. There are three classes of residues clearly
differentiated based on their choice of oxygen during ●OH labeling. Class 1a and 1b residues
provide experimental evidence in supporting hydrogen bonding between H2O2 and selected
residues. Although our first focus is +16 modifications, this approach can be applied to the several
other modifications that occur with hydroxyl radicals.
This is the first systematic study of FPOP labeling pathways, and the results elevate the
fundamental understanding of ●OH-based FPOP chemistry. This foundation allows us to tailor the
FPOP conditions to address specific biological questions. For example, the dissolved O2 can be
replaced with another free radical (e.g., nitrogen monoxide (NO), a stable radical species with
profound biological significance61) to test its reactivity with protein free radicals. NO should be
inserted into proteins via class 3 residues but also participate in selected reaction routes of class 1
and 2 residues that require O2 to complete. Another exciting possibility is footprinting by FPOP in
anaerobic conditions, where the application of HRF may be limited due to its demand in dissolved
O2 during labeling. FPOP brings additional oxygen source (H2O2) into the system and label the
212

protein in a different mechanism (class 1 and 2 residues), making it possible to label selected
residues even under reduced oxygen conditions.
Moreover, understanding pathways may enable residue-specific detection of selected biochemical
processes based on different reaction mechanisms. By time-dependent and rapid introduction of
an 18O source following the initial perturbation, it may be possible to follow protein dynamics even
in a residue-specific manner. Deeper mechanistic understandings of ●OH labeling opens new
possibilities for the FPOP platform, providing opportunities not clear prior to this fundamental
work.
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Chapter 5: Hydrogen Deuterium Exchange Reveals the
Interaction Partner Networks on Cell Membranes
This Chapter is based on the following publication:
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Gross, M. L.; Schuettpelz, L. G.; Li, W. Open conformation of tetraspanins shapes interaction
partner networks on cell membranes EMBO J. 2020, 39, e105246.
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5.1 Abstract
Tetraspanins are a group of membrane proteins that regulate many cellular processes through
organizing an interaction network. Previous chapters in this thesis cover three studies with FPOP.
In this chapter, we report a hydrogen deuterium exchange mass spectrometry (HDX-MS) study of
the two members of the tetraspanin family, CD53 and CD81, to elucidate the binding with their
partners, CD2 and CD19, respectively. HDX-MS results suggest that the variable C-D region on
the EC2 domains of the CD53 and CD81 are responsible for their partner recognition. With the
newly resolved crystal structure of CD53 in an open conformation, docking models of CD53 and
CD81 under both open and closed states were constructed. Through the docking analysis, we
conclude that open conformation is crucial for the partner binding of CD53 and CD81, as the open
conformation allows the variable C-D region in the EC2 domain to extend over the membrane
plane, providing steric clearance for partner interaction. We also hypothesize that the overmembrane height of the variable C-D region may be one of the determining factors that underlines
the partner recognition specificity of the tetraspanins.

5.2 Introduction
Tetraspanins are a group of membrane proteins that participate in several cellular processes,
including cell migration, adhesion, proliferation, fusion, and signal transduction.1-5 For example,
CD81, one of the most studied tetraspanin, facilitates sperm-egg fusion process,6 helps the
maturation of CD19,7, 8 and participates the regulation in the central nerve system.9, 10 Another
member of the tetraspanin family, CD53, is deeply involved in B cell differentiation and the
modulation of inflammatory processes.11-13 Unlike most tetraspanins, which are broadly
distributed in the cells and tissues, CD53 is exclusively found on leucocytes. Even though there
are only 33 tetraspanins identified in human genome, their profound functionality in facilitating
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numerous cellular processes and generating hierarchical interaction networks make them an
important group of membrane proteins.
In terms of their structures, tetraspanins contain four transmembrane helices (TMs), two of which
are connected by a short extracellular domain (EC1) whereas the other two are linked by a longer
extracellular domain (EC2).1 The N-terminus and C-terminus both reside in the cytoplasmic side.
The EC2 is further subdivided into a constant region (containing A, B, and E helices) and a variable
C-D region, containing various protein-protein interacting sites.14, 15 Among all tetraspanins, a
CCG motif after the B helix is highly conserved. There are two other conserved cysteine residues
that arrange with the CCG motif into two disulfide bonds. There are also tetraspanins containing
six or eight cysteines. Nearly all tetraspanins also contain membrane proximal cysteines that
undergo palmitoylation. These cysteine residues and disulfide bonds make it challenging to
analyze the tetraspanins through bottom-up hydrogen deuterium exchange mass spectrometry
(HDX-MS), in which a rapid and effective disulfide bond reduction is required for analysis.
Among all proteins in the tetraspanin superfamily, only two of the full-length structures are
resolved (CD8116 and CD917), both under their closed conformation. The EC2 domain in both
CD81 and CD9, and also in the EC2 domain of TSP-2 from Schistosoma mansoni18 (for which
there is an NMR structure), adopt the mushroom-like structure with A-E helices, known as
canonical mushroom fold. In both cases, the investigators proposed that the open conformation is
crucial for partner recognition of tetraspanins, yet only modeling results were available to support
such hypotheses.16, 17 In other words, a tetraspanin structure at its partner interactive state is crucial
for the deeper understanding of the molecular-level mechanism of tetraspanin-mediated cellular
processes.
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Figure 5.1. (a) Overall structure (side view). EC1 and secondary structure elements in EC2 are
shown in different colors, and the four TMs in blue. (b) Structure of the CD53 EC2 domain
showing the mushroom fold with a head and stalk. The stalk helices connect to TM3 and TM4
through two hinges. (c) Interactions stabilizing the EC1-EC2 binding.19
Very recently, our collaborators led by Weikai Li at Washington University, School of Medicine
resolved the crystal structure of CD53 at its open conformation (2.9 Å), making this the third
resolved crystal structure of full length protein in the tetraspanin family.19 As shown in Figure
5.1a, the four TMs adopt a cone-shaped conformation, in which the four TMs pack tightly into a
bundle at the cytoplasmic side. The TM1/TM2 and TM3/TM4 pairs start to split at approximately
half-way in the membrane, creating a tunnel, and they further elongate into a large opening at the
extracellular side. Such an opening may afford a potential binding site for the transmembrane
domain of the interacting partners.
There are two EC domains in CD53, namely, EC1 and EC2. EC2 domain of CD53 also adopts a
canonical “mushroom fold” (Figure 5.1b), where the stalk is composed of A and E helices, and the
pileus is of B, C, and D regions. Helices A and E are connected to the TM3 and TM4, respectively,
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through hinges with sharp bends (Figure 5.1b). These two helices are tightly bound to each other
through hydrophobic interactions and a hydrogen-bonding network between the polar residues,
stabilizing the relative positions of these two helices and further support the pileus.
Unlike CD81, whose C-D regions are by two helices, the C-D region in CD53 folds into two
antiparallel loops stabilized by two disulfide bonds.14 As the A, B, and E helices are usually
conserved among proteins in the tetraspanin family, a different folding scheme of the C-D region
of proteins in tetraspanin family is termed the “variable C-D region”.20, 21 The EC2 head region of
CD53, particularly the variable C–D region, is well exposed for interactions in the open
conformation.
One of the key features of this CD53 structure is that it was captured in its open conformation. The
exposed orientation of EC2 domain is supported by its interaction with EC1, as seen in Figure 5.1a
and highlighted in Figure 5.1c. Residues 43–47 in EC1 interact with a small groove of EC2, located
between the A and B helices. Side chains of hydrophobic residues Leu43 and Phe44 interact with
the hydrophobic part of the groove. Unlike CD81, whose EC1 is disordered, EC1 of CD53 at its
open conformation is well ordered owing to its interaction with EC2 domain. As a result, EC2
disengages from the transmembrane domain, extending it into the extracellular domain and making
it physically capable for partner binding as it is nearly free from steric hindrance.
To deepen the understanding of binding interactions between CD53 and CD81 with their
respective binding partners, we designed and executed HDX-MS to characterize the binding
interfaces between CD53 and its binding partner CD2, CD81 and its partner CD19. As introduced
in Chapter 1.4, HDX reports changes in protein structure through deuterium uptake on the
backbone amides, unlike FPOP that labels amino acid side chains. Upon binding with ligands,
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solvent accessibilities of binding area decrease, leading to decreased deuterium uptake as
compared with unbound state. HDX results suggest that both CD53 and CD81 interact with their
binding partners through the variable C-D region. Further, molecular docking of CD2 and CD19
with CD53 and CD81 at both open and closed conformations suggest that the open conformation
is essential for tetraspanin partner binding. The variable C-D region in the open conformation of
tetraspanin extended away from the membrane plane, creating an over-membrane distance that
differs between CD53 and CD81. Such distances may underline the specificity of partner
recognition.
In this chapter, we adopt a reductionist approach to address a biological question found for a
complex system. To afford a higher throughput, we chose to use the EC2 domain of CD53 and
CD81, and the extracellular Ig domain of CD2 and CD81 to resemble their interactions in vivo.
These protein constructs are soluble domains, eliminating the need of post HDX lipid/detergent
removal.

5.3 Materials and Methods
5.3.1 Materials
EC2 domain of CD53 (residues 107-181), EC2 domain of CD81 (residues 112-202), Ig domains
of CD2 (residues 1-205), and Ig domains of CD19 (residues 1-277) were used for HDX
experiments. Among the four proteins, CD53, CD2, and CD81 were expressed by Dr. Yihu Yang
from Dr. Weikai Li’s lab in Washington University School of Medicine. These proteins were
tagged with an N-terminal signal peptide (MGILPSPGMPALLSLVSLLSVLLMGCVA) and a Cterminal PreScission protease site (LEVLFQ/GP) followed by a GFP with 10x His tag (C-GFPHis). The coding DNA constructs were cloned into a modified BacMam expression vector. The
plasmids were transformed into DH10Bac cells to produce bacmids, which were subsequently
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transfected into Sf9 cells by using Cellfectin II (Thermo Fisher Scientific, Waltham, MA, USA)
for baculovirus production. The P2 virus was used to transfect HEK293 GnTI− suspension cells
that were grown in FreeStyle media at 37 °C. After 8–12 h infection, 10 mM sodium butyrate was
added, and the temperature was adjusted to 30 °C. The culture media containing the secreted
proteins were collected after 72 h of baculovirus transfection.
The media were diluted in 150 mM NaCl and 50 mM Tris pH 8.0 and incubated with TALON
metal-affinity resin. The resin was collected on a gravity-flow column and washed with the same
buffer containing 20 mM imidazole. The resin-bound protein was digested with 20 μg/mL
PreScission protease to remove the C-GFP-10xHis tag. The eluent was further purified through a
Superdex 200 column in a buffer containing 150 mM NaCl and 20 mM Tris pH 8.0. The purified
proteins were concentrated to 300 μM and stored at -80 °C before HDX-MS analyses.
CD19 was purchased from SinoBiological (Wayne, PA, USA). Concentrations for each of the
samples were determined by UV absorption with a Thermo Scientific NanoDrop OneC (Thermo
Fisher Scientific, Waltham, MA, USA). Trizma base, hydrochloric acid solution, urea, HPLC
water, and acetonitrile were from Sigma-Aldrich (St. Louis, MO, USA). MS-grade formic acid
was from CovaChem (Loves Park, IL, USA). D2O was Cambridge Isotope Lab (Tewksbury, MA,
USA). tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was from Santa Cruz Biotechnology
(Dallas, TX, USA). All chemicals were used without further purification. Tris buffer solution (50
mM) was made to match the condition of the protein stock by dissolving Trizma base in water.
Hydrochloric acid solution was added to obtain a pH of 8.0 (measured with an Orion Star A211
pH meter, Thermo Fisher Scientific, Waltham, MA, USA). Sodium chloride was added to the tris
buffer to give a concentration of 150 mM to ensure appropriate ionic strength of the buffer solution.
The quench solution was made by dissolving urea into tris buffer solution to a final urea
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concentration of 4 M. The pH of the quench solution was adjusted to 2.5 by adding hydrochloric
acid solution, whereas TCEP concentrations was varied based on the different requirements of
disulfide reduction.

5.3.2 Hydrogen Deuterium Exchange on Manual Platform
HDX experiments for CD81, CD19, and CD53 were executed on a manual platform. Prior to HDX,
peptide mapping of CD81, CD19, and CD53 was by MS/MS. The CD81 and CD53 were diluted
into Tris buffer (50 mM Tris, 150 mM NaCl, pH = 8.0) to a final concentration of 40 µM. The
CD19 was dissolved in water to a final concentration of 25 µM. In peptide mapping experiments
for CD81 and CD53, 2 µL, a 40 µM protein solution was diluted into 18 µL Tris buffer, followed
by adding 30 µL quench solution. For CD19, 4 µL, 25 µM protein solution was diluted into 16 µL
Tris buffer, followed by adding 30 µL quench solution. The quench solution for CD53 and CD81
(30 μL) contained 4M urea, 200 mM TCEP. The quench solution for CD19 (30 μL), however,
contained 4M urea and 500 mM TCEP for a more effective disulfide reduction. Both quench
solutions were adjusted to pH of 2.5 to minimize the back exchange. The mix was incubated at 25
°C for 60 s, and subsequently injected into a custom-packed column containing immobilized
pepsin for digestion at a flow rate of 200 μL/min with water containing 0.1% trifluoroacetic acid.
After 3 min digestion and desalting, the flow was then switched to a LC gradient (9.5 min for
CD53 and CD81, 5% phase B to 50% phase B in 5.5 min, followed by a sharper increase to 100%
B at 6 min, kept at 100% until 7.5min, ended by 5% B in the last 2min; 15min for CD19, 5% phase
B to 50% phase B in 11 min, followed by a sharper increase to 100% B at 11.5 min, kept at 100%
until 13 min, ended by 5% B in the last 2 min) with water (with 0.1% formic acid) as phase A and
80% acetonitrile (with 0.1% formic acid) as phase B. The LC gradient transferred the digested
peptides to a C-18 column (XSelect CSH C18 2.5 μm, 2.1 × 50 mm, Waters, Milford, MA) for
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separation and admission to the mass spectrometer for analysis. The data were collected on a
quadrupole time-of-flight mass spectrometer (Bruker MaXis, Billerica, MA) equipped with a
positive-ion electrospray ionization source and with MS/MS capabilities. The valves, columns,
and tubing for desalting and HPLC separation were submerged in an ice-water bath. The pepsin
column was at room temperature for effective digestion. For MS/MS data processing, peptides
were identified by Byonic (Protein Metrics, San Carlos, CA) and processed with Byologic (Protein
Metrics). Three mapping runs were executed, and the obtained peptides were combined as the
peptide mapping result.
HDX for each protein was performed for two different states, namely, unbound state and the
partner-bound state. In the case of CD81, the incubation ratio between CD81 and CD19 was 1:3.
For CD19, the bound state was performed at the CD19:CD81 of 1:3. The bound state of CD53 was
by mixing with CD2 at the ratio of 1:3. All of the bound-states were incubated at 4 °C overnight
to allow equilibration. The D2O buffer (Cambridge Isotope Lab, Tewksbury, MA) was prepared
to match the condition of the protein stock, which contained 150 mM NaCl and 50 mM Tris at pH
of 8.0. HDX for CD81 and CD53 was initiated by diluting 2 μL of protein solution (40 μM,
unbound or bound states) into 18 μL of D2O buffer (90% D) for exchange, with the exchange times
of 10s, 30s, 60s, 900s, 3600s, and 14400s at 4 °C. The exchange for CD19 was by diluting 4 μL
of protein solution (25 μM, unbound or bound states) into 16 μL of D2O buffer (80% D) for
exchange, with the exchange times of 10s, 30s, 60s, 900s, 3600s, and 14400s at 4°C. The exchange
was quenched by adding 30 μL quench solution. The quench solutions and conditions were the
same as ones used in the mapping experiments. Subsequent digestion, desalting, LC separation,
and sample injection into the mass spectrometer were the same as those used in the peptide
mapping runs described above. The data were collected on the Bruker MaXis Q-ToF mass
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spectrometer under MS-only mode. The valves, columns, tubing for desalting, and HPLC
separation were submerged in an ice-water bath to minimize back-exchange. The pepsin column
was at room temperature for effective digestion.

5.3.3 Hydrogen Deuterium Exchange on LEAP Platform
HDX experiments for CD53 and CD2 were executed on a LEAP platform. In a peptide mapping
experiment, 3 µL, 40 µM protein solution was diluted into 27 µL Tris buffer. After thorough
mixing, 25 μL of diluted mixture was transferred to a vial with pre-dispensed quench solution (50
μL), where the diluted protein solution was mixed with the quench solution and incubated at 25
°C for 60 s. The quench solution for CD53 contains 4 M urea, 200 mM TCEP. The quench solution
for CD2, however, contains 4 M urea and 500 mM TCEP for a more effective disulfide reduction.
Both quenching solutions were adjusted to pH of 2.5 to minimize back exchange. The quenched
mixture was then submitted into a custom-packed column containing immobilized pepsin for
digestion at a flow rate of 200 μL/min in water containing 0.1% trifluoro acetic acid. The digested
peptides were captured by a ZORBAX Eclipse XDB C8 column (2.1 mm × 15 mm, Agilent
Technologies, Santa Clara, CA). After 3 min digestion and desalting, the flow was then switched
to a 15 min LC gradient (5% phase B to 50% phase B in 11 min, followed by a sharper increase to
100% B at 11.5 min, kept at 100% until 13 min, ended by 5% B in the last 2 min) with water (with
0.1% formic acid) as phase A and 80% acetonitrile (with 0.1% formic acid) as phase B. The LC
gradient washed the digested peptide onto a C-18 column (XSelect CSH C18 2.5 μm, 2.1 × 50
mm, Waters, Milford, MA) for separation prior to MS analysis. The data were collected by a QToF mass spectrometer (Bruker MaXis, Billerica, MA) operating in the MS/MS mode. The valves,
columns, and tubing for desalting, and HPLC separation were kept in a chamber where the
temperature was regulated to be 4 °C to minimize back exchange. The pepsin column was kept in
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a separate chamber at temperature of 25 °C for an effective protein digestion. For MS/MS data
processing, peptides were identified by Byonic (Protein Metrics, San Carlos, CA) and processed
with Byologic (Protein Metrics). Three mapping runs were executed, and the obtained peptides
were combined as the peptide mapping result.
HDX for each protein was performed for two different states, namely, unbound and partner-bound.
For CD53, the bound state was obtained by mixing with CD2 at the ratio of 1:3. For CD2, the
bound state was achieved at the CD2:CD53 of 1:3. All of the bound-states were incubated at 4 °C
overnight to allow equilibration. The D2O buffer was prepared to match the condition of the protein
stock, which contains 150 mM NaCl and 50 mM Tris at pH of 8.0. The exchanges were executed
by a LEAP automation system (Morrisville, NC). To start, 3 μL of protein solution was diluted
into 27 μL of D2O buffer (90% D) for exchange, with the exchange time of 30 s, 60 s, 900 s, 3600
s, 7200 s and 14400 s. After exchange, 25 μL of HDX solution was transferred to a vial with predispensed quenching solution (50 μL), where the HDX solution was mixed with the quenching
solution and incubated at 25 °C for 60 s. The quench solutions and quench conditions were the
same with those in the mapping experiments. Subsequent digestion, desalting, LC separation, and
sample injection into mass spectrometer were the same as compared with peptide mapping runs
described above. The data were collected on the Bruker MaXis Q-ToF mass spectrometer in the
MS-only mode. The valves, columns, and tubing for desalting, and HPLC separation were kept in
a chamber where the temperature was regulated to be 4 °C to minimize back exchange. The pepsin
column was kept in a separate chamber at temperature of 25 °C for an effective protein digestion.
All experiments were executed in triplicate to assess precision.

5.3.4 Analyzing Hydrogen Deuterium Exchange Data
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For analyzing the HDX data, the peptide lists from the mapping runs consisting of peptide
sequence, charge state, retention time, mass, and score were submitted to HDExaminer (Sierra
Analytics, Modesto, CA) to create a protein template. The raw data containing MS-only HDX
information were then submitted into the template for analysis. To analyze the HDX data, the
isotopic envelope for a specific peptide was fit to obtain its isotopic distribution, thus determine
its deuterium uptake. The deuterium uptake for each peptide was manually inspected to insure
correct assignment. A similar strategy was used in analyzing data in Chapter 6.

5.4 Results and Discussion
5.4.1 Peptide Mapping of CD53, CD81, CD2, and CD19 under their Unbound
States
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Figure 5.2. Sequence coverage map for (a) CD53, (b) CD2, (c) CD81, and (d) CD19 in line with
their primary sequences. Each green and orange line indicates a peptide identified by MS/MS.
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To assess binding interactions through HDX-MS requires high sequence coverage, which is
usually achieved by optimizing denaturing conditions (quench condition) and tuning the
proteolytic digestion. Sequence coverage of all four proteins reached 100% under offline
denaturing, deglycosylating, and digestion conditions (data not shown). With the optimized online
HDX-MS conditions, however, the sequence coverage of CD53 under both manual and automated
platform combined to be 73% (Figure 5.2a). The shaded residues in the sequence coverage map
are residues that are not part of the wildtype protein but were included for the purpose of protein
expression and purification. The missing peptides contain N-glycosylation sites, represented by
NXT residues (X stands for any amino acid residue besides proline) in the protein sequence. As
glycans are usually highly heterogeneous, it is hard resolve them and follow them in HDX
experiments. Post-HDX deglycosylation of the resulting peptides is usually time-consuming and
is subject to back-exchange. Since glycosylated sites are not likely to be involved in binding in
tetraspanins, these missing regions were not further analyzed. Sequence coverage of CD2, CD81,
and CD19 are 73% (Figure 5.2b), 100% (Figure 5.2c), and 63% (Figure 5.2c), respectively. The
relatively low sequence coverages of CD2 and CD19 are due to three reasons: the N-glycosylation,
disulfide linkages, and the high β-sheet contents of these two proteins. From resolved crystal
structures of CD2 Ig domain (PDB ID: 1HNF) and CD19 Ig domain (PDB ID: 6AL5), both
proteins have high β-sheet contents. Stable interactions in β-sheets make the protein difficult to
fully digest; therefore, they compromise the sequence coverage. Such high structural stability also
challenges the disulfide reduction during quenching, and that also lowers the overall sequence
coverage in HDX-MS.

5.4.2 Differential HDX Results for CD53-CD2 Binding System
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Figure 5.3. Peptide-level HDX kinetic plots of CD53 EC2 domain under unbound (black) and
CD2-bound (red) states, obtained through LEAP automated platform. The exchange was executed
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at 4 °C. The labels above each panel include residue numbers, charge states, and peptide sequences.
Plots labeled in gray represent peptides that are not part of the wildtype protein but were included
for the purpose of protein expression and purification. Data points are averages of three
independent runs, and error bars are standard deviations.

Figure 5.4. Peptide-level HDX kinetic plots of CD53 EC2 domain under unbound (black) and
CD2-bound (red) states, obtained on this largely manual platform. The exchange was executed at
4 °C. The label above each panel includes residue numbers, charge state, and peptide sequence.
Plots labeled in gray represent peptides that are not part of the wildtype protein but were included
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for the purpose of protein expression and purification. Data points are averages from three
independent runs, and error bars are standard deviations.
Figures 5.3 and 5.4 show the peptide level HDX kinetic plots of CD53 EC2 domain under its
unbound and CD2-bound states. Among these plots, four plots show binding-induced protections.
They are 153-170 (+2), 153-170 (+3), and 153-171 (+3) from automated platform and 153-164
(+1) from the manual platform. Taken together, residues 153WTSGPPASCPSD164 are responsible
for the CD53-CD2 interaction. When mapped onto CD53 crystal structure, it is part of the variable
C-D region. Moreover, there are some peptides that can be found in both two datasets; for example,
107-112 (+1). Such peptides behave comparably in both cases, serving as a good control for
validating these two platforms. Note that the absolute deuterium uptake for this peptide is 15-20%
higher in the manual platform as compared with the automated platform, and similar phenomena
were seen for coexisting peptides. This is probably due to the extra liquid handling time in the
automated platform, leading to a higher back-exchange extent.
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Figure 5.5. Peptide-level HDX kinetic plots of CD2 Ig domain under unbound (black) and CD53bound (red) states, obtained by using a LEAP automated HDX platform. The exchange was
executed at 4 °C. The label above each panel includes residue numbers, charge state, and peptide
sequence. Data points are averages from three independent runs, and error bars are standard
deviations.
Figure 5.5 shows the peptide level HDX kinetic plots of CD2 Ig domain under its unbound and
CD53-bound states. The majority of the protein does not experience a noticeable conformational
change upon interacting with CD53, as seen by the overlapping kinetic curves between the
unbound and CD53-bound states. This overlap stems from the high β-sheet content of CD2.
Among all resolved peptides, three of them showed noticeable protection upon binding with CD53:
43-45 (+1), 120-128 (+2), and 124-128 (+1). Region 43-45 sits in the Ig-membrane interface; thus
it is unlikely to be involved in binding. Besides, none of its overlapping peptides show signs of
protection upon binding. Thus, region 124LKIQE128, situated in the “joint” between two Ig domains,
is responsible for binding with CD53.

5.4.3 Differential HDX Results for CD81-CD19 Binding System
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Figure 5.6. Peptide-level HDX kinetic plots of CD81 EC2 domain under unbound (black) and
CD53-bound (red) states, obtained by using a manual platform. The exchange was executed at 4
°C. The label above each panel includes residue numbers, charge state, and peptide sequence. Data
points are averages from three independent runs, and error bars are standard deviations.
Similarly, we conducted HDX-MS on the CD81 EC2 domain under its unbound and CD19-bound
states (HDX kinetic plots for all resolved peptides are presented in Figure 5.6). Five peptides, 171180 (+2), 171-185 (+1), 171-185 (+2), 180-185 (+1), and 181-185 (+1), show significant protection
upon binding with CD19. These peptides taken together, reveal a binding region of
171

KNNLCPSGSNIISNL185, located on the D-helix and its preceding loop.
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Figure 5.7. Peptide-level HDX kinetic plots of CD19 Ig domain under unbound (black) and CD81bound (red) states, obtained through manual platform. The exchange was executed at 4 °C. The
label above each panel includes residue numbers, charge state, and peptide sequence. Data points
are averages from three independent runs and error bars are standard deviations.
On the binding partner side, seven peptides of the CD19 Ig domain show decreased HDX when
interacting with CD81 EC2 domain, as shown in Figure 5.7. They are peptides 182-196 (+2), 185196 (+1), 185-197 (+1), 188-195 (+1), 188-196 (+1), 188-197 (+2), and 191-196 (+1). Decreased
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HDX of peptides suggests that the CD19 Ig domain binds to CD53 EC2 domain through the region
182

QSLSQDLTMAPGSTL196. Although the sequence coverage of CD19 Ig domain is not 100%

(Figure 5.2d), most regions that were not covered are heavily glycosylated, suggesting that is
unlikely they are part of the binding site.

5.4.4 Molecular Docking Reveals the Structures of Tetraspanin Binding
Complexes

Figure 5.8. CD53-CD2 and CD81-CD19 partner interactions identified by HDX-MS and modeled
onto open and closed conformations. (a) The partner-binding regions of CD53 and CD81. Their
EC2 sequences are aligned. Identical residues are shaded in dark gray, similar residues in light
gray, and partner-binding regions identified by HDX-MS in orange. Secondary structures are
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indicated above. (b) Representative HDX-MS curves showing the protected regions in CD53 EC2
domain and CD2 Ig domain. The HDX experiments were performed (manually or with a LEAP
automation system) in triplicate, and error bars show the standard deviation. (c) Left, CD53-CD2
docking model. The HDX-MS identified regions are shown as a red rod in CD53 and as a blue
arrow in CD2. The black box indicates the CD2 transmembrane region, and the dashed line
indicates the linker to Ig domains. Right, CD53-CD2 docking model with CD53 modeled in the
closed conformation. The modeling was based on the CD81 structure (by Dr. Yihu Yang,
Washington University School of Medicine), in which EC2 reorients to interact with the TM
domain. Docking of CD19 Ig to CD53 EC2 is in the same manner as the open conformation on
the Left. (d) Representative HDX-MS curves showing the protected regions in CD81 EC2 domain
and CD19 Ig domain. The HDX experiments were manually performed in triplicate. Error bars
show the standard deviation. (e) Left, CD81-CD19 docking model in the closed conformation. The
HDX-MS identified binding regions are colored as in (c). Right, modeled open conformation of
CD81 and docking with CD19 (in the same manner as Left).
The HDX-MS results presented above show that both CD53 and CD81 bind to their partners
through the variable C-D region (Figure 5.8a). Based on the binding interfaces identified through
HDX-MS (Figure 5.8b), a docking model was generated by Dr. Yihu Yang, Washington
University School of Medicine, using the crystal structures of CD53 (Figure 5.1) and CD2 Ig
domain (PDB ID: 1HNF). The model presented in Figure 5.8c suggests that the variable C-D
region of CD53 EC2 domain inserts into the groove at the joint of the two Ig domains in CD2.
Besides the binding interaction identified by HDX-MS, the docking model suggests a second
interacting site between variable C-D region of CD53 and the C-terminal Ig domain of CD2. Such
interaction was not captured by HDX, probably because HDX-MS utilizes the EC2 domain of
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CD53 rather than the full-length CD53 with its transmembrane and EC1 domains attached. The
open conformation of CD53 positions the variable C-D region well above the membrane plane
(dash lines in Figure 5.8c) and further orients the extracellular domain of CD2 to afford binding
interactions. In other words, CD53 needs to be in an open conformation for partner binding. To
illustrate better this point, a CD53 structure in its closed conformation was constructed through
homology modeling, with the closed-conformation CD81 (PDB ID: 5TCX) as a template. The
docking model between closed-conformation CD53 and CD2 Ig domain (shown in Figure 5.8c)
shows that the Ig domain of CD2 clashes with the membrane plane, making the interaction
unfeasible.
Similarly, a docking model between the closed-conformation CD81 (PDB IDL 5TCX) and CD19
Ig domain (PDB ID: 6AL5) was constructed (Figure 5.8e) with guidance from HDX-MS (Figure
5.8d). A similar clash of the CD19 Ig domain with the membrane plane is observed, and that
interaction is like that of the CD53 in its closed conformation. These two models suggest that
neither CD53 nor CD81 can bind to their partners in the closed-conformation, as previously
proposed for CD81.16
To illustrate better the binding interactions between CD81 and CD19 Ig domain, the open
conformation CD81 was constructed with the template of open conformation CD53. The docking
suggests that the variable C-D region of CD81 binds to a loop region of CD19 Ig domain,
positioning the whole CD19 Ig domain well above the membrane plane to avoid the clashes
observed in the closed conformation model.

5.4.5 Structural Similarities of CD53 and CD81 Revealed by HDX-MS and
Docking
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Figure 5.9. Regulation of tetraspanin-partner interaction in the open and closed conformational
changes. The cartoon shows the mushroom fold of EC2 (stalk and head) and supporting interaction
of EC1 (green). The spiral “roots” represent transmembrane helices. Left, Partner interaction at the
open conformation requires EC2 in an exposed orientation and its C-D variable region at an abovemembrane height (double arrow) matching that of the partner Ig domains. Right, Without the EC1
support (dimmed), changes in the EC2 orientation and the C-D height prevent partner interactions
in the closed conformation.
To summarize, HDX-MS identifies key interacting sites between the two binding pairs. This
interaction information was further utilized to construct structural model of the CD53-CD2 and
CD81-CD19 complexes through molecular docking. Comparison between the docking results for
CD53 and CD81 in their open and closed conformations suggests that the open conformation is
essential for partner binding (Figure 5.9 better visualizes this interpretation). Under the open
conformation, the mushroom fold of EC2 is supported by EC1, exposing the variable C-D domain
for partner binding. Without the support of EC1 domain, however, the mushroom is tilted to an
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orientation where the variable C-D domain is no longer accessible. Such a conformation induces
a steric hinderance of any partner interactions and prevents CD53 and CD81 from fulfilling their
function. The interaction between EC1 and EC2 of tetraspanins regulates the above-membrane
height of the mushroom fold and thus controls the accessibilities of the variable C-D region. Such
height-matching requirement may contribute to the partner specificity of different tetraspanins.

5.5 Summary and Conclusion
To summarize, we report in this chapter a detailed HDX-MS analysis of two protein pairs in the
tetraspanin family, CD53-CD2 and CD81-CD19, by using the constructs of their extracellular
domains. Differential experiments between bound and unbound states reveal the binding sites in
these two binding pairs, and the information was further utilized in a docking analysis. As a result,
docking models for these two protein pairs under both open and closed states of CD53 and CD81
were proposed. Through the docking models, we concluded that open states are essential for
partner interactions of CD53 and CD81, and the above-membrane height of the variable C-D
region of these two proteins may be one of the factors that determines the specificity of their
partner recognition. From a broader perspective, tetraspanins are emerging targets for cancer
therapeutics. Multiple members in the tetraspanin superfamily have been implicated in tumor
initiation, promotion, and/or metastasis.22-26 Results presented in this chapter contribute
significantly to the understanding of molecular aspects of tetraspanin structures and their partner
recognition. Such understanding may be applied to future work in developing novel therapeutic
strategies for cancers involving upregulated tetraspanin expression.
In addition to its biological significance, this study presents an example of utilizing MS-based
approaches for analyzing membrane protein structures in a reductionist way. As the goal is to
understand the interactions of the extracellular domains of four membrane proteins, instead of
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using the intact membrane protein, we chose to express and purify their extracellular domains and
analyze them using HDX-MS. This allows a faster throughput in terms of performing experiments
as it eliminates the complications of post-HDX lipid removal, which is likely to be time-consuming
and subject to the complications of back-exchange of D to H.
This reductionist approach is based on the premise that the extracellular domain construct shares
similar structural features as compared with the same domain in the full-length protein. It is,
however, not broadly applicable to any given membrane proteins. In the binding between CD53
and CD2 Ig domains, molecular docking suggests another interacting site that was not captured in
the current HDX experiment. That site is between the variable C-D region of CD53 and the Cterminal Ig domain of CD2. One possible reason is that the current construct of freestanding CD53
EC2 domain may adopt a slightly different orientation as compared with the EC2 domain in the
native protein, where the interaction between EC1 and EC2 domains of CD53 stabilizes the open
conformation of the CD53 (the orientation of the EC2 domain).
We showed in the previous section the binding models between the four proteins under both closed
and open conformations of CD53 and CD81. With the current reductionist approach it is not
feasible to replicate these two conformational states in the HDX-MS experiments. Moreover, as
the recognition between different tetraspanins may be height-specific, HDX-MS of the native
tetraspanins in the lipid bilayer may better capture such distinctions. All these limitations suggest
that improvements in the HDX-MS workflow are necessary for addressing more complicated
membrane protein problems in the future. As always, the goal is to mimic the conformational states
and make the proteins in a “native-like” environment during footprinting.
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On the other hand, this field is poorly developed. There are a few demonstrations that utilize HDXMS to study intrinsic membrane proteins dispensed in detergents, nanodisks, or lipid bilayers.27-33
The challenge is to remove effectively lipid/detergent and retain the deuterium labeling with a
minimum of back exchange. The protein stability in solution after removing the lipid is another
concern. High HDX sequence coverage, especially for the transmembrane helices, is also an
important challenge that needs effort. This research area has clear potential and will continue to
grow to meet the challenges of understanding this important topic.
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6.1 Abstract
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a diverse class of
peptides that are produced in the ribosome and subsequently undergo enzymatic post translational
modifications (PTMs). Class II lanthipeptides are one of such peptides. Like many others, a class
II lanthipeptide contains a N-terminal leader region for recognition purposes and a C-terminal core
region for enzymatic modifications. The modification of class II lanthipeptides are by bifunctional
lanthipeptide synthetase (LanM), which catalyzes both dehydration and cyclization reactions to
generate macrocyclic molecules. In this study, we characterized the leader peptide recognition of
HalM2, the LanM that facilitates the production of the antimicrobial peptide haloduracin ß.
Although the substrate processing by HalM2 is well understood, its mechanism of action,
specifically its binding to the corresponding leader peptide, HalA2-LP, has not been characterized.
Through hydrogen deuterium exchange mass spectrometry (HDX-MS), we identified key regions
in HalM2 that are responsible for the HalA2-LP recognition. Owing to the weak interaction
between HalM2 and HalA2-LP, HDX was performed under two different temperatures to afford
high-confidence binding-site identification. Results reported in this chapter not only provide a
deeper understanding of LanM-substrate interaction, but also demonstrate a novel way of
executing HDX for weak binding systems.

6.2 Introduction
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a diverse class of
peptides that are produced in the ribosome and subsequently undergo enzymatic post translational
modifications (PTMs).1,

2

Although they exhibit a broad range of biological functions, RiPP

precursors are generally homologous in terms of their structural components, a N-terminal leader
region for recognition purposes and a C-terminal core region for enzymatic modifications.3 The
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leader peptide facilitates the recognition by a wide variety of modifying enzymes to catalyze the
PTMs of the core peptides, enabling their custom synthesis for their distinct biological roles.
An important reason that RiPPs draw significant attention among many natural products is that
they are suitable for many biotechnological applications. Many demonstrations have shown the
feasibility of introducing non-proteogenic amino acids as part of the core peptide, leading to
modified-peptides with distinct activities.4-17 From another perspective, a library of substrates can
be obtained for a better understanding of the primary sequence-functionality relationship.18-32 All
in all, the PTM machinery between the enzyme and the RiPPs allows the tailoring of biosynthesis
processes with different core peptides, leading to controllable delivery of molecules with desired
properties. To achieve this goal, deeper understanding of the machinery mechanism, especially the
leader peptide recognition, is crucial.
Among all kinds of RiPPs, lanthipeptides are one of the largest groups and are symbolized by the
lanthionine (Lan) or methyllanthionine ((Me)Lan) residues. Lan or (Me)Lan are the product of
dehydrated serine/threonine residues crosslinked with cysteine residues, as shown in Figure 6.1.33
To date, four distinct enzyme classes that can facilitate such PTMs have been identified. Class I
lanthipeptide biosynthesis involves two different enzymes, a tRNAGlu-dependent LanB
dehydratase that catalyzes the phosphorylation and the subsequent dehydration, and a LanC
cyclase that facilitates the formation of the lanthionine moiety. The recognition between LanB and
their RiPP precursors is well understood; this is, both the characterization of the LanB substrate
binding domain and the recognition of motifs on the leader peptides that are responsible for LanB
and many other enzyme recognitions.34-36 In brief, Class I lanthipeptide precursor peptides are
recognized through the FNLD amino acid motif on the leader peptide37-39 by the RiPP recognition
element of the cognate dehydratase.34
266

Class II, III, and IV lanthipeptide synthetases, however, are multifunction enzymes that catalyze
both dehydrations and cyclizations.40-42 All these three classes of LanMs utilize nucleoside
triphosphates as phosphorylation reagents to modify serine/threonine residues on the substrate,
followed by phosphate elimination to fulfill the dehydration process.41,

43

Although previous

studies shed light on the substrate recognition of class III and IV lanthipeptides,43-46 the class II
LanM enzymes are poorly understood,47 despite a recent comprehensive hydrogen-deuterium
exchange mass spectrometry (HDX-MS) study along with biochemical functional assays that
reveal the binding interactions between class II lanthipeptide synthetase HalM2 and its full length
substrate HalA2 in the presence of an ATP analogue, AMP-PNP.48

Figure 6.1. Schematic illustration of class II lanthipeptide biosynthesis. LanM enzymes catalyze
phosphorylation of Ser/Thr residues and subsequent phosphate elimination to yield Dha/Dhb,
which is followed by Michael-type addition of a cysteine thiol to form lanthionine or
methyllanthionine.
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Class II lanthipeptide synthetase initiate the catalytic process by phosphorylating serine/threonine
residues under the presence of ATP, followed by phosphate elimination to form Dha/Dhb.
Subsequently, Michael-type cycloadditions occur with another cysteine thiol to form lanthionine
or methyllanthionine products (Figure 6.1). Among all Class II lanthipeptide synthetases, CylM is
the only one that is structurally resolved at high spatial resolution. CylM facilitates the biosynthesis
of enterococcal cytolysin and contains an N-terminal dehydratase domain that is structurally
similar to that of eukaryotic lipid kinases, and a C-terminal cyclase domain that is structurally
similar to those in the class I LanC proteins.47 The interaction mechanism between CylM and its
substrate, however, is not yet understood as there is not a high resolution structure for the substratebound state. The interest of the class II LanM-leader peptide recognition mechanism originates
from the tolerance of class II LanM in core peptide processing, elevating its potential in
biotechnological applications. For example, one specific LanM from Prochlorococcus MIT9313
has been shown to act on over 20 distinct precursor peptides to generate multiple unique
(methyl)lanthionine ring topologies.49, 50
To elevate our understanding of class II LanM-leader peptide recognition mechanism, we chose
hydrogen deuterium exchange to examine the binding process. Proteins that were chosen for this
study is HalM2 and its substrate HalA2-leader peptide (HalA2-LP), a pair of biomacromolecules
that are involved in the maturation of the antimicrobial peptide haloduracin β.51, 52 As compared
with the recent HDX-MS analysis utilized earlier, the system we examine does not involve the
core peptide and the ATP analogue.48 Such a system may provide direct evidence for substrate
recognition without the interference of other structural motifs. Chapter 5 discusses an example
where HDX-MS coupled with molecular docking can provide critical information on membrane
protein structures. This chapter utilizes HDX-MS coupled with many other characterization
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approaches, conducted in our collaborator’s laboratory, to report a binding site between HalM2
and its partner. Through HDX-MS at two exchange temperatures, we demonstrate that HalM2
binds to the leader peptide on the dehydratase domain, specifically on the architectural motif
known as the capping helices, which complements the aforementioned HDX studies.48 Together
with fluorescence polarization and photo crosslinking results from collaborator’s lab, we
concluded that the binding of HalA2-LP on the capping helices of HalM2 triggers a remote
conformational change of the dehydratase and cyclase domain of HalM2, preparing the enzyme
for subsequent core-peptide processing.2
Identification of LanM binding elements will aid in genome-mining efforts and facilitate rational
design and implementation of LanM enzymes to perform post-translational modifications for other
biotechnological processes. Moreover, we demonstrate that HDX-MS at two exchange
temperatures can enhance the confidence when identifying the binding sites for weak binding
systems. Together with the reductionist approaches discussed in Chapter 5, we demonstrate clearly
that HDX-MS has become an important tool in structural proteomics. Such an approach is readily
applicable in addressing other biological questions that are previously challenging for HDX-MS.

6.3 Materials and Methods
6.3.1 Materials
HalM2(1-990) and HalA2-LP were used for HDX experiments. They were obtained from Dr. van
der Donk’s lab in University of Illinois, Urbana-Champaign. Both were prepared through
overexpression in BL21 (Star) cells. Concentrations for each of the samples was determined by
UV absorption with a Thermo Scientific NanoDrop OneC (Thermo Fisher Scientific, Waltham,
MA, USA). Trizma base, hydrochloric acid solution, urea, HPLC water, and acetonitrile were from
Sigma-Aldrich (St. Louis, MO, USA). MS-grade formic acid was from CovaChem (Loves Park,
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IL, USA). D2O was Cambridge Isotope Lab (Tewksbury, MA, USA). All chemicals were used
without further purification. Tris buffer solution (10 mM) was made by dissolving Trizma base in
water. Hydrochloric acid solution was added to adjust the pH to 7.4 (measured with an Orion Star
A211 pH meter, Thermo Fisher Scientific, Waltham, MA, USA). Potassium chloride was added
to the tris buffer to give a concentration of 100 mM to ensure appropriate ionic strength of the
buffer solution. The HDX quench solution was made by dissolving urea into tris buffer to a final
urea concentration of 4 M. The pH of the quench solution was adjusted to 2.5 by adding
hydrochloric acid solution.

6.3.2 Hydrogen Deuterium Exchange
Prior to HDX, peptide mapping of HalM2 was by MS/MS. The HalM2 was diluted into Tris buffer
(10 mM Tris, 100 mM KCl, pH = 7.4) to a final concentration of 40 µM. In a peptide mapping
experiment, 2 µL, 40 µM HalM2 solution was diluted into 18 µL Tris buffer, followed by adding
30 µL quench solution. The mix was incubated at 25 °C for 10 s, and subsequently injected into a
custom-packed column containing immobilized pepsin for digestion at a flow rate of 200 μL/min
with water containing 0.1% trifluoroacetic acid. The digested peptides were captured by a
ZORBAX Eclipse XDB C8 column (2.1 mm × 15 mm, Agilent Technologies, Santa Clara, CA).
After 3 min digestion and desalting, the flow was switched to an LC gradient: 15 min, 5% phase
B to 50% phase B in 11 min, followed by a sharper increase to 100% B at 11.5 min, kept at 100%
until 13 min, and completed with 5% B for the last 2 min. Phase A was water (with 0.1% formic
acid), and phase B was 80% acetonitrile (with 0.1% formic acid). The LC gradient transferred the
digested peptides to a C-18 column (XSelect CSH C18 2.5 μm, 2.1 × 50 mm, Waters, Milford,
MA) for separation and admission to the mass spectrometer for analysis. The data were collected
on an LTQ-FT mass spectrometer (Thermo Fisher Scientific, Waltham, MA) equipped with a
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positive-ion electrospray ionization source operating in the MS/MS mode. The valves, columns,
tubing for desalting, and HPLC separation were submerged in an ice-water bath. The pepsin
column was at room temperature for effective digestion. For MS/MS data processing, peptides
were identified by Byonic (Protein Metrics, San Carlos, CA) and processed with Byologic (Protein
Metrics). Three mapping runs were executed, and the obtained peptides were combined as the
peptide mapping result.
HDX was performed for two different states, namely, unbound state and the HalA2-LP bound
state. In the unbound state, HalM2 was diluted into Tris buffer (10 mM Tris, 100 mM KCl, pH =
7.4) to a final concentration of 40 µM. In the HalA2-LP bound state, a stock solution containing
40 µM HalM2 and 560 µM HalA2-LP (mixed in a 1:14 ratio) was prepared 12 h before the HDX
experiment to allow equilibration. The D2O solution was prepared to match the buffer condition
of the protein stock solution. The HDX experiments were executed on a manual platform as
previously described.46 The HDX was initiated by diluting 2 µL of protein solution into 18 μL of
D2O buffer (to achieve a maximum of 90% D) for exchange. Exchanges at 4 °C were executed in
triplicate with exchange times of 10 s, 30 s, 60 s, 900 s, and 7200 s, whereas HDX at 25 °C was in
duplicate at 10 s, 30 s, 60 s, 900 s, 3600 s, and 7200 s. The HDX was quenched by adding 30 μL
quench solution and incubating at 25 °C for 10 s. Subsequent digestion, desalting, LC separation,
and sample injection into mass spectrometer were the same as compared with peptide mapping
runs described before. The data were collected on an LTQ-FT mass spectrometer in the MS-only
mode. The valves, columns, tubing for desalting, and HPLC separation were submerged in an icewater bath to minimize back-exchange. The pepsin column was at room temperature for effective
digestion.
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For analyzing the HDX data, the peptide lists from the mapping runs consisting peptide sequence,
charge state, retention time, mass, and score were submitted to HDExaminer (Sierra Analytics,
Modesto, CA) to create a protein template. The raw data containing MS-only HDX information
were then submitted to the template for analysis. To analyze HDX data, the idea was to fit the
isotopic envelope for a specific peptide to determine its deuterium uptake. The deuterium uptake
for each peptide was manually inspected to insure correct assignment.

6.4 Results and Discussion
6.4.1 Peptide Mapping of HalM2 under its Unbound State

Figure 6.2. Sequence coverage map for HalM2 (1-990, with N-terminal His-tag) in line with its
primary sequence. Each green line indicates a peptide identified by MS/MS.
To extract import nearly complete binding information from the HDX-MS experiments, high
sequence coverage is essential. Usually, high sequence coverage is achieved through optimizing
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the quenching conditions and the digestion conditions. Quench of HDX at higher temperature for
a longer time will ensure a complete denaturation of the protein and thus a better digestion in the
immobilized pepsin column, whereas quenching at lower temperature for shorter time will
minimize the back exchange. Denaturant in the quench solution is another factor that can be
optimized. Here we achieve 99.7% sequence coverage for HalM2 (Figure 6.2) by using a 10 s
incubation with the quench solution at 25 °C, a condition that is sufficient for HalM2 denaturation
and also minimal back exchange.

6.4.2 Differential HDX Experiments under Two Exchange Temperatures
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Figure 6.3. Peptide-level cumulative deuterium uptake differences between HalA2-LP bound and
unbound states at 25 °C. Shaded area indicates three times the propagated standard deviations,
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where a bar exceeding the shaded area indicates a significant difference in binding/opening at
99.7% confidence. Notably, peptides that show protection upon HalA2-LP binding are labeled in
red.
There are regions, marked with bars in Figure 6.3, where the peptide-level cumulative deuterium
exchange differences (across all exchange times) between HalA2-LP bound and unbound states at
25 °C. For instance, a bar beyond the shaded area suggests a binding/opening with 99.7%
confidence. Among all identified peptides, 45 showed significant protection upon binding with
HalA2-LP. They cover the regions of 26-54, 70-73, 78-90, 110-150, 154-195, 209-260, 325-335,
379-388, 436-467, 511-535, 545-571, 625-627, 681-701, 748-764, 801-820, 847-861, and 873902. These regions almost span the whole protein, and many regions are only supported by a single
peptide or even at a single charge state. For example, peptide 110-150 shows protection at all three
identified charge states whereas its overlapping peptide, 110-144 and 110-147 do not show
significant protection upon binding with HalA2-LP. Such observations make it critical to develop
another approach to differentiate the false positives from the real binding regions.
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Figure 6.4. Peptide-level cumulative deuterium uptake differences between HalA2-LP bound and
unbound states at 4 °C. Shaded area indicates three times the propagated standard deviations,
where a bar exceeding the shaded area indicates a significant difference in binding/opening at
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99.7% confidence. Notably, peptides that show protection upon HalA2-LP binding are labeled in
red.
The peptide-level cumulative deuterium differences (across all exchange times) between HalA2LP bound and unbound states at 4 °C can indicate regions that interact with the substrate. For
instance, a bar beyond the shaded area suggests a binding/opening with 99.7% confidence. Among
all identified peptides, seven showed significant protection upon binding with HalA2-LP. They
cover the regions of 26-54, 70-73, 379-388, and 625-627. When viewed together with results
shown in Figure 6.3, it can be seen that regions that show protections at both exchanges
temperatures are 26-54, 70-73, 379-388, and 625-627. In other words, HDX at lower temperatures
further pinpoints the potential binding regions and largely minimizes any false positives.

6.4.3 HDX at Two Temperatures Elevates the Confidence in Binding Site
Determinations
As the binding affinity between HalM2 and HalA2-LP is around 10 µM, a number that is not ideal
for HDX experiments, three alternative approaches can be applied to better identify the binding
regions. The first is to increase the concentration of the binding partner, HalA2-LP in this case,
and push the equilibrium further to the complex. With this protein system, however, the HalA2LP concentration is limited by its solubility, and a 1:14 mixing ratio (HalM2:HalA2-LP) is the
limit. The second is to increase the HalM2 concentration during HDX to push the equilibrium
toward the complex. As the HalA2-LP cannot be further concentrated, increasing HalM2
concentration is this case will compromise the 1:14 mixing ratio of HalM2:HalA2-LP, and the
overall effect on the binding equilibrium may not favor the complex-forming direction. Moreover,
this requires post-exchange system dilution, which further complicates the experiment.
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The last approach is to measure the HDX at a lower temperature. As mentioned in Chapter 1.4,
when used as a footprinting method, HDX monitors the changes in protein backbone solvent
accessibility through examining the breathing motion of the backbone hydrogen bonding.
Moreover, when examining a ligand-binding system, HDX usually provides a composite readout
that combines the effect of backbone-breathing dynamics and ligand-binding dynamics. For
systems with relative low binding affinities, the ligand binding process is usually highly dynamic
as compared with systems that enjoy tight binding (Kd is usually at nanomolar level). The
highlighted dynamic process is reflected numerically by a high ligand off-rate. When lowering the
temperature, while not affecting the macroscopic binding affinity, both ligand on- and off-rates are
lowered, making it easier for HDX to capture the binding-induced structural protection over the
time course of exchange.
When adopting the third strategy, two-temperature HDX identifies seven distinct peptides that
show decreased solvent accessibilities upon interacting with HalA2-LP. Note that only peptides
with specific charge states and detected in both exchange temperatures qualify as candidates for
potential binding regions, and among the candidates only seven peptides show binding-induced
protection at both exchange temperatures. As compared with exchange at 25 °C alone, where 45
peptides show decreased HDX upon interacting with HalA2-LP, this approach greatly elevates the
confidence of binding sites identifications.
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Figure 6.5. HDX kinetic plots for peptides that exhibit decreased deuterium uptake upon HalA2LP binding at two exchange temperatures. Plots with axes in blue represent HDX at 4 °C whereas
those in red show HDX at 25 °C. The label above each panel includes residue numbers, charge
state, exchange temperature, and peptide sequence. In each panel, the black curve is deuterium
uptake for unbound state whereas the green curve is for HalA2-LP bound state.
The HDX kinetic plots for the aforementioned seven peptides at both exchange temperatures show
clearly the binding regions (Figure 6.5). Two distinct features are worth highlighting when
comparing these kinetic plots. First, as the exchange temperature increases form 4 °C to 25 °C, the
279

deuterium uptake percentiles increases significantly. As mentioned before, HDX reports on the
breathing motions of protein backbone hydrogen bonding. Increases in temperature increase the
breathing motions of the backbone hydrogen bonding and consequently increase in the HDX of
these peptides. Second, the diverging regions between the unbound and HalA2-LP bound kinetic
curves occur at shorter exchange times when increasing the exchange temperature. Such
phenomena can be reasonably explained through an increase in ligand off-rate when increasing the
exchange temperature. Ultimately, the kinetic curves for each state will merge as the protein
becomes fully deuterated even when mixed with the binding partner. The kinetic curve divergence
between bound and unbound states for all binding peptides happen between time zero to infinite.
Over the time course of HDX, such divergence may or may not be observed owing to the unique
dynamics of each peptide, and that dynamics is usually a combination of backbone breathing
motion and ligand-binding dynamics. When executed in differential manner (e.g., bound vs
unbound), the effect of backbone breathing motion cancels, leaving the ligand binding dynamics
as the primary factor. When increasing the temperature, both ligand on- and off-rates increase,
making the ligand dissociation and association processes faster. As a result, in HDX experiments,
the divergence is observable at a shorter exchange time where there is no difference between bound
and unbound.
Seven kinetic plots, shown in Figure 6.5, agree well with the expected phenomena, further
consolidating the binding sites assignment.

6.4.4 HDX-MS Reveals Critical Binding Areas of HalA2-LP in HalM2
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Figure 6.6. Homology model of HalM2 based on the structure of CylM generated using ITASSER.53-55 Regions of HalM2 that were observed to interact with HalA2-LP by HDX mass
spectrometry (green), fluorescence polarization (pink), and photocrosslinking mass spectrometry
(blue) are highlighted. Protein structure colored in grey, blue, and pink denotes capping helices,
dehydratase domain, and cyclase domain, respectively.
As mentioned in the introduction, LanMs are bifunctional enzymes that catalyze both dehydration
and cyclization. The high-resolution structure of HalM2, however, has not been resolved. Figure
6.6 presents a structural model of HalM2 based on homology modeling using structure of CylM
as a template.48, 53-55 Similar to other LanMs, three distinct regions can be found in HalM2, namely,
the capping helices, the dehydratase domain, and the cyclization domain. When the HDX-MS
results were mapped onto the structure, we see that region 26-54 is a flexible loop in the capping
helices. Such identification is also supported by a photo crosslinking study and a fluorescence
polarization study (highlighted by blue and pink in Figure 6.6, respectively) done in the van der
Donk’s lab in University of Illinois, Urbana-Champaign.2 Interestingly, the recent HDX-MS study
on the HalM2 and full length HalA2 suggest another binding region that is spatially adjacent to
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the region identified in the current study. Notably, these loops lack electron density in the CylM
crystal structure, suggesting that they are disordered and flexible.47
Two other binding sites were identified based on HDX-MS; they are regions 379-388 and 625627. The latter is supported by photo crosslinking results. Region 625-627 is located close to the
dehydratase-cyclase interface. Because it is spatially distal to the capping helices, it is likely that
leader peptide binding at the capping helices triggers a remote conformational change that brings
both dehydratase and cyclase domains closer to the core peptide for core-peptide processing. The
remote conformational change also brings this region closer to the HalA2-LP, consistent with
photo crosslinking results. When measuring the distance based on the model in Figure 6.6, the two
loops of the capping helices are over 60 Å from the cyclase active site. The recent HDX-MS report
on full-length HalA2 (leader peptide plus core peptide) also suggests that ligand binding triggers
conformational changes in the cyclase domain of HalM2.48 An activity assay between HalM2 and
full length HalA2 also supports this conclusion, as both dehydratase and cyclase domains are
essential for effective core peptide processing.2 We propose the HDX protection in region 625627 is from a remote conformational change rather than binding to HalA2-LP based on steric
relationship between the HalM2 and its full length substrate. If region 625-627 is a secondary
binding site, the substrate would have to disengage from and re-engage with the enzyme when
switching between dehydration and cyclization, a process that is not favored kinetically. Region
379-388 is located in between the capping helices and the cyclase domain and is likely to be part
of the conformational change.

6.5 Conclusion
HDX-MS is a powerful approach to analyze the binding interactions between enzyme HalM2 and
its substrate HalA2-LP. Owing to the weak binding interactions between the two proteins, we
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implemented an approach where HDX is executed under two exchange temperatures to allow high
confidence in the binding-site identification. As a result, HDX at 4 °C and 25 °C together reveal
three potential binding regions on HalM2. Taken together with fluorescence polarization and photo
crosslinking results from our collaborator’s lab, we hypothesize that HalA2-LP binds to the
capping helices of HalM2, and that this binding further triggers a remote conformational change
at the dehydratase and cyclase domain to prepare HalM2 for subsequent core-peptide processing.
Results presented in this chapter complement those in a recent publication, in which HDX-MS was
used to characterize binding interactions between HalM2 and full length HalA2.48
From a broader perspective, LanMs are a class of enzyme with distinct properties in substrate
tolerance, making them great candidates for biotechnological applications. The substrate tolerance
has been explored for variety purposes and demonstrated that LanMs process core peptides with
variations in their primary sequence. To facilitate such tolerance requires relatively conserved
leader peptides for recognition purposes. The results presented in this chapter contribute
significantly to the understanding of molecular aspects of leader-peptide binding to the enzyme.
Such understanding may be applied to future work in developing these enzymes as biocatalysts for
design of libraries of potentially therapeutic molecules.
Through the two studies presented in Chapter 5 and 6, it is clearly demonstrated that HDX-MS in
combination with other biophysical approaches can be productively applied in answering complex
biological questions. As pointed out in Chapter 1.4, the advantages of HDX, as envisioned by early
pioneers, have been realized, and new applications are being implemented, making HDX an
important technology for HOS nearly three decades after its introduction
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Chapter 7: Conclusions and Perspectives
This Chapter is based on the following publication:
Liu, X. R.; Zhang, M. M.; Gross, M. L. Mass Spectrometry-Based Protein Footprinting for HigherOrder Structure Analysis: Fundamentals and Applications Chem. Rev. 2020, 120, 4355-4454.
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MS-based protein HOS analysis has increased the throughput and decreased the sample amount
requirements of protein HOS determination while becoming an effective complement to traditional
biophysical characterization methods. More importantly, availability of several protein
footprinting approaches allows viewing the protein HOS from different perspectives. For example,
HDX measurements usually provide the kinetics of exchange and infer HOS from the “labeling”
of protein backbone amide bonds. Targeted or specific labeling reagents exploit various organic
reactions to report on side-chain solvent accessibilities. Fast labeling reagents react with residue
side chains on the time scale of ns to ms, affording a “snapshot” of protein structure and dynamics.
Taken together, MS-based protein labeling approaches “paint” the protein solvent-accessible
surfaces over a time frame from ns to days to afford a comprehensive understanding of the protein
of interest. Moreover, the use of modern proteomics digestion (bottom-up) workflows, top-down
fragmentation techniques together with ultra-sensitive MS instruments yield not only HOS
information at mid-to-single-residue level but also dynamics of the protein under various
conditions that are not accessible by a single technique. This is important because a footprint
should be done with high coverage, unlike primary structure identification in traditional
proteomics where 100% coverage is not needed. Over the past decades, MS-based structural
proteomics approaches have grown extensively and now can answer important and challenging
biological questions. None of these developments were possible without the impressive technical
innovations in the field of MS that have occurred over the past 50 years.

7.1 LITPOMS for Binding Measurements of Other Systems
Chapters 2 and 3 describe the LITPOMS workflow, which enables MS measurements together
with radical labeling to be used to determine binding affinity. LITPOMS provides most of the key
information about the protein-ligand interactions via a single approach that reveals not only the
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binding sites and binding affinities but also the binding orders, allosteric behavior, and protein
binding dynamics at high spatial resolution.1-4 Obtaining all this information previously required
a combination of several sophisticated methods. LITPOMS should have utility in studying
complex binding systems and signaling proteins, as mentioned in Chapter 3, because it fills the
gap between methods offering no spatial resolution to high-resolution x-ray and NMR structures
and offers mid spatial resolution for ligand-free and ligand-bound states. Such capability enables
enormous potential for LITPOMS in addressing other poorly characterized binding pairs.
Challenges remain, however, as there is not yet a radical species that can react with all 20 amino
acid residues in a single experiment. For example, ●OH reacts with all 20 amino acids, but the
range of reactivity is too large (~ 103) to allow the least reactive residue to compete with the most
reactive in a single experiment and FPOP conditions. Thus, development of novel and
complementary labeling reagents is vital, whereby one footprinter reacts broadly with the residues
with competitive reactivity, and several footprinters can cover all the amino acids in several
experiments, or even in a single experiment utilizing multiple reagents. In that way, all residues
can be involved in binding to report binding-induced SASA changes. Moreover, modeling of
titration data can be challenging, especially for proteins that bind multiple ligands and yield
titration curves whose fitting requires construction of complex mathematical models. These
aspects need further development to afford an easier accessibility for the general MS and
biochemistry communities.

7.2 Visualization of LITPOMS Results
One of the key features that was highlighted in Chapter 3 is that LITPOMS can reveal complex
allosteric behavior and conformational changes of calmodulin during its binding with calcium.1, 2
This ability to probe remote conformational changes and allostery allows regional to single-residue
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level spatial resolution. Although powerful, scientists may find it challenging to visualize the
protein conformation at each stage of binding. This has been a long-standing issue for labelingbased protein footprinting, as it measures changes upon external perturbation through differential
experiments, rather than affording a protein structure through a single-state footprinting
experiment.
To visualize the protein structure with a single footprinting experiment requires proper
quantification of footprinting results and the help of computer-based structure prediction. The
quantification of radical protein footprinting results was demonstrated in a number of studies.5-7 In
2018, Lindert and coworkers8 developed a new Rosetta score term named hrf_ms_labeling that
utilizes residue-level protection factors5 from ●OH footprinting data as constrains to predict protein
structures. This work demonstrates for the first time that incorporating ●OH protein footprinting
data in modeling can greatly enhance model quality in protein structural prediction, elevating the
use of MS-based footprinting from a qualitative description to a quantitative evaluation. Such an
elegant approach can be applied to model the protein structures across different titration stages,
providing a compelling way to visualize the conformational changes of the protein upon binding
with its partner. This combination is particularly useful when characterizing complex binding
pairs, whose binding stoichiometry is greater than 1:1 and usually involve allosteric behavior that
is hard to assess through other approaches.

7.3 Exploring Capabilities of the Degassing Apparatus and
Selective Isotopic Labeling
Chapter 4 describes a custom-made degassing apparatus and its application in highlighting residuespecific oxygen uptake preferences in FPOP platform. The idea of selective isotopic labeling
originates from NMR analysis and is now more commonly seen in the field of mass spectrometry,
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particularly in proteomics and metabolomics. In the case of protein labeling and labeling-related
protein footprinting, isotopic labeling is a good method for investigating the labeling pathway and
the reaction mechanism behind it. Protein oxidation is an important issue in the biopharmaceutical
industry, and deeper understanding of its mechanism will greatly contribute to the development of
drug products.
In a recent extension of this labeling strategy, we collaborated with Eli Lilly and Company to
investigate the oxidative pathway of monoclonal antibody under stressed conditions. Similarly, we
replaced the potential oxygen source with

18

O-enriched material one at a time to highlight the

oxygen uptake pathway for selected “hotspots” on the monoclonal antibody under different
stressed conditions (e.g., heat, ultraviolet exposure, and oxidative environment). Moreover, the
incorporation of 18O labeling enables the identification of post translational modifications whose
abundance are usually low and challenging for MS to detect in general, for example, aspartic acid
isomerization. Aspartic acid isomerization involves eliminating a water molecule, followed by
intermediate hydrolysis with the help of another water molecule. With the help of

18

O labeling,

specifically H218O, when the second water molecule is 18O-labeled, such isomerization process can
be identified with a +2 Da mass shift. The results of this study will be reported elsewhere.

7.4 Developing Novel Workflows for Intrinsic Membrane
Protein Footprinting
Chapter 5 presents an HDX analysis of the partner binding behavior of the membrane protein
tetraspanin. Through a reductionist approach, the characterization utilizes the extracellular
domains rather than the full-length proteins, to resemble partner binding in vivo. Such idea can be
generalized to the study of other intrinsic membrane proteins whose stability is usually poor and
requires special media, thus challenging proper handling of the protein. Although easier in terms
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of experimental processes, however, such a reductionist approach is not always applicable to study
complex membrane protein systems. For example, the experimental design in Chapter 5 cannot
differentiate the differences in binding between the open and closed conformations of the proteins
CD53 and CD81. Attacking these complex biological questions requires model systems that better
resemble the in vivo protein environment and probably involves the use of intrinsic membrane
proteins. These scenarios further challenge the technical evolution of the HDX workflow, as the
post labeling detergent/lipid removal is usually time consuming and will compromise the
deuterium labeling owing to back-exchange. Although these studies demonstrate the capability of
intrinsic membrane protein HDX,9-15 they mainly emphasize the characterization of protein
dynamics. Its capability to report structural changes through differential experiments remains to
be established.
Other than HDX, there are other protein footprinting approaches including protein covalent
labeling by targeted reagents,16,

17

FPOP and other radical-based protein footprinting,18,

19

proximity labeling,20, 21 and native spray22, 23 that can be used for intrinsic membrane protein
characterization. These approaches produce irreversible footprint on the protein, meaning that the
post labeling sample clean-up is no longer limited by the back-exchange in HDX. Together with
HDX, the toolbox of footprinting for membrane protein analysis is growing, and this approach is
expected to address more and more biological questions.

7.5 Applying Two-Temperature HDX for Other Weak
Binding Systems
HDX is a popular tool in characterizing protein-ligand and protein-protein interactions. In the
ligand/protein-bound state, apparent deuterium uptake is a composite of two dynamics, namely,
the intrinsic dynamics of the target protein and the ligand binding dynamics of the binding partner.
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For a tight binding pair with nM-level binding affinity, the effect of the ligand off-rate is not
significant. For binding systems whose binding is not strong, however, the effect of off-rate
becomes more profound. In such cases, the HDX kinetic curves may converge early in the
exchange between bound and unbound states, leading to false negative readout where there is no
longer a difference between bound and unbound. The common solution is to oversaturate the
system with binding partner so that the protein preferentially stays in the ligand-bound state. In
cases where the binding partner is a protein, however, such an approach will overload the LC and
MS systems with many peptides that are of low interest and may compromise the detection of the
target protein. In chapter six, I described an approach that utilizes HDX at two different exchange
temperatures. The lower exchange temperature slows down the ligand binding dynamics, affording
a better chance of capturing any decreases in the binding-induced deuterium uptake. On the other
hand, protein intrinsic dynamics are also slowed down, leading to a lower absolute deuterium
uptake, which decreases the dynamic range of the HDX readout. Higher exchange temperatures
facilitate a higher absolute deuterium uptake, but with the possibility of sacrificing deuterium
uptake differences between the bound and unbound states owing to greater ligand-binding
dynamics. Recording HDX under both temperatures provides an opportunity to crosscheck the
HDX kinetics under different conditions, therefore increasing the confidence in binding site
assignment. Such workflows can be generalized to analyze other binding systems with relatively
low binding affinities (weak binding).

7.6 Concluding Remarks
In the dissertation I addressed both reversible and irreversible labeling approaches for the
understanding of protein HOS. The two approaches have advantages and disadvantages, and
together they constitute a more effective toolkit for MS-based protein footprinting. From a broad
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view, each MS-based labeling approach contributes to understanding protein HOS from a different
perspective, motivating the thoughtful and creative choice of different reagents.4, 19, 24-26 Applying
combinations of different approaches can provide a deeper understanding of the protein and a
higher resolution structure. Recent demonstrations have shown the power of such integrated
strategies.17, 27-36 Broad application of integrated methods, however, remains to be explored.
Platform integration not only expands the protein footprinting approaches but also requires clever
application of the various sample handling and MS techniques. For example, one can couple native
MS and protein footprinting in a preliminary analysis to assist in the study design of protein ligand
interactions by determining mixing ratios that push the binding equilibriums to the product
complex and by exploring the binding regions. Ion mobility MS coupled with protein footprinting
will illuminate protein conformational changes during and after labeling, providing a view of
protein conformational changes induced by chemical labeling. Multiple ion dissociation
techniques coupled with different enzymatic digestions will deliver better sequence coverage, even
to the residue level, which is an important goal in MS-based protein HOS analysis.
Improved reversed-phase chromatography and adoption of other separation strategies (e.g., normal
phase, capillary electrophoresis, asymmetric flow field flow fractionation) may allow separation
of isomeric peptides formed in labeling (e.g., chemically modified peptides that bear the same
modification on multiple residues) or aggregated proteins in different states and their
quantification from extracted ion chromatograms and other approaches. Improved digestion
strategies (e.g., mixed and immobilized enzymes) will also improve spatial resolution. Better
separation will also minimize ion suppression during ionization, separate structural isomers that
have the same m/z, and ultimately improve the precision of quantification and the spatial resolution
of the protein HOS analysis. Enhanced separation capability, possibly even with 2D approaches,
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is particularly important for footprinting complex mixtures of proteins or large proteins that digest
to provide many peptides. Modern protein and peptide separation approaches, including multidimensional LC,37, 38 size exclusion chromatography,39, 40 ion-exchange chromatography,41 have
all been coupled with MS analysis. Although most of the current demonstrations are for primarystructure proteomics and native MS, they will surely be soon adopted for protein HOS analysis.
Upon obtaining the MS data, database searching and spectra identifications by software is also
critical. Over the past decade, we witnessed a burst of MS software for MS/MS identification, de
novo sequencing, HDX, irreversible labeling, chemical cross-linking, native MS, ion mobility MS,
for proteomics, glycomics, lipidomics, and metabolomics. Although these developments largely
contribute to data processing and visualization, they will continue to be important components in
the “engine” of MS-based structural proteomics and ultimately lead to more automated data
processing.
Lastly, to increase the spatial resolution of MS-based protein HOS studies, computer modeling is
also critical. Pioneering efforts demonstrate a promising future in this area. Incorporating
footprinting data into structural predictions in a straightforward way breaks the resolution limit of
MS approaches, making MS-based protein HOS analysis a biophysical method that delivers high
resolution results as does X-ray crystallography, cryo EM, and NMR or that, at least, complements
them, even for protein complexes.42 A simple example is the use of footprinting to recover the
information loss for flexible protein regions in an X-ray crystal structure. Thus, footprinting data
can increase the confidence of protein structural predictions both on its own and in combination
with other approaches.
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To achieve these goals, deeper understanding of footprinting fundamentals is crucial,43 because
only from a solid understanding of fundamentals can we evaluate the data properly, especially for
a single protein state rather than employing a differential experiment. Development of userfriendly software that can take footprinting data as input for structural modeling is also needed.
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